[go: up one dir, main page]

WO2023189281A1 - Information processing apparatus, information processing method, cell culturing system, and program - Google Patents

Information processing apparatus, information processing method, cell culturing system, and program Download PDF

Info

Publication number
WO2023189281A1
WO2023189281A1 PCT/JP2023/008548 JP2023008548W WO2023189281A1 WO 2023189281 A1 WO2023189281 A1 WO 2023189281A1 JP 2023008548 W JP2023008548 W JP 2023008548W WO 2023189281 A1 WO2023189281 A1 WO 2023189281A1
Authority
WO
WIPO (PCT)
Prior art keywords
cell
culture
cells
information processing
processing device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2023/008548
Other languages
French (fr)
Japanese (ja)
Inventor
真寛 松本
健治 山根
和博 中川
憲治 池田
萌絵 坂田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sony Group Corp
Original Assignee
Sony Group Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sony Group Corp filed Critical Sony Group Corp
Publication of WO2023189281A1 publication Critical patent/WO2023189281A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus

Definitions

  • the present technology relates to an information processing device, an information processing method, a cell culture system, and a program. More specifically, the present invention relates to an information processing device, an information processing method, a cell culture system, and a program that can provide an overview of culture conditions for cell groups including different cells.
  • Cell production in regenerative medicine requires culturing the required amount of cells at the desired time.
  • a skilled operator determines the culture conditions and adjusts the culture conditions as necessary by observing the culture state of the cells during culture.
  • automatic culture systems are sometimes used.
  • Cited Document 1 describes a culture support device for culturing cells in a culture tank, and a target, which is a specific growth rate to obtain a target number of cells at a target time, among a plurality of performance data.
  • Set culture conditions which are culture conditions for obtaining the target specific growth rate, are determined based on a neighboring data group, which is a set of actual data similar to the query point, including the specific growth rate and the culture status of the culture tank.
  • a culture support device comprising a calculation device, wherein each of the plurality of performance data is data regarding culture performed in the past, and includes a specific growth rate and a culture status when the specific growth rate was obtained. is disclosed.
  • the main purpose of this technology is to provide a technology that allows a bird's-eye view of the culture conditions of a cell group containing different cells.
  • the present technology includes a control unit that predicts a plurality of culture prediction results for each culture condition of a cell group including different cells, and the control unit is configured to predict a cultured cell composition and cell growth based on the culture prediction results.
  • An information processing device is provided that controls a process to be visualized.
  • the present technology includes a control step of predicting a plurality of culture prediction results for each culture condition of a cell group including different cells, and in the control step, the culture prediction results include the composition of the cultured cells and the growth of the cells. It also provides an information processing method that controls the process to make it visible.
  • the present technology includes a cell culture device having a cell culture section for culturing cell groups containing different cells, and a measurement section for measuring the cell composition of the cell groups, and a cell culture device for each culture condition of the cell groups containing different cells.
  • a control unit that predicts a plurality of culture prediction results, the control unit comprising an information processing device that controls to visualize the cultured cell composition and cell growth process as the culture prediction results;
  • Cell culture systems are also provided.
  • the present technology predicts a plurality of culture prediction results for each culture condition of a cell group containing different cells, and controls to visualize the cultured cell composition and cell growth process as the culture prediction results.
  • a program that causes a computer to execute a process including steps is also provided.
  • FIG. 1 is a schematic diagram showing an example of an embodiment of a cell culture system according to a first embodiment. It is a schematic diagram of a sample holding part.
  • FIG. 2 is a schematic diagram of an immobilized first molecule.
  • FIG. 2 is a schematic diagram showing an example of the configuration of a cell processing container.
  • FIG. 3 is a schematic diagram showing an example of the configuration of an optical control section.
  • 1 is a diagram schematically showing the overall configuration of a microscope system.
  • 1 is a diagram schematically showing the overall configuration of a biological sample analyzer.
  • FIG. 3 is a flow diagram of an information processing method according to a second embodiment. It is a flow diagram of a control process. It is a flow diagram of a processing process.
  • FIG. 12 is a diagram showing an example of culture prediction results different from FIG. 11.
  • FIG. 12 is a diagram showing an example of culture prediction results different from FIGS. 11 and 12.
  • FIG. 13 is a diagram showing an example of culture prediction results different from FIGS. 11 to 13.
  • FIG. 14 is a diagram showing an example of culture prediction results different from FIGS. 11 to 14.
  • FIG. 16 is a diagram showing an example of culture prediction results different from FIGS. 11 to 15.
  • First embodiment (cell culture system 1000 and information processing device 2) (1) Overall configuration (2) Cell culture device 1 (2-1) Cell culture section 10 (2-2) Measuring section 3 (2-2-1) Microscope system 5000 (2-2-2) Biological sample analyzer 6100 (3) Information processing device 2 2. Second embodiment (information processing method) (1) Overall configuration (2) Sample preparation process S100 (3) Information acquisition step S110 regarding cells before treatment (4) Control process S120 (5) Processing step S130 (6) Information acquisition step S140 regarding cells after treatment (7) Learning process
  • First embodiment (cell culture system 1000 and information processing device 2)
  • the cell culture system 1000 includes at least a cell culture device 1 and an information processing device 2. Additionally, other devices and parts may be included as necessary. Note that each device and each part may be stored in the same housing, or may be stored in separate housings and connected via a wired or wireless network. Hereinafter, each device and each part of the cell culture system 1000 will be explained in detail.
  • the cell culture device 1 includes at least a cell culture section 10 for culturing a cell group containing different cells, and a measurement section 3 for measuring the cell composition of the cell group and the cell growth process. In addition, other parts may be included as necessary.
  • cell may be any of human-derived cells, immune cells, animal-derived cells, plant-derived cells, microbial-derived cells, cancer cells, normal cells, stem cells, and epithelial cells.
  • examples of the cells include cells in blood and cells collected from living tissue. Further, the cells may be either adherent cells or non-adherent cells.
  • the number of types of cells contained in the sample may be one or more, and the term "cell” includes cell clusters, such as spheroids, organoids, and the like.
  • FIG. 2 A schematic diagram of the sample holding section 100 of the cell culture section 10 is shown in FIG. 2.
  • a first molecule 104 capable of binding to cells is immobilized on the sample holding part 100 via a degradable linker 103.
  • Degradable linker 103 may be fixed to the bottom of container 101, as shown in FIG.
  • the sample holder 100 may be variable so that its volume increases or decreases.
  • the sample holding unit 100 captures the cells using the first molecules 104 immobilized therein. The captured cells are cultured within the culture container 101.
  • a first molecule 104 is immobilized inside the culture container 101 of the sample holding unit 100 via a polymer 102 and a degradable linker 103, for example.
  • the degradable linker 103 may directly immobilize the first molecule 104 without using the polymer 102.
  • Immobilization is not limited to the bottom surface of the culture vessel 101, but may be on the inner wall, or, if a planar or three-dimensional internal structure exists inside the culture vessel 101, the surface of the structure. may be immobilized.
  • the inner surface of the culture container 101 is preferably coated with a substance suitable for cell survival (eg, collagen, fibroblast, etc.).
  • the polymer 102 is preferably one that does not stress cells or is non-toxic, or one that is biocompatible.
  • polymers include polyethylene glycol (PEG), 2-methacryloyloxyethyl phosphorylcholine polymer (MPC polymer), and the like.
  • a degradable linker 103 may be bonded to the end of the polymer 102 opposite to the bonding portion with the culture vessel 101.
  • the degradable linker 103 is a molecule that is decomposed by a specific external stimulus. Degradable linker 103 connects first molecule 104 to the bottom of the container, with or without polymer 102 .
  • Examples of the degradable linker 103 include a linker that is decomposed by light of a specific wavelength, a linker that is decomposed by an enzyme, a linker that is decomposed by temperature, and the like.
  • the degradable linker is preferably a photodegradable linker because it allows control on a single cell basis and takes a short time to degrade.
  • the photodegradable linker is a molecule having a structure that is decomposed by light of a specific wavelength, and conventionally known linkers can be used. Furthermore, the wavelength at which the photodegradable linker is decomposed almost coincides with the absorption wavelength of the molecule. For example, when the photodegradable linker contains a methoxynotrobenzyl group, assuming that the absorption at 346 nm is 1, it exhibits an absorption of 0.89 at 364 nm, 0.15 at 406 nm, and 0.007 at 487 nm.
  • the wavelength of the light irradiated to the photodegradable linker may be any wavelength that corresponds to each photodegradable linker.
  • the wavelength is around 330 to 450 nm.
  • the first molecule 104 has a site capable of binding to cells.
  • site capable of binding to cells for example, oleyl groups, cholesteryl groups, antibodies, aptamers, molecular recognition polymers, etc. can be used.
  • the oleyl group and cholesteryl group are hydrophobic and adhere to the surface of floating cells.
  • the first molecule 104 may be formed by adding a spacer such as PEG to the oleyl group and including an NHS group (N-hydroxysuccinimide group) at the end thereof.
  • the antibody binds to a cell surface molecule antigen present on the cell.
  • the antibodies include antibodies against cancer-specific antigens, antibodies against major histocompatibility antigens, and antibodies against sugar chains.
  • the aptamer is a nucleic acid molecule or peptide that specifically binds to molecules possessed by cells.
  • Examples of the aptamer include DNA aptamers, RNA aptamers, peptide aptamers, and modified aptamers in which specificity is improved by introducing modifications into the nucleic acid backbone or base.
  • the molecular recognition polymer captures target cell surface molecules with high selectivity even in the presence of compounds with physicochemical properties similar to cell surface molecules.
  • the molecular recognition polymer is also called a molecular imprint polymer and has a selectively synthesized compound recognition region.
  • FIG. 3 shows a schematic example of the state in which the first molecule 104 is immobilized within the culture container 101.
  • a first molecule 104 is immobilized on the bottom surface of the culture container 101 via a polymer 102 and a degradable linker 103.
  • the first molecule 104 is directly bonded to the degradable linker 103, but it may also be bonded to the degradable linker 103 via a polymer.
  • the first molecule 104 is preferably immobilized so that one cell is bound to each spot.
  • cells having molecules eg, antibodies, sugar chains, etc.
  • sorting can also be performed for all spots.
  • the first molecules 104 are preferably immobilized in an array within the culture container 101.
  • a method of spotting the first molecules 104 in an array a microcontact printing method, a spotting method, or a method of disassembling unnecessary portions after placing them on the entire surface using the characteristics of the photodegradable linker is used. good.
  • the PEG or the MPC polymer may be coated or bonded to the part of the culture vessel 101, thereby suppressing non-specific adsorption of cells. After releasing unnecessary cells by irradiating the photodegradable polymer with light, it is preferable that PEG or MPC polymer remain so as to prevent non-specific adsorption of cells to the released spots.
  • the first molecule 104 to be spotted may be one type, and for example, the first molecule 104 configured to specifically capture only one type of cell may be employed.
  • first molecules 104 having different specificities may be immobilized for each spot, and different cells may be captured for each spot.
  • the inside of the culture container 101 may be divided into sections, and the first molecules 104 having different specificities may be immobilized in each section, thereby making it possible to capture different cells in each section in the same container. can.
  • the first molecule 104 that captures all types of cells may be immobilized, and in this case, cells may be sorted using a labeled second molecule, which will be described later. Multicolor analysis becomes possible by using multiple types of labeled second molecules.
  • the culture container 101 may be configured so that its volume can be changed. It is preferable that the variable part of the culture container 101 be formed of a flexible material, and it is preferable that the culture container 101 can be expanded and contracted vertically and/or horizontally.
  • the volume can be changed by adjusting the amount of liquid or the amount of air introduced from the connecting part 105 provided in the culture container 101. Additionally, the flow rate of the liquid or air supplied into the culture container 101 is controlled so as to change the volume of the liquid (for example, culture medium, buffer solution, staining buffer, etc.) in the culture container 101 without changing the volume. may be implemented. Thereby, reactions and the like can be performed on the cells in the culture container 101 at an optimal concentration.
  • the volume of the culture container 101 or the volume of the medium is reduced. This is because when the volume or medium volume is small, the probability of contact between the cells and the first molecules 104 increases. Further, after culturing the cells captured by the first molecules 104, if the cell density becomes high, it is preferable to increase the volume of the culture container 101 or the volume of the medium. Increasing the volume or medium volume increases the cell culture space. Further culture medium can be added by increasing the volume.
  • the culture container 101 preferably has gas permeability. This makes it possible to create an environment in the container suitable for cell culture (e.g., optimal CO 2 concentration, optimal temperature, etc.) when, for example, oxygen supply and/or carbon dioxide evacuation are required in cell culture. I can do it.
  • the surface on which cells proliferate is preferably formed of, for example, a porous membrane or an oxygen permeable membrane.
  • the culture container 101 may be connected to a sample containing the cells or a container containing the culture solution by a connecting portion 105.
  • a cell input section 106, a second molecule supply section 107, an activating agent supply section 108, a gene supply section 109, a culture solution supply section 110, a washing solution supply section 111, a waste liquid storage section 112, and the cell collection unit 113, or a plurality of them may be connected to the culture container 101.
  • the whole of these may be installed under conditions suitable for cell culture, or only the culture container 101 may be installed under conditions suitable for cell culture.
  • the cell input unit 106 holds a sample (particularly a liquid sample) containing cells, and inputs the sample into the culture container 101.
  • the second molecule supply unit 107 holds the second molecule therein and is configured to feed the second molecule into the culture container 101. If multiple types of second molecules are required, the number of second molecule supply units 107 may be increased according to the number.
  • the second molecule may be a molecule capable of binding to cells.
  • the second molecule may be labeled with a fluorescent substance or the like.
  • the first molecule 104 and the second molecule form a structure (for example, a sandwich structure) in which a cell is sandwiched, and the formation of the structure can be recognized by the label.
  • the second molecule, like the first molecule 104 may be selected from the group consisting of, for example, oleyl groups, antibodies, aptamers, and molecular recognition polymers.
  • the second molecule may be a molecule that specifically binds only to desired cells among the cells captured by the first molecule 104.
  • the label of the second molecule may be one type of fluorescent substance or multiple types of fluorescent substances.
  • one type of cell may be recognized using one type of fluorescent substance.
  • multiple types of cells may be recognized using multiple types of fluorescent substances, and a technique such as so-called multicolor analysis may be used.
  • Cells that cannot be recognized by the second molecule apply stimulation to the degradable linker 103 at the spot where the cell is captured, and the stimulation cleaves the degradable linker 103, releasing the cell. Free cells can be washed away from the culture container 101 with a washing solution as unnecessary substances. Based on pseudo-stained images for each cell feature identified from information learned from bright field images, phase contrast images, polarized images, unstained images, and fluorescent images without using a second molecule.
  • Cells may be identified and released by light stimulation.
  • the identification may be performed by the information processing device 2 described later.
  • the information processing device 2 can drive the optical control unit 210 based on the result of the identification to apply the optical stimulation.
  • a second molecule is not required, which can contribute to reducing process costs. Also, since the dyeing process can be omitted, it contributes to shortening the process.
  • the cleaning liquid supply unit 111 holds the cleaning liquid.
  • a cleaning liquid is supplied when cleaning unnecessary materials etc. in the culture container 101.
  • the washing liquid may be one commonly used for cell culture and the like. Examples of the washing solution include, but are not limited to, physiological saline, Tris buffer, HEPES buffer, purified water, and the like.
  • the activating agent supply unit 108 holds an activating agent for activating cells, particularly a liquid containing the activating agent.
  • the activating agent supply unit 108 may be configured to supply an activating agent into the culture container 101.
  • the activator may be selected depending on the cell and includes, but is not particularly limited to, cytokines, hormones, interleukins, antibodies, and the like.
  • the activating agent can activate the cells before, during, or after culturing the cells.
  • the gene supply unit 109 holds genes that are desired to be introduced into cells.
  • the gene supply unit 109 may be configured to supply the gene into the culture container 101.
  • the gene may be an endogenous gene or a foreign gene.
  • the gene may be incorporated into a phage vector, plasmid vector, viral vector, or the like suitable for gene introduction.
  • the gene supply unit 109 can supply a virus vector incorporating a target gene to the culture container 101. Thereby, cells can be infected with the virus vector to introduce genes.
  • the gene supply unit 109 may supply a genome editing reagent containing a specific base sequence and a specific enzyme, such as the CRISPR/Cas9 system, to the culture container 101, thereby introducing the gene into the cells. Good too.
  • the culture solution supply unit 110 holds a culture solution suitable for cells and supplies the culture solution to the culture container 101.
  • a culture medium suitable for the cells can be selected; for example, Eagle's medium, D-MEM medium, E-MEM medium, RPMI-1640 medium, Dulbecco's PBS medium, etc. can be used. Note that if the culture solution is colored with phenol red or the like, the optimum pH range of the culture solution (for example, pH 6.8 to 7.2) can be controlled while the cells are being cultured in the culture container 101.
  • the waste liquid storage section 112 temporarily receives the waste liquid, culture liquid, etc. containing the above-mentioned unnecessary substances.
  • the waste liquid is subjected to sterilization treatment, etc., as necessary, and then discarded.
  • the cell collection unit 113 collects and retains the cells cultured in the culture container 101.
  • the recovery method is not particularly limited, but can be performed by suction, extrusion, placing the cell recovery unit 113 below the culture container 101, or the like.
  • the physicochemical environment supply unit 114 maintains or provides the physicochemical environment of the sample holding unit 100.
  • the physicochemical environment during culture can be appropriately selected depending on the cells, and examples thereof include, but are not limited to, humidity, pH, osmotic pressure, oxygen partial pressure, carbon dioxide partial pressure, and the like. This provides cells with an optimal physicochemical environment and increases cell survival rate.
  • the connecting part 105 connects the culture container 101 and any one or more of the above-mentioned parts 106 to 114, through which the liquid flows.
  • a tube is used for the connecting portion 105.
  • a peristaltic pump or the like that does not come in contact with liquid is preferable.
  • the cell culture section 10 may further include a cell culture section control section 200, and the cell culture section control section 200 includes, for example, an optical control section 210 and an environment control section.
  • the cell culture section control section 200 performs physicochemical control on the cells included in the sample holding section 100 and/or the environment around the cells.
  • the optical control unit 210 may apply stimulation by irradiating the degradable linker 103 with light of a specific wavelength through optical control.
  • the optical control unit 210 may include, for example, a light source and a MEMS (Micro Electro Mechanical Systems) element for causing the light emitted from the light source to reach a predetermined position (a predetermined position in the container 101).
  • the MEMS device may be, for example, a DMD or a scanning mirror.
  • the optical control unit 210 may further include an optical element (for example, a lens, a filter, a mirror, a prism, etc.) for controlling the shape and/or wavelength of the light.
  • the environment control unit may maintain or provide a physicochemical or physiological environment around the cells contained in the sample holding unit 100 through physicochemical or physiological control.
  • FIG. 5 shows an example of the configuration of the optical control section 210.
  • the optical control unit 210 shown in FIG. 5 includes a light source 211, a focusing lens 212, an excitation filter 213, a digital mirror device 214, and a projection lens 215 in order to irradiate the light of the specific wavelength.
  • the light source 211 emits light of a wavelength corresponding to the degradable linker 103.
  • a focusing lens 212 focuses the light, and an excitation filter 213 extracts and transmits only light of a specific wavelength.
  • the digital mirror device 214 is composed of movable micromirrors, and by tilting each micromirror, it is possible to selectively irradiate each spot on which the first molecules 104 are immobilized.
  • the projection lens 215 irradiates the light reflected by the digital mirror device 214 toward the surface of the culture container 101 where the spot where the first molecule 104 is immobilized is located.
  • the optical control unit 210 By selective light irradiation by the optical control unit 210, the degradable linker 103 in the spot where the cells to be released are captured can be selectively decomposed.
  • the optical control unit 210 may further include a stimulation control unit that makes it possible to stimulate the degradable linker 103 for each of the first spots.
  • a stimulation control unit that makes it possible to stimulate the degradable linker 103 for each of the first spots.
  • the optical control unit 210 is a light irradiation device, it is sufficient to individually irradiate cells arranged in the culture container 101 at intervals of several tens of ⁇ m, for example, a digital micromirror device (DMD), a liquid crystal panel, MEMS shutters etc. can be used. It is possible to support multicolor analysis by disposing an excitation filter 213 between the light source 211 and the DMD 214, and adding a mechanism for rotating the filter so as to obtain an optimal filter configuration depending on the purpose.
  • DMD digital micromirror device
  • the stimulation control section of a light irradiation device using this can simultaneously control (turn ON/OFF irradiation on) 1920 ⁇ 1080 sites. Therefore, individual control of approximately 2 ⁇ 10 6 cells is possible at the same time. For example, when cells (ie, ⁇ 30 um or less) are arranged at a pitch of 30 ⁇ m at 1920 ⁇ 1080 sites, an area of approximately 58 ⁇ 33 mm is required. If you want to treat 107 cells, prepare 10 sides of this. When five sides are arranged in two rows, the size is 116 x 165 mm, which is one size smaller than B6 size, and is a size that can be realized for analysis of 2 x 10 7 cells.
  • the environment control unit controls the physicochemical environment and/or physiological environment within the container 101.
  • the environment control section controls the physicochemical environment supply section 114, thereby controlling the humidity, pH, osmotic pressure, oxygen partial pressure, or carbon dioxide inside the container 101. Partial pressure, etc. can be controlled. This provides an optimal physicochemical environment for the cells in the culture environment and increases the survival rate of the cells.
  • the environment control section can control at least one selected from the group consisting of the activator supply section 108, the gene supply section 109, and the culture solution supply section 110. . This provides an optimal physiological environment for the cells in the culture environment and improves the efficiency of cell culture. Control of the physiological environment may include control by at least one of culture medium, stimulation factors, transcription factors, and cell density.
  • the cell culture system 1000 includes a measurement unit 3 that acquires at least one selected from the group consisting of information regarding cells before treatment, information regarding cells after treatment, and information regarding cells during treatment.
  • the measurement unit 3 includes an image acquisition unit 600 that acquires information regarding cells being processed by the cell culture unit control unit 200 by acquiring images.
  • the image acquired by the image acquisition unit 600 may be a stained image and/or a non-stained image.
  • the stained image may include a fluorescent image.
  • the unstained image is at least one of a bright field image, a phase contrast image, a polarized light image, and an image that is identified from information learned from the unstained image and the fluorescent image and pseudostained for each cell feature. may include.
  • the measurement section 3 includes a signal detection section that acquires information regarding the cells being processed by the cell culture section 10 by acquiring signals. Good too.
  • the image acquisition unit 600 may be configured as a microscope system 5000 described below (2-2-1).
  • the measuring section 3 may be configured as a biological sample analyzer 6100.
  • the biological sample analysis device 6100 will be explained in “(2-2-2) Biological sample analysis device 6100”.
  • the measurement unit 3 can analyze the proliferation state of the cells from the information regarding the size of the cell mass and the number of cells acquired by the measurement unit 3. For example, in the case of T cells, cell clusters may be created during cell proliferation. By measuring the area of the cell cluster, it is possible to predict the number of cells, and by measuring the number of clusters, it is possible to predict the total number of cells in the container. By acquiring measurement values regarding the mass in time series, the proliferation state of the cells can be confirmed.
  • a microscope system 5000 shown in FIG. 6 includes a microscope device 5100, a control section 5110, and an information processing section 5120.
  • the microscope device 5100 includes a light irradiation section 5101, an optical section 5102, and a signal acquisition section 5103.
  • the microscope device 5100 may further include a sample mounting section 5104 on which a biological sample S1 such as a cell is placed. Note that the configuration of the microscope system 5000 is not limited to that shown in FIG. may be used as the light irradiation unit 5101.
  • the light irradiation unit 5101 may be arranged so that the sample mounting unit 5104 is sandwiched between the light irradiation unit 5101 and the optical unit 5102, and may be arranged, for example, on the side where the optical unit 5102 is present.
  • the microscope device 5100 may be configured with one or more selected from the group consisting of bright field observation, phase contrast observation, differential interference observation, polarized light observation, fluorescence observation, and dark field observation.
  • the microscope system 5000 may be configured as a so-called WSI (Whole Slide Imaging) system or a digital pathology system, and may be used mainly for pathological diagnosis.
  • the microscope system 5000 may also be configured as a fluorescence imaging system, particularly a multiplex fluorescence imaging system.
  • the microscope system 5000 may be used to perform intraoperative pathological diagnosis or remote pathological diagnosis.
  • the microscope device 5100 acquires data of the biological sample S1 obtained from the patient undergoing the surgery, and transmits the data to the information processing unit 5120. I can do it.
  • the microscope device 5100 can transmit the data of the acquired biological sample S1 to the information processing unit 5120 located in a location apart from the microscope device 5100 (for example, in another room or building). .
  • the information processing unit 5120 receives and outputs the data. Based on the output data, the user of the information processing unit 5120 can perform a pathological diagnosis.
  • the biological sample S1 may be a sample containing biological components.
  • the biological component may be a biological tissue, a cell, a biological liquid component (eg, blood, urine, etc.), a culture, or a living cell (eg, a cardiac muscle cell, a nerve cell, a fertilized egg, etc.).
  • the biological sample S1 may be a solid substance, and may be a specimen fixed with a fixing reagent such as paraffin or a solid substance formed by freezing.
  • the biological sample S1 may be a section of the solid object.
  • a specific example of the biological sample S1 is a section of a biopsy sample.
  • the biological sample S1 may be subjected to treatments such as staining or labeling.
  • the treatment may be staining to show the form of the biological component or to show the substances (for example, surface antigens, etc.) that the biological component has, such as HE (Hematoxylin-Eosin) staining and immunohistochemistry staining. etc. can be mentioned.
  • the biological sample S1 may be subjected to the above-mentioned treatment using one or more reagents, and the reagents may be fluorescent dyes, coloring reagents, fluorescent proteins, fluorescently labeled antibodies, or the like.
  • the specimen may be prepared from a specimen or tissue sample collected from a human body for the purpose of pathological diagnosis or clinical examination. Further, the specimen is not limited to the human body, but may be derived from animals, plants, or other materials.
  • the specimen includes the type of tissue used (e.g., organ, cell, etc.), the type of disease targeted, the attributes of the subject (e.g., age, sex, blood type, race, etc.), and the lifestyle habits of the subject. (For example, eating habits, exercise habits, smoking habits, etc.)
  • the specimens may be managed by being assigned identification information (for example, various barcode information, etc.) that allows each specimen to be identified.
  • the light irradiation unit 5101 includes a light source for illuminating the biological sample S1 and an optical unit that guides the light irradiated from the light source to the sample.
  • the light source can irradiate the biological sample with visible light, ultraviolet light, or infrared light, or a combination thereof.
  • the light source may be one or more selected from the group consisting of a halogen lamp, a laser light source, an LED lamp, a mercury lamp, and a xenon lamp.
  • a plurality of types and/or wavelengths of light sources may be used in fluorescence observation, and may be appropriately selected by those skilled in the art.
  • the light irradiation unit 5101 can have a configuration of a transmission type, a reflection type, or an epi-illumination type (a coaxial epi-illumination type or a side-emission type).
  • the optical section 5102 is configured to guide light from the biological sample S1 to the signal acquisition section 5103.
  • the optical unit 5102 may be configured to enable the microscope device 5100 to observe or image the biological sample S1.
  • Optical section 5102 can include an objective lens.
  • the type of objective lens may be appropriately selected by those skilled in the art depending on the observation method.
  • the optical section 5102 may include a relay lens for relaying the image magnified by the objective lens to the signal acquisition section 5103.
  • the optical unit 5102 may further include optical components other than the objective lens and the relay lens, such as an eyepiece, a phase plate, and a condenser lens.
  • the optical section 5102 may further include a wavelength separation section configured to separate light having a predetermined wavelength from among the light from the biological sample S1.
  • the wavelength separation section may be configured to selectively allow light of a predetermined wavelength or wavelength range to reach the signal acquisition section.
  • the wavelength separation section may include, for example, one or more selected from the group consisting of a filter that selectively transmits light, a polarizing plate, a prism (Wollaston prism), and a diffraction grating.
  • the optical components included in the wavelength separation unit may be placed on the optical path from the objective lens to the signal acquisition unit 5103, for example.
  • the wavelength separation section is provided in the microscope apparatus 5100 when fluorescence observation is performed, particularly when the excitation light irradiation section is included.
  • the wavelength separation unit may be configured to separate fluorescent light from each other or white light and fluorescent light.
  • the signal acquisition unit 5103 may be configured to receive light from the biological sample S1 and convert the light into an electrical signal, particularly a digital electrical signal.
  • the signal acquisition unit 5103 may be configured to be able to acquire data regarding the biological sample S1 based on the electrical signal.
  • the signal acquisition unit 5103 may be configured to be able to acquire data of an image (image, in particular, a still image, a time-lapse image, a moving image) of the biological sample S1, and in particular, an image of the biological sample S1 magnified by the optical unit.
  • the image data may be configured to obtain image data.
  • the signal acquisition unit 5103 includes one or more image sensors, CMOS, CCD, etc., each having a plurality of pixels arranged one-dimensionally or two-dimensionally.
  • the signal acquisition unit 5103 may include an image sensor for obtaining a low-resolution image and an image sensor for obtaining a high-resolution image, or an image sensor for sensing for AF etc. and an image sensor for outputting images for observation etc. It may also include an element.
  • the image sensor includes a signal processing unit (including one, two, or three of a CPU, a DSP, and a memory) that performs signal processing using pixel signals from each pixel;
  • the signal processing sensor may also include an output control section that controls output of image data generated from pixel signals and processed data generated by a signal processing section.
  • the image sensor may include an asynchronous event detection sensor that detects as an event that a change in brightness of a pixel that photoelectrically converts incident light exceeds a predetermined threshold.
  • the image sensor including the plurality of pixels, the signal processing section, and the output control section may preferably be configured as a one-chip semiconductor device.
  • the control unit 5110 controls imaging by the microscope device 5100.
  • the control unit 5110 can adjust the positional relationship between the optical unit 5102 and the sample platform 5104 by driving the movement of the optical unit 5102 and/or the sample platform 5104 for imaging control.
  • the control unit 5110 can move the optical unit 5102 and/or the sample mounting unit 5104 in a direction toward or away from each other (for example, in the direction of the optical axis of the objective lens). Further, the control unit 5110 may move the optical unit 5102 and/or the sample mounting unit 5104 in any direction in a plane perpendicular to the optical axis direction.
  • the control unit 5110 may control the light irradiation unit 5101 and/or the signal acquisition unit 5103 for imaging control.
  • the sample mounting section 5104 may be configured such that the position of the biological sample S1 on the sample mounting section 5104 can be fixed, and may be a so-called stage.
  • the sample placement unit 5104 may be configured to be able to move the position of the biological sample S1 in the optical axis direction of the objective lens and/or in a direction perpendicular to the optical axis direction.
  • the information processing unit 5120 can acquire data (for example, imaging data, etc.) acquired by the microscope device 5100 from the microscope device 5100.
  • the information processing unit 5120 can perform image processing on imaging data.
  • the image processing may include color separation processing.
  • the color separation process is a process of extracting data of a light component of a predetermined wavelength or wavelength range from imaging data to generate image data, or removing data of a light component of a predetermined wavelength or wavelength range from the imaging data. This may include processing, etc.
  • the image processing may include autofluorescence separation processing that separates the autofluorescence component and dye component of the tissue section, and fluorescence separation processing that separates the wavelengths of dyes that have different fluorescence wavelengths from each other.
  • an autofluorescence signal extracted from one of the plurality of samples that are the same or have similar properties may be used to remove an autofluorescence component from image information of the other sample. .
  • the information processing unit 5120 may transmit data for controlling imaging to the control unit 5110, and the control unit 5110 that has received the data may control imaging by the microscope device 5100 in accordance with the data.
  • the information processing unit 5120 may be configured as an information processing unit such as a general-purpose computer, and may include a CPU, RAM, and ROM.
  • the information processing unit 5120 may be included within the casing of the microscope device 5100, or may be located outside the casing.
  • various processes or functions by the information processing unit may be realized by a server computer or cloud connected via a network.
  • the image acquired by the signal acquisition unit 5103 may be a stained image and/or a non-stained image.
  • the signal acquisition unit 5103 may acquire information regarding cells before processing, during processing, and after processing as feature amounts from the image. Specific examples of information regarding the cells will be described later.
  • the stained image is, for example, a fluorescent image obtained by the light irradiation unit 5101 irradiating excitation light onto the biological sample S1 stained with a fluorescent reagent.
  • a fluorescent image obtained by the light irradiation unit 5101 irradiating excitation light onto the biological sample S1 stained with a fluorescent reagent.
  • the unstained image may be a bright field image, a phase contrast image, or a polarized image obtained from the unstained biological sample S1.
  • the non-stained image may be an image that is identified from information learned from the non-stained image and the fluorescent image and pseudo-stained for each cell feature.
  • the pseudo-stained images allow prediction of various labels such as nucleus, cell type (e.g. nerve), cell state (e.g.
  • the information processing unit 6103 includes an information processing unit 6103 that processes information regarding the emitted light.
  • Specific examples of the biological sample analyzer 6100 include a flow cytometer and an imaging cytometer.
  • the biological sample analyzer 6100 may include a sorting section 6104 that sorts out specific biological particles P in the biological sample S2.
  • a specific example of the biological sample analyzer 6100 including the sorting section 6104 is a cell sorter.
  • the biological sample S2 may be a liquid sample containing biological particles P.
  • the biological particles P are, for example, cells or non-cellular biological particles.
  • the cells may be living cells, and more specific examples include blood cells such as red blood cells and white blood cells, and reproductive cells such as sperm and fertilized eggs. Further, the cells may be directly collected from a specimen such as whole blood, or may be cultured cells obtained after culturing. Examples of the non-cellular biological particles include extracellular vesicles, particularly exosomes, microvesicles, and the like.
  • the biological particles P may be labeled with one or more labeling substances (for example, a dye (particularly a fluorescent dye), a fluorescent dye-labeled antibody, etc.). Note that the biological sample analyzer 6100 according to this embodiment may analyze particles other than the biological particles P, and beads or the like may be analyzed for calibration or the like.
  • the flow path C may be configured to allow the biological sample S2 to flow, in particular, to form a flow in which biological particles contained in the biological sample S2 are substantially aligned.
  • the channel structure including the channel C may be designed to form a laminar flow, and in particular, a laminar flow is formed in which the flow of the biological sample S2 (sample flow) is surrounded by the flow of the sheath liquid. Designed to be.
  • the design of the channel structure may be appropriately selected by those skilled in the art, and a known design may be adopted.
  • the flow channel C may be formed in a flow channel structure such as a microchip (a chip having a flow channel on the order of micrometers) or a flow cell.
  • the width of the channel C may be 1 mm or less, particularly 10 ⁇ m or more and 1 mm or less.
  • the channel C and/or the channel structure including the channel C may be formed from a material such as plastic or glass.
  • the biological sample analyzer 6100 is configured such that the biological sample S2 flowing in the flow path C, in particular, the biological particles P in the biological sample S2, is irradiated with the light from the light irradiation unit 6101. may be configured.
  • the biological sample analyzer 6100 may be configured such that the interrogation point of the light on the biological sample S2 is in the channel structure in which the channel C is formed, or the interrogation point of the light may be configured to be located outside the channel structure.
  • the former include a configuration in which the light is irradiated onto a channel C within a microchip or a flow cell.
  • the biological particles P may be irradiated with the light after exiting from the flow path structure (particularly, the nozzle portion thereof), and for example, a jet-in-air type flow cytometer can be mentioned.
  • the light irradiation unit 6101 includes a light source unit that emits light, and a light guide optical system that guides the light to the flow path C.
  • the light source section includes one or more light sources.
  • the type of light source may be, for example, a laser light source or an LED.
  • the wavelength of light emitted from each light source may be any wavelength of ultraviolet light, visible light, or infrared light.
  • the light guide optical system includes, for example, optical components such as a beam splitter group, a mirror group, or an optical fiber. Further, the light guiding optical system may include a lens group for condensing light, and may include, for example, an objective lens.
  • the number of light irradiation points on the biological sample S2 may be one or more.
  • the light irradiation unit 6101 may be configured to collect light irradiated from one or a plurality of different light sources onto one irradiation point.
  • the detection unit 6102 includes at least one photodetector that detects light generated by the light irradiation of the biological particles P by the light irradiation unit 6101.
  • the light to be detected is, for example, fluorescence or scattered light (for example, any one or more selected from the group consisting of forward scattered light, back scattered light, and side scattered light).
  • Each photodetector includes one or more light receiving elements, and has, for example, a light receiving element array.
  • Each photodetector may include one or more photomultiplier tubes (PMTs) and/or photodiodes such as APDs and MPPCs as light receiving elements.
  • PMTs photomultiplier tubes
  • the photodetector includes, for example, a PMT array in which a plurality of PMTs are arranged in one dimension.
  • the detection unit 6102 may include, for example, an image sensor such as a CCD or a CMOS.
  • the detection unit can acquire images of biological particles (for example, bright field images, dark field images, fluorescence images, etc.) using the imaging device.
  • the detection unit 6102 includes a detection optical system that causes light of a predetermined detection wavelength to reach a corresponding photodetector.
  • the detection optical system includes a spectroscopic section such as a prism or a diffraction grating, or a wavelength separation section such as a dichroic mirror or an optical filter.
  • the detection optical system may be configured, for example, to separate light from the biological particles P, and to detect light in different wavelength ranges by a plurality of photodetectors, the number of which is greater than the number of fluorescent dyes.
  • a flow cytometer including such a detection optical system is called a spectral flow cytometer.
  • the detection optical system may be configured, for example, to separate light corresponding to the fluorescence wavelength range of the fluorescent dye from the light from the biological particle P, and to cause the corresponding photodetector to detect the separated light. good.
  • the detection unit 6102 may include a signal processing unit that converts the electrical signal obtained by the photodetector into a digital signal.
  • the signal processing section may include an A/D converter as a device that performs the conversion.
  • a digital signal obtained by conversion by the signal processing section can be transmitted to the information processing section.
  • the digital signal can be handled as data related to light (hereinafter also referred to as "optical data") by the information processing section.
  • the optical data may include, for example, fluorescence data. More specifically, the light data may be light intensity data, and the light intensity may be light intensity data of light including fluorescence (for example, may include feature quantities such as Area, Height, and Width). It's good.
  • the information processing unit 6103 includes, for example, a processing unit that processes various data (for example, optical data) and a storage unit that stores various data.
  • the processing section acquires light data corresponding to a fluorescent dye from the detection section, the processing section can perform fluorescence leakage correction (compensation processing) on the light intensity data. Further, in the case of a spectral flow cytometer, the processing unit performs fluorescence separation processing on the optical data and obtains light intensity data corresponding to the fluorescent dye.
  • the fluorescence separation process may be performed, for example, according to the unmixing method described in JP-A No. 2011-232259.
  • the processing unit may acquire morphological information of the biological particles based on the image acquired by the imaging device.
  • the storage unit may be configured to store the acquired optical data.
  • the storage unit may further be configured to store spectral reference data used in the unmixing process.
  • the information processing section 6103 can determine whether or not to sort out the biological particles P based on the optical data and/or the morphological information. Then, the information processing unit 6103 controls the sorting unit 6104 based on the result of the determination, so that the sorting unit 6104 can sort out the biological particles P.
  • the information processing unit 6103 may be configured to be able to output various data (for example, optical data, images, etc.). For example, the information processing unit 6103 can output various data (eg, two-dimensional plot, spectral plot, etc.) generated based on the optical data. Further, the information processing unit 6103 may be configured to be able to accept input of various data, for example, accept gating processing on a plot by a user.
  • the information processing unit 6103 can include an output unit and/or a user interface for executing the output or input.
  • the information processing unit 6103 may be configured as a general-purpose computer, and may be configured as an information processing unit 6103 that includes a CPU, RAM, and ROM, for example.
  • the information processing unit 6103 may be included in the casing in which the light irradiation unit 6101 and the detection unit 6102 are provided, or may be located outside the casing. Further, various processes or functions by the information processing unit 6103 may be realized by a server computer or cloud connected via a network.
  • the sorting unit 6104 can perform sorting of the biological particles P, for example, according to the determination result by the information processing unit 6103.
  • the separation method may be a method in which droplets containing biological particles P are generated by vibration, an electric charge is applied to the droplets to be separated, and the traveling direction of the droplets is controlled by electrodes.
  • the fractionation method may be a method in which the traveling direction of the biological particles P is controlled within the flow path structure and the fractionation is performed.
  • the flow path structure is provided with a control mechanism using, for example, pressure (injection or suction) or electric charge.
  • the flow path C has a flow path structure in which the flow path C branches into a recovery flow path and a waste fluid flow path downstream thereof, and specific biological particles are directed to the recovery flow path.
  • Examples include chips that are collected (for example, the chip described in Japanese Patent Application Laid-open No. 2020-76736).
  • the information processing device 2 has at least a control section 300, as shown in FIG. Further, it may include an input section 301, a storage section 302, an output section 303, a display section 304, a learning section 400, a database 500, etc., as necessary. Note that each part of the information processing device 2 may be connected via a network. In addition, there may be a plurality of these parts, and they may be provided externally, such as in a cloud, and connected via a network.
  • the information processing device 2 may be configured as a general-purpose computer, and may be configured as an information processing section including a CPU, RAM, and ROM, for example.
  • the information processing device 2 may be included in the housing in which the cell culture section 10 and the measurement section 3 are provided, or may be located outside the housing. Further, various processes or functions performed by the information processing device 2 may be realized by a server computer or cloud connected via a network. Each part of the information processing device 2 will be described in detail below.
  • Control unit 300 The control unit 300 predicts a plurality of culture prediction results for each culture condition of a cell group including different cells, and performs control to visualize information regarding the cultured cell composition and cell proliferation process as the culture prediction results. . This makes it possible to see a bird's-eye view of the culture prediction results for each culture condition, and allows the user to select from multiple culture condition options and link the predictions for reaching the desired cell group with the culture conditions to increase efficiency. It can be done in a specific manner. The specific process performed by the control unit 300 will be explained in "(4) Control step S120" described later.
  • the input unit 301 allows a user or the like to operate the visualized culture prediction results. This allows, for example, to select the culture conditions to be performed.
  • the control unit 300 can control the culture conditions based on the culture conditions selected by the input unit 301.
  • the user etc. access each part of the cell culture device 1 and the information processing device 2 via the input unit 301 and operate these parts.
  • the installation location and number of input units 301 are not particularly limited, and they may be installed on the side of the casing that includes the control unit 300, on the side of the cell culture device 1 described above, or on both sides. It may be installed.
  • the input unit 301 for example, one or more buttons, a mouse, a keyboard, a touch panel, a mobile information terminal, etc. can be used. Furthermore, the input unit 301 is not an essential component of the information processing device 2, and may be installed outside the cloud or the like and connected to the control unit 300 via a network, or may use an external storage device.
  • the storage unit 302 can store all matters in the cell culture system 1000 according to the present technology.
  • an external storage device or the like may be used to store all matters related to the cell culture system 1000 according to the present technology.
  • the installation location and number of storage units 302 are not particularly limited, and they may be installed on the side of the casing that includes the control unit 300 described above.
  • the storage unit 302 is not an essential component of the information processing device 2, and may be installed outside the cloud or the like and connected to the control unit 300 via a network, or an external storage device may be used.
  • the output unit 303 receives instructions from the control unit 300 and outputs, for example, all matters related to the cell culture system 1000 according to the present technology.
  • the installation location and number of output units 303 are not particularly limited, and they may be installed on the side of the casing that includes the control unit 300, on the side of the cell culture device 1 described above, or on both sides. It may be installed.
  • the output unit 303 As the output unit 303, a printer, speaker, mobile information terminal, etc. can be used. Further, the output unit 303 is not an essential component of the information processing device 2, and may be installed outside the cloud or the like and connected to the control unit 300 via a network, or an external output device may be used.
  • the display unit 304 receives instructions from the control unit 300 and displays, for example, all matters related to the cell culture system 1000 according to the present technology.
  • the installation location and number of display units 304 are not particularly limited, and they may be installed on the side of the casing that includes the control unit 300, on the side of the cell culture device 1 described above, or on both sides. It may be installed.
  • the display unit 304 a display, a touch panel, a projector, a mobile information terminal, etc. can be used. Furthermore, the display unit 304 is not an essential component of the information processing device 2, and may be installed outside the cloud or the like and connected to the control unit 300 via a network, or may use an external output device.
  • the learning unit 400 uses information regarding the cells processed under the processing conditions predicted by the control unit 300 and information regarding the treatment using the cells as input information for learning, and determines the relationship between the cells and the information regarding the treatment.
  • a first learning device to learn, information regarding the unprocessed cells, the processing conditions predicted by the control unit 300, and the unprocessed cells processed according to the processing conditions as input information for learning.
  • a second learning device that learns the relationship between the information regarding the cells before treatment and the treatment conditions.
  • the database 500 acquires and retains processing conditions for cells acquired by the cell culture unit 10, information regarding cells acquired by the measurement unit 3, and information regarding cell treatment acquired from an external database.
  • the database 500 may be configured to transmit the above information to the control section 300 and the learning section 400.
  • the control unit 300 and the learning unit 400 can refer to the information held in the database 500, and the prediction efficiency and learning efficiency of the control unit 300 and the learning unit 400 are improved.
  • FIG. 8 shows an example of the flow of the information processing method according to the present technology.
  • the information processing method according to the present technology includes a sample preparation step S100, an information acquisition step S110 regarding cells before treatment, a control step S120, a treatment step S130, and an information acquisition step S140 regarding cells after treatment. It can be included. Each of these steps will be explained in detail below.
  • the cell culture unit 10 prepares a cell group containing target cells (target cells).
  • target cells target cells
  • the type of target cells is not particularly limited, and at least one selected from the group consisting of human-derived cells, immune cells, animal-derived cells, plant-derived cells, microbial-derived cells, cancer cells, normal cells, stem cells, epithelial cells, and organoids.
  • the cells include cells in blood and cells collected from living tissue.
  • the target cells may be either adherent cells or non-adherent cells.
  • the cell group may be peripheral blood mononuclear cells (PBMC) collected from a patient or donor.
  • PBMC peripheral blood mononuclear cells
  • the PBMC is composed of various immune cell groups, including T cells, B cells, macrophages, and the like.
  • the T cells may further be comprised of T cell subsets, including naive T cells, central memory T cells, effector T cells, and the like.
  • the sample preparation step S100 may include a sample input step.
  • a group of cells including target cells input from the cell input unit 106 of the cell culture unit 10 is captured in the culture container 101 by the first molecules 104 that can bind to cells.
  • non-target cells may be collected from the waste liquid storage section 112 or the cell collection section 113 without being captured in the culture container 101.
  • the sample preparation step S100 may include a second molecule supply step.
  • the cells captured in the culture vessel 101 can be combined with the second molecule supplied from the second molecule supply unit.
  • the supplied second molecule may be, for example, a fluorescent reagent, which allows the measurement unit 3 to identify the target cell.
  • cells that are not bound to the second molecule and that are not determined as target cells by the measurement unit 3 may be collected from the waste liquid storage unit 112 or the cell recovery unit 113.
  • this technology uses information learned from bright field images, phase contrast images, polarized images, unstained images, and fluorescent images to perform pseudo-staining for each cell feature without using a second molecule.
  • the cells may be identified based on the image obtained, and the cells may be released by light stimulation.
  • the identification may be performed by the information processing device 2.
  • the information processing device 2 drives the optical control unit 210 based on the result of the identification.
  • An optical control unit 210 may perform the optical stimulation.
  • the sample preparation step S100 may include an environment control step.
  • the environment control step the environment of the culture container 101 containing the cells before treatment is controlled by the environment control section.
  • the culture container 101 receives physicochemical environment control by the environment control section, and receives physicochemical environment control such as humidity, pH, osmotic pressure, oxygen partial pressure, carbon dioxide partial pressure, etc. from the physicochemical environment supply section 114. environment may be provided.
  • the culture container 101 is subjected to physiological environment control by the environment control section, and receives stimulation factors,
  • a physiological environment such as culture media, hormones, cytokines, interleukins, etc. may be provided.
  • This provides an optimal environment for the target cells in the culture environment, thereby increasing cell survival rate and/or culture efficiency.
  • This provides an optimal physiological environment for the target cells in the culture environment and improves the efficiency of cell culture.
  • the environmental control step may be performed not only in the sample preparation step S100 but also in steps before and after the step as appropriate.
  • the information processing device 2 acquires information regarding the target cells before treatment prepared in the sample preparation step S100.
  • the information acquisition step S110 regarding cells before treatment may include a step of measuring cells before treatment.
  • the measurement unit 3 acquires image information and/or signal information. From the acquired image information and/or signal information, it is possible to extract information regarding the target cells before treatment.
  • the image information and/or signal information may be information derived from the second molecule, for example, a fluorescent reagent, provided in the sample preparation step S100.
  • the information on the cells before processing extracted by the measurement unit 3 includes, for example, cell morphology, cell composition (in particular, cell number, cell ratio), and cell growth process (in particular, cell proliferation rate, cell survival rate). , cell type, genetic information, and information regarding molecules.
  • cell morphology refers to the shape of a cell or the appearance of a cell.
  • Information regarding the molecule includes, but is not particularly limited to, gene expression control factors such as transcription factors and transcription control factors, molecular marker information, cell surface antigen information, sequence information, molecular weight, type, and the like.
  • Information regarding the cells is acquired by the measurement unit 3 and then transmitted to the control unit 300. Further, information regarding the cells may be transmitted to the database 500 of the information processing device 2, and the database 500 may be updated.
  • the information acquisition step S110 regarding cells before treatment may include a step of accepting treatment conditions (in particular, culture conditions).
  • the information processing device 2 may include a step of receiving information regarding the predetermined processing conditions or the target cells after the predetermined treatment.
  • Information regarding the predetermined processing conditions and the target cells after the predetermined processing may be received by the input unit 301 set in the information processing device 2 .
  • the control step S120 which will be described later, it becomes possible to predict the information regarding the cells after the user's desired treatment and the treatment conditions for obtaining the desired treatment conditions.
  • information regarding the predetermined treatment conditions and target cells after the predetermined treatment may be obtained by obtaining threshold values from the database 500 and/or an external database. Thereby, the threshold value can be utilized in the control step S120, which will be described later.
  • the information processing device 2 may further include a step of receiving information regarding approval of the commercialized cell as a threshold value from the database 500 and/or an external database.
  • the control step S120 which will be described later, by referring to information regarding the approval of existing commercialized cells, the processing conditions for the cells and information regarding the cells necessary to meet the approval criteria are presented to the user. can do.
  • Information regarding the approval of the cells can be appropriately selected from information regarding the cells, processing conditions for the cells, and information regarding the treatment.
  • information regarding the approval of the cell can be received through a user interface appropriately set in the information processing device 2.
  • the control unit 300 may set information regarding the predetermined cell and/or the predetermined processing condition based on information regarding approval of the cell.
  • the processing conditions are particularly culture conditions, and the culture conditions include, for example, stimulating factors, number of culture days, types of culture reagents, number of culture reagents, number of culture steps, complexity of culture steps, and culture cost. It can be one or more selected from the group. Further, the specified predetermined processing conditions may be cell sorting or cell culture control processed by the cell culture unit control unit 200, as described later.
  • Information regarding the target cells after treatment may be information regarding treatment of the cells in addition to the information regarding the cells before treatment described above.
  • the information regarding the treatment can be, for example, any one or more selected from the group consisting of the therapeutic effect of the cells on the patient, the response rate, the recurrence rate, the side effects, and the patient's treatment history.
  • information regarding the treated cells is learned in order to arrive at information regarding the treatment, and it becomes possible to execute the cell configuration and cell proliferation process in accordance with the individual patient.
  • Information regarding the predetermined processing conditions or target cells after the predetermined processing received by the information processing device 2 may be transmitted to the control unit 300 and/or the database 500 as appropriate.
  • the control unit 300 predicts a plurality of culture prediction results for each culture condition of a cell group containing different cells.
  • the culture prediction result is selected from among the information regarding the target cells before treatment acquired in the pre-processing information acquisition step S110 and the information regarding the target cells after the predetermined treatment conditions and predetermined treatment acquired in the treatment condition receiving step.
  • a processing condition that allows the cell group to be derived from information regarding a predetermined cell, or information regarding the cell after processing of the cell group derived by the predetermined processing condition is predicted as a prediction condition. .
  • the prediction condition refers to "a processing condition that allows the cell group to be derived from the information regarding the predetermined cells" generated by the prediction process by the control unit 300, or a prediction condition by the prediction process by the control unit 300. It may be the generated "information regarding the cells after the treatment of the cell group derived from the predetermined treatment conditions.” That is, the prediction condition may mean information regarding a predicted prediction condition or a predicted cell.
  • Processing conditions that allow the cell group to be derived from information regarding predetermined cells are processing conditions that can be derived by the cell culture unit control unit 200 in order to arrive at information regarding the predetermined cells specified in the processing condition receiving step.
  • it may be a culture condition.
  • the information regarding the processed cells of the cell group derived based on the predetermined processing conditions is the post-processing information that can be obtained by the cell culture unit control unit 200 executing a predetermined process specified by the user. This is information about cells.
  • the predetermined process specified by the user is not particularly limited as long as it is a process condition in process step S130, which will be described later.
  • Information regarding the cells after treatment is not particularly limited as long as it is as described above.
  • Information regarding the cells after the treatment includes, for example, cell morphology, cell composition (in particular, cell number, cell ratio), cell proliferation process (in particular, cell proliferation rate, cell survival rate), cell type, and genetics.
  • the information may be at least one selected from the group consisting of information and information regarding molecules.
  • FIG. 9 shows an example of the flow of the control step S120 of the present technology.
  • the control step S120 may include a prediction result generation step S121 and a visualization step S122.
  • the prediction result generation step S121 the control unit 300 selects the cell based on the information regarding the target cell before treatment acquired in the pre-treatment cell measurement step and the predetermined treatment conditions acquired in the treatment condition reception step. Predict information about the cells after processing the group and generate prediction results.
  • the control unit 300 performs a predetermined measurement based on the information regarding the target cells before treatment acquired in the pre-treatment cell measurement step and the information regarding the target cells after a predetermined treatment acquired in the treatment condition receiving step.
  • a processing condition that allows the cell group to be derived is predicted based on the information regarding the cells, and a result is generated.
  • the control unit 300 may acquire information regarding the target cells before processing from the measurement unit 3 and/or the database 500. Furthermore, the control unit 300 acquires information regarding the cells after the user's desired treatment and desired treatment conditions from at least one of the group consisting of the database 500, an external database, and the user interface of the information processing device 2. You may.
  • control unit 300 may further generate a prediction result using either one of the first learning device and the second learning device generated by the learning unit 400 in the learning step described later.
  • control step S120 means a step of executing a process of generating information regarding the derivable treatment conditions or the treated cells based on information regarding the target cells, that is, Includes inference processing in the field of learning.
  • the control step S120 may include a visualization step S122.
  • the control unit 300 particularly selects a plurality of culture prediction results from among the plurality of prediction results for each culture condition of a cell group containing different cells created in the prediction result generation step S121. Control is performed to visualize information regarding the cultured cell composition and cell growth process as a prediction result. In addition, control may be performed to visualize the prediction conditions generated in the prediction result generation step S121 described above.
  • the culture prediction result may be presented to the user via the display section 304 set in the information processing device 2, for example. This allows the user to visually recognize the culture prediction results.
  • the presented culture prediction results may be transmitted to the database 500, and the database 500 may be updated. Further, the output culture prediction result may be transmitted to the cell culture unit control unit 200 of the cell culture unit 10, and the cell culture unit control unit 200 controls the cell culture unit 10 based on the output conditions. It becomes possible to treat target cells.
  • FIGS. 11 to 16 are diagrams illustrating the state of visualization in the visualization step S122.
  • the visualization is performed, for example, by illustrating the culture prediction results in a table, graph, tree, etc., or three-dimensionally, but it is particularly preferable to present the results in a tree shape. It is preferable to illustrate this.
  • FIG. 11 is a diagram showing an example of culture prediction results.
  • the cell configuration and cell growth process are illustrated using line segments and end points of the line segments.
  • the cell proliferation process in particular, the cell proliferation rate
  • the cell composition in particular, the number of cells
  • the end points of the line segment is illustrated using the end points of the line segment, and the name of each cell type is presented at the end of the line segment, and the end points of different sizes are shown. is shown, and the larger the size of this endpoint, the higher the proportion of each cell type whose name was presented.
  • FIG. 12 is a diagram showing an example of culture prediction results, which is different from FIG. 11.
  • the thickness of the line segment is used to illustrate the cell proliferation process (in particular, cell survival rate), and the thicker the line segment, the higher the cell survival rate. It is shown that.
  • the cell composition in particular, the number of cells
  • the end points of the line segment is illustrated using the end points of the line segment, and the name of each cell type is presented at the end of the line segment, and the end points with different colors are shown. The darker the color of this end point, the greater the number of cells.
  • the colors presented in Figure 12 are only an example; the lighter the color of the endpoints, the higher the proportion of each cell type whose name is presented, or any other color may be used as appropriate, not just black and white. Cell composition can be shown.
  • the starting points of the culture conditions may be displayed separately as shown in FIG. 11, or may be displayed as one as shown in FIG. 12. Displaying the cells as one as shown in FIG. 12 is useful when the target cells are determined in advance and a systematic diagram can be created based on the target cells.
  • the direction in which the line segment extends from the starting point of the culture conditions (“lymphocyte" in FIGS. 11 and 12) is not particularly limited, and is not limited to the top, bottom, left, and right, but 360 degrees, all directions, as shown in FIG. 13 (described later). can be extended to.
  • each starting point, each line segment, and each end point include cell type (cell type), cell number, cell ratio, number of culture days, culture medium type, culture medium replenishment date, culture medium exchange date, culture temperature, culture Information such as humidity may also be presented. Based on this information, the user can appropriately select culture conditions that will yield desired culture results.
  • the cell composition is particularly the cell number or cell ratio
  • the cell proliferation process is particularly the cell proliferation rate or cell survival rate.
  • FIG. 13 is a diagram showing an example of culture prediction results, which is different from FIGS. 11 and 12.
  • the length of the line segment is used to illustrate the cell proliferation process (in particular, the cell proliferation rate), and the longer the line segment is, the higher the cell proliferation rate is. It is shown that.
  • the cell composition in particular, the number of cells
  • the cell composition is illustrated using the end points of the line segment, and at the end of the line segment, the name of the BR>E cell type is presented, and the shape is Different endpoints are shown, and the closer the shape is to a circle, the greater the number of cells.
  • the line segment is a group consisting of the length of the line segment, the type of the line segment (for example, a solid line, a broken line, a dashed line, a double line, etc.), the thickness of the line segment, and the color of the line segment.
  • the end point of the line segment is determined by using one or more selected from the group consisting of the size of the end point, the shape of the end point, the type of the end point (e.g., pie chart, graph, etc.), and the color of the end point, Cell composition and cell proliferation process (particularly cell composition) can be visualized and presented to the user. Note that the name of the cell type, etc. may be presented inside the type of the end point.
  • FIG. 14 is a diagram showing an example of culture prediction results, which is different from FIGS. 11 to 13. Unlike FIG. 12 described above, FIG. 14 shows a case where there are a plurality of target cells and the proportion thereof is shown by end points. If there are two types of target cells, the ratio can be shown by the size of the endpoints, and if there are three or more types, the ratio can be further shown by using a pie chart as the type of endpoints. Specifically, in FIG. 14, the length of the line segment is used to illustrate the cell proliferation process (in particular, the cell proliferation rate), and the longer the line segment is, the higher the cell proliferation rate is. It is shown that. On the other hand, in FIG.
  • the end points of the line segment are used to illustrate the cell composition (in particular, the cell proportion), and the name and proportion of each cell type are presented at the end of the line segment, and the size The endpoints with different values are shown, and the larger the endpoint, the higher the cell percentage.
  • the control unit 300 sets a threshold value by the user or the database 500, and uses the set threshold value to perform the culture. Conditions can be determined.
  • the threshold value can be set, for example, as to whether or not the above-described cell configuration and cell growth process satisfy desired conditions. For example, in FIG. 14, "CD4CD62L/CD8CD62L ⁇ 1" is set. If it is determined that the desired condition is not satisfied, the tree may be visualized by graying out the tree or erasing the tree itself, for example, as shown in FIG. Moreover, along with the visualization, culture conditions that do not satisfy the threshold value may not be automatically selected. This makes it possible to narrow down effective options from a plurality of options, improving usability.
  • the threshold value can be used to present culture conditions suitable for the mode set by the user.
  • the mode may be, for example, a survival priority mode that prioritizes cell survival rate, a proliferation priority mode that prioritizes cell proliferation rate, a ratio priority mode that prioritizes cell proportion, or a purity priority mode that prioritizes cell purity. It can be done.
  • FIG. 15 is a diagram showing an example of culture prediction results, which is different from FIGS. 11 to 14, and it is predicted that four strains J1 to J4 will eventually appear.
  • a survival priority mode or a proliferation priority mode is set using the threshold value, for example, a culture condition in which the line segment is the longest or is equal to or greater than a certain threshold value may be selected.
  • culture conditions may be selected such that the size of the end point of the line segment is the maximum or minimum, or above or below a certain threshold value.
  • FIG. 15 shows a case where a proliferation priority mode that prioritizes the cell proliferation rate is set, and culture conditions may be set so that line segment J4 has the longest line segment.
  • the user can further give conditions to take into consideration as appropriate, such as considering the cell proliferation process.
  • culture conditions suitable for the mode may be presented to the user as "positive selection” and culture conditions unsuitable for the mode may be presented as "negative selection”.
  • This presentation includes not only simply notation but also visualization techniques such as graying out the tree or erasing the tree itself as shown in FIG. 15.
  • an input unit 301 may be provided that allows selection of whether or not to proceed to the subsequent processing step S130.
  • FIG. 16 is a diagram showing an example of culture prediction results, which is different from FIGS. 11 to 15.
  • the control unit 300 may perform the illustration in chronological order, as shown in FIG. 16.
  • FIG. 16 shows the cell composition and the cell proliferation process from day 0 to day 2 of culture in chronological order
  • this embodiment is not limited to this, and may be used for several minutes, several hours, or several days. , it is possible to visualize the cell composition and cell growth process in a time-series manner over a period of several weeks or the like.
  • the control unit 300 performs processing regarding the sample containing the cells based on the information regarding the cells acquired in the information acquisition step S110 regarding the cells before treatment and the prediction conditions output in the control step. Processing regarding a sample containing cells may be performed, for example, by performing cell sorting or culture control on unprocessed cells captured in the cell culture device 1.
  • the degradable linker 103 is stimulated by optical control by the optical control unit 210, and cells bound to the sample holding unit 100 via the degradable linker 103 are released.
  • Cells that can be treated and non-target cells are determined based on the information on the cells acquired in the information acquisition step S110 regarding the cells before treatment, for example, the fluorescence signal derived from the second molecule imparted to the cells, and the non-target cells are determined. Only cells can be released by the stimulation.
  • the identification may be performed by the information processing device 2.
  • the information processing device 2 can drive the optical control section 210 based on the result of the identification.
  • the optical control unit 210 may perform optical stimulation.
  • a sample containing cells bound to the sample holding unit 100 is cultured under environmental control by the environmental control unit.
  • the culture container 101 is subjected to feedback control by the environment control section based on the information about the cells acquired in the information acquisition step S110 about the cells before treatment, and the physicochemical environment supply section 114 provides humidity, pH, osmosis, etc.
  • Physicochemical environments such as pressure, oxygen partial pressure, carbon dioxide partial pressure, etc. may be provided.
  • the culture container 101 is subjected to feedback control by the environment control unit based on the information about the cells acquired in the information acquisition step S110 about the cells before treatment, and the activator supply unit 108 and the gene supply unit 109 , and the culture solution supply unit 110, a physiological environment such as a stimulation factor, a transcription factor, a transcription control factor, a culture solution, a hormone, a cytokine, an interleukin, etc. may be supplied.
  • a physiological environment such as a stimulation factor, a transcription factor, a transcription control factor, a culture solution, a hormone, a cytokine, an interleukin, etc.
  • the cell group after culture processing may be The proliferation of CD4- and CD8-positive cells contained in the cells may be different. Furthermore, the proportions of na ⁇ ve T cells, central memory T cells, and effector cells included in the cell group, that is, the proportions of T cell subsets, may also differ.
  • anti-CD3 antibody is added to the cell group from the activator supply unit 108 in the cell culture system 1000, CD8-positive cells proliferate significantly, whereas when anti-CD3/CD28 antibody is added to the cell group, CD8-positive cells proliferate significantly.
  • the proportion of CD4 and CD8 positive cells can be maintained and proliferated. Furthermore, depending on the culture medium, cytokines, and/or cytokine type and concentration, the proportion of T cell subsets after a certain number of days of culture may vary.
  • the environment control section controls the activating agent supply section 108 to supply only anti-CD3 antibodies into the culture vessel 101 in the initial culture step. Can be controlled. This increases the proportion of CD8 positive cells within the cell group. Then, in response to the measurement unit 3 determining that the percentage of CD8 positive cells has reached the target value, the environmental control unit causes the activator supply unit 108 to stop supplying the anti-CD3 antibody. Additionally, the activating agent supply section 108 may be controlled.
  • the environmental control unit controls the activating agent supply unit 108 to supply the activating agent into the culture container 101 so as to increase or decrease the proportion of one or more predetermined cells in the cell group. I can do it.
  • the environment control unit also controls the activating agent supply unit 108 to supply the activating agent into the culture container 101 so as to increase or decrease the survival rate of one or more predetermined cells in the cell group. sell.
  • the environmental control unit is configured such that the activating agent supply unit 108 supplies the activating agent into the culture vessel 101 so as to increase or decrease the gene introduction efficiency of one or more predetermined cells in the cell group. Can be controlled.
  • the environment control unit may control the activating agent supply unit 108 to additionally supply anti-CD28 antibody into the culture container 101. This allows the cell group to proliferate while maintaining the proportion of CD4- and CD8-positive cells in the cell group. Furthermore, in response to the measurement unit 3 determining that the proportion of T cell subsets in the cell group has reached the target, the environment control unit controls the culture solution supplied by the activating agent supply unit 108 and The activator supply 108 may be controlled to change the type and/or concentration of the cytokine.
  • the environmental control unit can control the activating agent supply unit 108 to supply the activating agent into the culture vessel 101 so as to maintain the proportion of one or more predetermined cells in the cell group. .
  • the processing conditions processed by the cell sorting and/or culture control may be transmitted to the database 500, and the database 500 may be updated. This improves the accuracy of generating prediction conditions in the prediction result generation step S121.
  • the content processed by the cell sorting and/or culture control may also include dates and periods, such as the number of culture days, the date of culture solution replenishment, or the date of culture solution exchange. .
  • the treatment step S130 may include a treatment execution step S131 (in particular, a culturing step).
  • a treatment execution step S131 in particular, a culturing step.
  • the cell culture section control section 200 cultivates the sample containing the cells bound to the sample holding section 100 under the environmental control by the environment control section.
  • the user can select the culture conditions to be executed, for example, via the input unit 301.
  • the control unit 300 can control the culture conditions based on the culture conditions selected by the input unit 301.
  • the processing step S130 may include an in-process cell information acquisition step S132 (particularly a measurement step).
  • the cell culture section control section 200 controls the measurement section 3 to start measurement, and obtains information regarding the processing cells.
  • the measuring method by the measuring section 3 is, for example, as described above, and is not particularly limited. By acquiring information about cells over time, cells can be constantly observed and abnormalities in cells can be immediately detected.
  • the information regarding the processing is the same as the information regarding the cells before the treatment described above, and is not particularly limited. Information regarding the cells being processed may be sent to a database 500, and the database 500 may be updated.
  • the PBMCs can be measured by the measurement unit 3 having the image acquisition unit 600 and/or the signal detection unit 700.
  • the lymphocyte fraction is identified based on the forward scattered light, side scattered light, or back scattered light acquired by the measurement unit 3, and from information regarding the fluorescence of the target cells stained with fluorescence and/or metal-labeled antibodies.
  • the number and percentage of living cells can be identified from information about cell types such as T cells, B cells, and macrophages, T cell subsets such as naive T cells, central memory T cells, and effector T cells, and nuclear staining of target cells. sell.
  • the PBMC may also be obtained from images that are identified from information learned from unstained images and fluorescent images and pseudo-stained for each cell feature.
  • cell information can be acquired during the treatment process, so that it is possible to select the cells in the treatment process S130 and omit the moving process of extracting them from the culture container 101 and the measurement process after the cells have been extracted. This makes it possible to move cells from the culture container 101 while maintaining a sterile state, and furthermore, by omitting the measurement process in the measurement unit 3, each process in the cell culture system 1000 can be simplified. It becomes possible.
  • the processing step S130 may include a comparison step S133.
  • the cell culture unit control unit 200 compares the information regarding the cells being processed acquired in the in-process cell information acquisition step S132 and the treatment conditions acquired in the treatment condition acceptance step, and makes a treatment decision. Execute. For example, if the information regarding the cells being processed satisfies the processing conditions, the cell culture section control section 200 can proceed to the subsequent culture step, but if the processing conditions are not satisfied, the cell culture section control section 200 It is possible to select as appropriate whether unnecessary cells are removed, a manufacturing stop process is performed in which the control unit 300 is controlled to stop cell production, or the control unit 300 is controlled to re-collect the cells. . Thereby, by observing information regarding the cells being processed from the measurement unit 3 over time, it becomes possible to switch the process content midway through the process and perform optimization processing.
  • the measurement unit 3 acquires information regarding the treated cells.
  • the cell collection unit 113 collects the cell group.
  • the collected cells may be evaluated for information regarding treatment by the information processing device 2, or may be evaluated by an evaluation device outside the system.
  • Information regarding the treatment of the evaluated treated cells may be sent to the database 500 after the evaluation, and the database 500 may be updated.
  • Information regarding the target cells after treatment may be information regarding treatment of the cells in addition to the information regarding the cells before treatment described above.
  • the information regarding the treatment may be any one or more selected from the group consisting of the therapeutic effect of the cells on the patient, the response rate, the recurrence rate, the side effects, and the patient's treatment history.
  • information regarding the treated cells is learned in order to arrive at information regarding the treatment, and it becomes possible to execute treatment conditions (in particular, culture conditions) according to the individual patient.
  • the information processing method may further include a learning step.
  • the learning step the learning unit 400 learns the relationship between information regarding cells and information regarding treatment of the cells, and generates a first learning device.
  • the learning unit 400 learns the relationship between information regarding cells and processing conditions and generates a second learning device. This makes it possible to predict the treatment conditions (in particular, culture conditions) to achieve a desired cell group and the desired therapeutic effect of the cells from information about the cells in the cell group before treatment, and to improve the cell treatment process. Efficiency can be increased.
  • the control unit 300 may execute the above-described prediction process using the generated first learning device and/or second learning device.
  • the first learning device uses information regarding cells processed according to the prediction conditions predicted by the control unit 300 and information regarding the treatment of the cells as input information for learning, and determines the relevance of the information regarding the cells and the treatment. Learn.
  • the information regarding the cells after treatment and the treatment of the cells after treatment are as described above.
  • the control unit 300 may perform inference using a learning device generated by the learning device. This also makes it possible to predict optimal treatment conditions (especially culture conditions) depending on the patient.
  • the PBMC when the cell group treated in the cell culture system 1000 is PBMC, the PBMC is used for therapeutic purposes.
  • the relationship between information about the cell group after culture, such as the cell composition of the PBMC and the cell proliferation process, and information about the treatment, such as donor information, treatment success rate, incidence of side effects, and cell quality. it is also possible to optimize the timing of collecting PBMC. This makes it possible to predict the treatment conditions to achieve a desired cell group and the desired cell treatment effect from information about the cells in the cell group before treatment, increasing the efficiency of the cell treatment process. .
  • the second learning device uses the information regarding the unprocessed cells, the processing conditions predicted by the control unit 300, and the unprocessed cells processed according to the processing conditions as input information for learning, and uses the information regarding the unprocessed cells as learning input information.
  • the relationship between information about cells before treatment and the treatment conditions is learned.
  • the processing conditions are not particularly limited as long as they are conditions that can be processed in the processing step. This makes it possible to predict the treatment conditions (in particular, culture conditions) to achieve a desired cell group and the desired therapeutic effect of the cells from information about the cells in the cell group before treatment, and to improve the cell treatment process. Efficiency can be increased.
  • the control unit 300 may perform inference using a learning device generated by the learning device. This makes it possible to predict treatment conditions (especially culture conditions) and therapeutic effects.
  • the first learning device may be a learning device generated by performing machine learning on a data set including information regarding cells and information regarding treatment of the cells.
  • the machine learning may be, for example, deep learning.
  • the machine learning may be performed, for example, according to the information processing device or the information processing method described in International Publication No. 2021/049365 pamphlet.
  • information regarding the cells may be treated as an explanatory variable, and information regarding treatment of the cells may be treated as a target variable.
  • the second learning device includes information regarding the cells before the treatment, the treatment conditions, and information regarding the cells before the treatment that have been treated according to the treatment conditions (i.e., information regarding the cells after the treatment);
  • the learning device may be generated by performing machine learning on a data set including the following.
  • the machine learning may be, for example, deep learning.
  • the machine learning may be performed, for example, according to the information processing device or the information processing method described in International Publication No. 2021/049365 pamphlet.
  • information regarding the cells before the treatment and the treatment conditions may be treated as explanatory variables, and information regarding the cells after the treatment may be treated as the objective variable.
  • explanatory variables and objective variables may be applied, for example, in an embodiment in which the control unit 300 predicts information regarding cells after processing the cell group.
  • information regarding the cells before the treatment and information regarding the cells after the treatment may be treated as explanatory variables, and the treatment conditions may be treated as the objective variable.
  • explanatory variables and objective variables are, for example, an embodiment in which the control unit 300 predicts processing conditions (in particular, culture conditions) to enable the control unit 300 to derive information regarding the predetermined cells from the cell group. may be applied in
  • the control unit has a control unit that predicts multiple culture prediction results for each culture condition of a cell group containing different cells
  • the control unit is an information processing device that performs control to visualize the cultured cell composition and cell proliferation process as the culture prediction result.
  • the information processing device according to [1] wherein the visualization is performed by illustrating the culture prediction results.
  • the information processing device according to any one of [1] to [4], wherein the cell proliferation process is a cell proliferation rate or a cell survival rate.
  • the line segment is used to visualize the cell proliferation process using any one or more selected from the group consisting of line segment length, line segment type, line segment thickness, and line segment color.
  • the information processing device according to [3].
  • the end points of the line segment are visualized by using any one or more selected from the group consisting of the size of the end point, the shape of the end point, the type of the end point, and the color of the end point. The information processing device described.
  • the information processing device according to any one of [1] to [7], wherein the control unit determines the culture conditions using a set threshold value.
  • the information processing device which visualizes cell culture conditions that do not satisfy the threshold value.
  • the information processing device which uses the threshold value to present culture conditions suitable for a mode set by the user.
  • the mode is any one of a survival priority mode that prioritizes cell survival rate, a proliferation priority mode that prioritizes cell proliferation rate, a ratio priority mode that prioritizes cell proportion, or a purity priority mode that prioritizes cell purity. 10].
  • a cell culture device having a cell culture section for culturing cell groups containing different cells, and a measurement section for measuring the cell composition and cell growth process of the cell group;
  • the control unit includes a control unit that predicts a plurality of culture prediction results for each culture condition of a cell group containing different cells, and the control unit controls so as to visualize the cultured cell composition and cell growth process as the culture prediction result.
  • a cell culture system with [19] A process including a step of predicting a plurality of culture prediction results for each culture condition of a cell group containing different cells, and controlling the cultured cell composition and cell growth process to be visualized as the culture prediction results is performed on a computer.
  • Cell culture device 2 Information processing device 3: Measurement section 10: Cell culture section 100: Sample holding section 200: Cell culture section control section 300: Control section 301: Input section 302: Storage section 303: Output section 304: Display unit 400: Learning unit 500: Database 600: Image acquisition unit 1000: Cell culture system 5000: Microscope system 6100: Biological sample analyzer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The present invention provides a technology that enables visual confirmation of a culturing condition of a cell group including different cells. The present technology provides an information processing apparatus comprising a control unit for predicting multiple culturing prediction results for each culturing condition of a cell group including different cells. The control unit performs control so as to visualize, as the culture prediction results, the composition of cultured cells and the proliferative process of the cells. The present technology also provides a cell culturing system having: a cell culturing device comprising a cell culturing unit for culturing a cell group including different cells, and a measurement unit for measuring the cellular composition of the cell group and the proliferative process of the cells; and an information processing apparatus which comprises a control unit for predicting multiple culturing prediction results for each culturing condition of a cell group including different cells, and in which the control unit performs control so as to visualize, as the culturing prediction result, the composition of the cultured cells and the proliferative process of the cells.

Description

情報処理装置、情報処理方法、細胞培養システム、及びプログラムInformation processing device, information processing method, cell culture system, and program

 本技術は、情報処理装置、情報処理方法、細胞培養システム、及びプログラムに関する。より詳しくは、異なる細胞を含む細胞群の培養条件を俯瞰可能な、情報処理装置、情報処理方法、細胞培養システム、及びプログラムに関する。 The present technology relates to an information processing device, an information processing method, a cell culture system, and a program. More specifically, the present invention relates to an information processing device, an information processing method, a cell culture system, and a program that can provide an overview of culture conditions for cell groups including different cells.

 再生医療における細胞の生産では、所望の時期に必要な量の細胞を培養することが要求される。これに対して、従来は、熟練したオペレータが培養条件を決定し、培養中に細胞の培養状態を観察することで、必要に応じて培養条件を調整している。しかしながら、生体細胞を安定的に培養することが難しいことから、自動培養システムが用いられることがある。 Cell production in regenerative medicine requires culturing the required amount of cells at the desired time. In contrast, conventionally, a skilled operator determines the culture conditions and adjusts the culture conditions as necessary by observing the culture state of the cells during culture. However, since it is difficult to stably culture living cells, automatic culture systems are sometimes used.

 例えば、引用文献1には、培養槽において細胞を培養するための培養支援装置であって、複数の実績データのうちの、目標時期に目標細胞数の細胞を得るための比増殖速度である目標比増殖速度と前記培養槽の培養状況とを含むクエリ点に類似する実績データの集合である近傍データ群に基づいて、前記目標比増殖速度を得るための培養条件である設定培養条件を決定する演算装置を備え、前記複数の実績データのそれぞれは、過去に行われた培養に関するデータであって、比増殖速度と、当該比増殖速度を得たときの培養状況と、を含む、培養支援装置が開示されている。 For example, Cited Document 1 describes a culture support device for culturing cells in a culture tank, and a target, which is a specific growth rate to obtain a target number of cells at a target time, among a plurality of performance data. Set culture conditions, which are culture conditions for obtaining the target specific growth rate, are determined based on a neighboring data group, which is a set of actual data similar to the query point, including the specific growth rate and the culture status of the culture tank. A culture support device comprising a calculation device, wherein each of the plurality of performance data is data regarding culture performed in the past, and includes a specific growth rate and a culture status when the specific growth rate was obtained. is disclosed.

特開2019-41656号公報JP2019-41656A

 しかしながら、従来、異なる細胞タイプを分類する手法は存在するが、それが階層的に分類され、且つ、培養条件に応じた細胞構成及び細胞の増殖過程などの予測結果が一覧俯瞰的に確認できる手法が存在しないという問題があった。 However, although there are conventional methods for classifying different cell types, there is a method that allows for hierarchical classification and a bird's-eye view of predicted results such as cell composition and cell growth process according to culture conditions. The problem was that it didn't exist.

 そこで、本技術では、異なる細胞を含む細胞群の培養条件を俯瞰可能な技術を提供することを主目的とする。 Therefore, the main purpose of this technology is to provide a technology that allows a bird's-eye view of the culture conditions of a cell group containing different cells.

 まず、本技術では、異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測する制御部を有し、前記制御部は、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御する、情報処理装置を提供する。 First, the present technology includes a control unit that predicts a plurality of culture prediction results for each culture condition of a cell group including different cells, and the control unit is configured to predict a cultured cell composition and cell growth based on the culture prediction results. An information processing device is provided that controls a process to be visualized.

 また、本技術では、異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測する制御工程を有し、前記制御工程では、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御する、情報処理方法も提供する。 In addition, the present technology includes a control step of predicting a plurality of culture prediction results for each culture condition of a cell group including different cells, and in the control step, the culture prediction results include the composition of the cultured cells and the growth of the cells. It also provides an information processing method that controls the process to make it visible.

 更に、本技術では、異なる細胞を含む細胞群を培養する細胞培養部と、前記細胞群の細胞構成を測定する測定部と、を有する細胞培養装置と、異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測する制御部を有し、前記制御部は、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御する、情報処理装置と、を有する、細胞培養システムも提供する。 Furthermore, the present technology includes a cell culture device having a cell culture section for culturing cell groups containing different cells, and a measurement section for measuring the cell composition of the cell groups, and a cell culture device for each culture condition of the cell groups containing different cells. a control unit that predicts a plurality of culture prediction results, the control unit comprising an information processing device that controls to visualize the cultured cell composition and cell growth process as the culture prediction results; Cell culture systems are also provided.

 加えて、本技術では、異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測し、且つ、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御するステップを含む処理をコンピュータに実行させる、プログラムも提供する。 In addition, the present technology predicts a plurality of culture prediction results for each culture condition of a cell group containing different cells, and controls to visualize the cultured cell composition and cell growth process as the culture prediction results. A program that causes a computer to execute a process including steps is also provided.

第1実施形態に係る細胞培養システムの実施形態の一例を示す模式図である。FIG. 1 is a schematic diagram showing an example of an embodiment of a cell culture system according to a first embodiment. 試料保持部の模式図である。It is a schematic diagram of a sample holding part. 固定化された第一の分子の模式図である。FIG. 2 is a schematic diagram of an immobilized first molecule. 細胞処理容器の構成の一例を示す模式図である。FIG. 2 is a schematic diagram showing an example of the configuration of a cell processing container. 光学制御部の構成の一例を示す模式図である。FIG. 3 is a schematic diagram showing an example of the configuration of an optical control section. 顕微鏡システムの全体構成を概略的に示す図である。1 is a diagram schematically showing the overall configuration of a microscope system. 生体試料分析装置の全体構成を概略的に示す図である。1 is a diagram schematically showing the overall configuration of a biological sample analyzer. 第2実施形態に係る情報処理方法のフロー図である。FIG. 3 is a flow diagram of an information processing method according to a second embodiment. 制御工程のフロー図である。It is a flow diagram of a control process. 処理工程のフロー図である。It is a flow diagram of a processing process. 培養予測結果の一例を示す図である。It is a figure showing an example of a culture prediction result. 図11とは異なる、培養予測結果の一例を示す図である。12 is a diagram showing an example of culture prediction results different from FIG. 11. FIG. 図11及び12とは異なる、培養予測結果の一例を示す図である。12 is a diagram showing an example of culture prediction results different from FIGS. 11 and 12. FIG. 図11~13とは異なる、培養予測結果の一例を示す図である。13 is a diagram showing an example of culture prediction results different from FIGS. 11 to 13. FIG. 図11~14とは異なる、培養予測結果の一例を示す図である。14 is a diagram showing an example of culture prediction results different from FIGS. 11 to 14. FIG. 図11~15とは異なる、培養予測結果の一例を示す図である。FIG. 16 is a diagram showing an example of culture prediction results different from FIGS. 11 to 15. FIG.

 以下、本技術を実施するための好適な形態について図面を参照しながら説明する。以下に説明する実施形態は、本技術の代表的な実施形態の一例を示したものであり、いずれの実施形態も組み合わせることが可能である。また、これらにより本技術の範囲が狭く解釈されることはない。なお、説明は以下の順序で行う。
 
1.第1実施形態(細胞培養システム1000、及び情報処理装置2)
(1)全体構成
(2)細胞培養装置1
(2-1)細胞培養部10
(2-2)測定部3
(2-2-1)顕微鏡システム5000
(2-2-2)生体試料分析装置6100
(3)情報処理装置2
2.第2実施形態(情報処理方法)
(1)全体構成
(2)サンプル調製工程S100
(3)処理前の細胞に関する情報取得工程S110
(4)制御工程S120
(5)処理工程S130
(6)処理後の細胞に関する情報取得工程S140
(7)学習工程
 
Hereinafter, preferred forms for implementing the present technology will be described with reference to the drawings. The embodiment described below shows an example of a typical embodiment of the present technology, and any embodiment can be combined. Furthermore, the scope of the present technology should not be interpreted narrowly due to these. Note that the explanation will be given in the following order.

1. First embodiment (cell culture system 1000 and information processing device 2)
(1) Overall configuration (2) Cell culture device 1
(2-1) Cell culture section 10
(2-2) Measuring section 3
(2-2-1) Microscope system 5000
(2-2-2) Biological sample analyzer 6100
(3) Information processing device 2
2. Second embodiment (information processing method)
(1) Overall configuration (2) Sample preparation process S100
(3) Information acquisition step S110 regarding cells before treatment
(4) Control process S120
(5) Processing step S130
(6) Information acquisition step S140 regarding cells after treatment
(7) Learning process

1.第1実施形態(細胞培養システム1000、及び情報処理装置2) 1. First embodiment (cell culture system 1000 and information processing device 2)

(1)全体構成 (1) Overall composition

 図1を参照して、本技術の第1実施形態に係る細胞培養システム1000の全体構成について説明する。本実施形態に係る細胞培養システム1000は、細胞培養装置1と、情報処理装置2と、を少なくとも有する。また、必要に応じて、その他の装置や部位を有していてもよい。なお、各装置や各部位は、同一の筐体内に格納されていてよく、別々の筐体に格納され、有線又は無線ネットワークを介して繋がっていてもよい。
 以下、細胞培養システム1000の各装置や各部位について詳細に説明する。
With reference to FIG. 1, the overall configuration of a cell culture system 1000 according to a first embodiment of the present technology will be described. The cell culture system 1000 according to this embodiment includes at least a cell culture device 1 and an information processing device 2. Additionally, other devices and parts may be included as necessary. Note that each device and each part may be stored in the same housing, or may be stored in separate housings and connected via a wired or wireless network.
Hereinafter, each device and each part of the cell culture system 1000 will be explained in detail.

(2)細胞培養装置1 (2) Cell culture device 1

 細胞培養装置1は、異なる細胞を含む細胞群を培養する細胞培養部10と、前記細胞群の細胞構成及び細胞の増殖過程を測定する測定部3と、を少なくとも有する。また、必要に応じて、その他の部位を有していてもよい。 The cell culture device 1 includes at least a cell culture section 10 for culturing a cell group containing different cells, and a measurement section 3 for measuring the cell composition of the cell group and the cell growth process. In addition, other parts may be included as necessary.

 本明細書において、「細胞」には、ヒト由来細胞、免疫細胞、動物由来細胞、植物由来細胞、微生物由来細胞、がん細胞、正常細胞、幹細胞、及び上皮細胞のうちのいずれでもよい。例えば、動物細胞の場合、細胞として、血液中の細胞及び生体組織から採取した細胞等が挙げられる。また、細胞は、接着性細胞及び非接着性細胞のいずれでもよい。更に、サンプルに含まれる細胞の種類は、1つであってよく又は複数であってもよく、「細胞」には、細胞塊も含まれ、例えば、スフェロイド、オルガノイドなどが含まれうる。 As used herein, "cell" may be any of human-derived cells, immune cells, animal-derived cells, plant-derived cells, microbial-derived cells, cancer cells, normal cells, stem cells, and epithelial cells. For example, in the case of animal cells, examples of the cells include cells in blood and cells collected from living tissue. Further, the cells may be either adherent cells or non-adherent cells. Furthermore, the number of types of cells contained in the sample may be one or more, and the term "cell" includes cell clusters, such as spheroids, organoids, and the like.

(2-1)細胞培養部10 (2-1) Cell culture section 10

 細胞培養部10の試料保持部100の模式図を図2に示す。試料保持部100には、細胞と結合可能な第一の分子104が、分解性リンカー103を介して固定化されている。分解性リンカー103は、図2に示されるように、容器101の底面に固定されていてよい。試料保持部100はその容積が増加又は減少するように可変であってもよい。試料保持部100は、培養容器101に細胞が投入されると、その内部に固定化された第一の分子104で細胞を捕捉する。捕捉された細胞は、その培養容器101内で培養される。 A schematic diagram of the sample holding section 100 of the cell culture section 10 is shown in FIG. 2. A first molecule 104 capable of binding to cells is immobilized on the sample holding part 100 via a degradable linker 103. Degradable linker 103 may be fixed to the bottom of container 101, as shown in FIG. The sample holder 100 may be variable so that its volume increases or decreases. When cells are introduced into the culture container 101, the sample holding unit 100 captures the cells using the first molecules 104 immobilized therein. The captured cells are cultured within the culture container 101.

 試料保持部100の培養容器101の内部には、例えば、ポリマー102と、分解性リンカー103とを介して第一の分子104が固定化されている。なお、ポリマー102を介すことなく、分解性リンカー103が第一の分子104を直接固定化されてもよい。固定化は、培養容器101の底面に限定されず内壁にされてもよいし、又は、培養容器101内部に、平面的又は立体的な内部構造体が存在している場合、その構造体の表面に固定化されてもよい。なお、培養容器101の内部表面は、細胞の生存に適した物質(例えば、collagen、fibroblastなど)によってコーティングされていることが好ましい。 A first molecule 104 is immobilized inside the culture container 101 of the sample holding unit 100 via a polymer 102 and a degradable linker 103, for example. Note that the degradable linker 103 may directly immobilize the first molecule 104 without using the polymer 102. Immobilization is not limited to the bottom surface of the culture vessel 101, but may be on the inner wall, or, if a planar or three-dimensional internal structure exists inside the culture vessel 101, the surface of the structure. may be immobilized. Note that the inner surface of the culture container 101 is preferably coated with a substance suitable for cell survival (eg, collagen, fibroblast, etc.).

 ポリマー102が用いられる場合、当該ポリマー102は、細胞にストレスを与えず若しくは無毒であるもの又は生体適合性を有するものが好ましい。ポリマーの例としては、例えばポリエチレングリコール(PEG)、2-methacryloyloxyethyl phosphorylcholineポリマー(MPCポリマー)などが挙げられる。また、ポリマー102の培養容器101との結合箇所の反対側の端に、分解性リンカー103が結合していてよい。分解性リンカー103は、特定の外部からの刺激で分解する分子である。分解性リンカー103は、第一の分子104を、ポリマー102を介して又は介さずに、容器底面に接続する。分解性リンカー103としては、例えば、特定の波長の光で分解されるリンカー、酵素で分解されるリンカー、温度で分解されるリンカー等が挙げられる。前記分解性リンカーは、シングルセル(単一細胞)ごとの制御が可能な点や分解時間が短い点から、光分解性リンカーであることが好ましい。 When the polymer 102 is used, the polymer 102 is preferably one that does not stress cells or is non-toxic, or one that is biocompatible. Examples of polymers include polyethylene glycol (PEG), 2-methacryloyloxyethyl phosphorylcholine polymer (MPC polymer), and the like. Further, a degradable linker 103 may be bonded to the end of the polymer 102 opposite to the bonding portion with the culture vessel 101. The degradable linker 103 is a molecule that is decomposed by a specific external stimulus. Degradable linker 103 connects first molecule 104 to the bottom of the container, with or without polymer 102 . Examples of the degradable linker 103 include a linker that is decomposed by light of a specific wavelength, a linker that is decomposed by an enzyme, a linker that is decomposed by temperature, and the like. The degradable linker is preferably a photodegradable linker because it allows control on a single cell basis and takes a short time to degrade.

 光分解性リンカーは、特定の波長の光によって分解される構造を持つ分子であり、従来公知のものを用いることができる。また、光分解性リンカーが分解される波長は、その分子の吸収波長とほぼ一致する。例えば、光分解性リンカーがメトキシノトロベンジル基を含む場合、346nmでの吸収を1とすると、364nmでは0.89、406nmでは0.15、487nmでは0.007の吸収を示す。すなわち、365nmの光源を用いれば、当該光分解性リンカーの分解効率がよく、当該光分解性リンカーは488nmの光源ではほぼ分解されないという性質を有する。このように、光分解性リンカーに照射する光の波長は、各光分解性リンカーに対応する波長であればよい。例えば、330~450nm付近の波長である。また、細胞にダメージを与えない、例えば、30mW/cm,100sec.→3J/cmで照射することが好ましい。 The photodegradable linker is a molecule having a structure that is decomposed by light of a specific wavelength, and conventionally known linkers can be used. Furthermore, the wavelength at which the photodegradable linker is decomposed almost coincides with the absorption wavelength of the molecule. For example, when the photodegradable linker contains a methoxynotrobenzyl group, assuming that the absorption at 346 nm is 1, it exhibits an absorption of 0.89 at 364 nm, 0.15 at 406 nm, and 0.007 at 487 nm. That is, if a 365 nm light source is used, the photodegradable linker is decomposed efficiently, and the photodegradable linker has a property that it is hardly decomposed by a 488 nm light source. In this way, the wavelength of the light irradiated to the photodegradable linker may be any wavelength that corresponds to each photodegradable linker. For example, the wavelength is around 330 to 450 nm. In addition, for example, 30 mW/cm 2 , 100 sec. → It is preferable to irradiate at 3 J/cm 2 .

 前記第一の分子104は、細胞と結合可能な部位を有する。細胞と結合可能な部位としては、例えば、オレイル基、コレステリル基、抗体、アプタマー、分子認識ポリマー等を用いることができる。 The first molecule 104 has a site capable of binding to cells. As the site capable of binding to cells, for example, oleyl groups, cholesteryl groups, antibodies, aptamers, molecular recognition polymers, etc. can be used.

 前記オレイル基及びコレステリル基は、疎水性であり、浮遊する細胞表面と接着する。オレイル基に、例えば、PEG等のスペーサーを付与し、その末端にNHS基(N-ヒドロキシスクシンイミド基)を含めて、第一の分子104としてもよい。 The oleyl group and cholesteryl group are hydrophobic and adhere to the surface of floating cells. The first molecule 104 may be formed by adding a spacer such as PEG to the oleyl group and including an NHS group (N-hydroxysuccinimide group) at the end thereof.

 前記抗体は、細胞に存在する細胞表面分子抗原と結合する。前記抗体として、例えば、ガン特異的抗原に対する抗体、主要組織適合抗原に対する抗体、糖鎖に対する抗体等が挙げられる。 The antibody binds to a cell surface molecule antigen present on the cell. Examples of the antibodies include antibodies against cancer-specific antigens, antibodies against major histocompatibility antigens, and antibodies against sugar chains.

 前記アプタマーは、細胞が有する分子と特異的に結合する核酸分子やペプチドである。前記アプタマーとして、例えば、DNAアプタマー、RNAアプタマー、ペプチドアプタマー、核酸骨格や塩基に修飾を導入して特異性を向上させた修飾アプタマー等が挙げられる。 The aptamer is a nucleic acid molecule or peptide that specifically binds to molecules possessed by cells. Examples of the aptamer include DNA aptamers, RNA aptamers, peptide aptamers, and modified aptamers in which specificity is improved by introducing modifications into the nucleic acid backbone or base.

 前記分子認識ポリマーは、細胞の細胞表面分子に似た物理化学特性を持つ化合物の存在下でも、高い選択性で目的の細胞表面分子を捕捉する。前記分子認識ポリマーは、モレキュラーインプリントポリマーとも呼ばれ、選択的に合成された化合物認識領域を有する。 The molecular recognition polymer captures target cell surface molecules with high selectivity even in the presence of compounds with physicochemical properties similar to cell surface molecules. The molecular recognition polymer is also called a molecular imprint polymer and has a selectively synthesized compound recognition region.

 前記第一の分子104が、培養容器101内に固定化された状態の模式的な例を図3に示す。培養容器101の底面にポリマー102と分解性リンカー103を介して第一の分子104が固定化されている。図3では、第一の分子104は、分解性リンカー103と直接結合しているが、ポリマーを介して分解性リンカー103と結合されていてもよい。この構成を採用することにより、第一の分子104と培養容器101に投入された細胞とが接近又は接触すると、第一の分子104は細胞を捕捉することができる。 FIG. 3 shows a schematic example of the state in which the first molecule 104 is immobilized within the culture container 101. A first molecule 104 is immobilized on the bottom surface of the culture container 101 via a polymer 102 and a degradable linker 103. In FIG. 3, the first molecule 104 is directly bonded to the degradable linker 103, but it may also be bonded to the degradable linker 103 via a polymer. By employing this configuration, when the first molecule 104 and the cells introduced into the culture container 101 approach or come into contact with each other, the first molecule 104 can capture the cells.

 第一の分子104は、1スポットにつき細胞1個が結合するように固定化されていることが好ましい。1スポットにつき細胞1個が捕捉されることにより、第一の分子104と結合可能な分子(例えば、抗体、糖鎖など)を有する細胞をシングルセルレベルで選別することができる。また、このような選別を、全てのスポットに対して実行することもできる。 The first molecule 104 is preferably immobilized so that one cell is bound to each spot. By capturing one cell per spot, cells having molecules (eg, antibodies, sugar chains, etc.) that can bind to the first molecule 104 can be selected at a single cell level. Moreover, such sorting can also be performed for all spots.

 また、第一の分子104は、培養容器101内にアレイ状に固定化されていることが好ましい。アレイ状に第一の分子104をスポットする手法としては、マイクロコンタクトプリント法、スポット法、又は前記光分解性リンカーの特徴を利用して全面配置した後に不要な部分を分解する手法が用いられてよい。細胞が捕捉されないようにしたい部分に関しては、上記PEG又は上記MPCポリマーが、培養容器101の当該部分にコーティング又は結合されてよく、これにより、細胞の非特異的吸着を抑制することができる。そして、前記光分解性ポリマーに光を照射して不要な細胞を遊離後、遊離したスポットに細胞が非特異的吸着しないように、PEGやMPCポリマーが残るようにすることが好ましい。 Furthermore, the first molecules 104 are preferably immobilized in an array within the culture container 101. As a method of spotting the first molecules 104 in an array, a microcontact printing method, a spotting method, or a method of disassembling unnecessary portions after placing them on the entire surface using the characteristics of the photodegradable linker is used. good. Regarding the part where it is desired to prevent cells from being captured, the PEG or the MPC polymer may be coated or bonded to the part of the culture vessel 101, thereby suppressing non-specific adsorption of cells. After releasing unnecessary cells by irradiating the photodegradable polymer with light, it is preferable that PEG or MPC polymer remain so as to prevent non-specific adsorption of cells to the released spots.

 なお、スポットする第一の分子104は1種類であってよく、例えば一の種類の細胞のみ特異的に捕捉するように構成された第一の分子104が採用されてよい。或いは、スポットごとに特異性の異なる第一の分子104が固定化されていてもよく、スポットごとに異なる細胞を捕捉するようにしてもよい。また、培養容器101内を区画分けし、それぞれの区画ごとに特異性の異なる第一の分子104が固定化されてもよく、これにより、同一の容器で区画ごとに異なる細胞を捕捉することができる。もしくは、あらゆる種類の細胞を捕捉する第一の分子104が固定化されていてもよく、この場合において、後述する標識された第二の分子で細胞の選別を行ってもよい。複数種の標識された第二の分子を利用すると多色解析が可能となる。 Note that the first molecule 104 to be spotted may be one type, and for example, the first molecule 104 configured to specifically capture only one type of cell may be employed. Alternatively, first molecules 104 having different specificities may be immobilized for each spot, and different cells may be captured for each spot. Alternatively, the inside of the culture container 101 may be divided into sections, and the first molecules 104 having different specificities may be immobilized in each section, thereby making it possible to capture different cells in each section in the same container. can. Alternatively, the first molecule 104 that captures all types of cells may be immobilized, and in this case, cells may be sorted using a labeled second molecule, which will be described later. Multicolor analysis becomes possible by using multiple types of labeled second molecules.

 前記培養容器101は、その容積が変化可能であるように構成されていてよい。培養容器101は、可変部が柔軟性のある材質で形成されることが好ましく、上下及び/又は左右に伸縮できることが好ましい。容積の変化は、培養容器101に備える連結部105から入れられる液の量又は空気の量等を調節することにより行うことができる。また、容積を変化させずに、培養容器101内の液体(例えば、培地、緩衝溶液、染色用バッファーなど)の体積を変化させるように培養容器101内に供給される液又は空気の流量の制御を実施してもよい。これによって、培養容器101内の細胞に対して最適な濃度で反応等を実施できる。 The culture container 101 may be configured so that its volume can be changed. It is preferable that the variable part of the culture container 101 be formed of a flexible material, and it is preferable that the culture container 101 can be expanded and contracted vertically and/or horizontally. The volume can be changed by adjusting the amount of liquid or the amount of air introduced from the connecting part 105 provided in the culture container 101. Additionally, the flow rate of the liquid or air supplied into the culture container 101 is controlled so as to change the volume of the liquid (for example, culture medium, buffer solution, staining buffer, etc.) in the culture container 101 without changing the volume. may be implemented. Thereby, reactions and the like can be performed on the cells in the culture container 101 at an optimal concentration.

 培養容器101に細胞を含む試料を投入後、細胞を第一の分子104に効率よく捕捉させるためには、培養容器101の容積又は培地体積を小さくすることが好ましい。容積又は培地体積が小さいと、細胞と第一の分子104との接触確率が高くなるからである。また、第一の分子104に捕捉された細胞を培養後、細胞密度が高くなったら、培養容器101の容積又は培地体積を大きくすることが好ましい。容積又は培地体積を大きくすれば、細胞培養スペースが大きくなる。容積の増加によって、更に培養液を追加することもできる。 After a sample containing cells is introduced into the culture container 101, in order to efficiently trap the cells in the first molecules 104, it is preferable to reduce the volume of the culture container 101 or the volume of the medium. This is because when the volume or medium volume is small, the probability of contact between the cells and the first molecules 104 increases. Further, after culturing the cells captured by the first molecules 104, if the cell density becomes high, it is preferable to increase the volume of the culture container 101 or the volume of the medium. Increasing the volume or medium volume increases the cell culture space. Further culture medium can be added by increasing the volume.

 なお、培養容器101はガス透過性を有することが好ましい。これにより、細胞培養において、例えば、酸素の供給及び/又は二酸化炭素の排出が求められる場合などにおいて、容器内を細胞培養に適した環境(例えば、最適CO濃度、最適温度など)にすることができる。特に、細胞が増殖する面は、例えば、多孔質膜又は酸素透過性膜で形成されることが好ましい。 Note that the culture container 101 preferably has gas permeability. This makes it possible to create an environment in the container suitable for cell culture (e.g., optimal CO 2 concentration, optimal temperature, etc.) when, for example, oxygen supply and/or carbon dioxide evacuation are required in cell culture. I can do it. In particular, the surface on which cells proliferate is preferably formed of, for example, a porous membrane or an oxygen permeable membrane.

 培養容器101は、上記細胞を含む試料又は上記培養液が入った容器と連結部105により連結されてもよい。例えば、図4に示すように、細胞投入部106、第二の分子供給部107、活性化剤供給部108、遺伝子供給部109、培養液供給部110、洗浄液供給部111、廃液貯留部112、及び細胞回収部113からなる群より選ばれるいずれか1つ、或いは、複数が、培養容器101と連結されてよい。これら全体を細胞培養に好適な条件下に設置してもよいし、培養容器101のみを細胞培養に好適な条件下に設置してもよい。 The culture container 101 may be connected to a sample containing the cells or a container containing the culture solution by a connecting portion 105. For example, as shown in FIG. 4, a cell input section 106, a second molecule supply section 107, an activating agent supply section 108, a gene supply section 109, a culture solution supply section 110, a washing solution supply section 111, a waste liquid storage section 112, and the cell collection unit 113, or a plurality of them may be connected to the culture container 101. The whole of these may be installed under conditions suitable for cell culture, or only the culture container 101 may be installed under conditions suitable for cell culture.

 細胞投入部106は、細胞を含むサンプル(特には、液状サンプル)を保持しており、培養容器101にサンプルを投入する。 The cell input unit 106 holds a sample (particularly a liquid sample) containing cells, and inputs the sample into the culture container 101.

 第二の分子供給部107は、その中に第二の分子を保持しており、培養容器101に第二の分子を投入するように構成されている。複数種の第二の分子が必要な場合は、その数に応じて、第二の分子供給部107が増やされてもよい。第二の分子は、細胞と結合可能な分子であってよい。第二の分子は、蛍光物質等で標識されていてもよい。第一の分子104と第二の分子とで細胞を挟むような構造(例えば、サンドイッチ構造など)を形成させ、そして、当該構造が形成されたことを当該標識によって認識することができる。前記第二の分子は、第一の分子104と同様、例えば、オレイル基、抗体、アプタマー、及び分子認識ポリマーからなる群から選択されてよい。第二の分子は、第一の分子104に捕捉された細胞のうち、所望の細胞のみに特異的に結合する分子であってよい。 The second molecule supply unit 107 holds the second molecule therein and is configured to feed the second molecule into the culture container 101. If multiple types of second molecules are required, the number of second molecule supply units 107 may be increased according to the number. The second molecule may be a molecule capable of binding to cells. The second molecule may be labeled with a fluorescent substance or the like. The first molecule 104 and the second molecule form a structure (for example, a sandwich structure) in which a cell is sandwiched, and the formation of the structure can be recognized by the label. The second molecule, like the first molecule 104, may be selected from the group consisting of, for example, oleyl groups, antibodies, aptamers, and molecular recognition polymers. The second molecule may be a molecule that specifically binds only to desired cells among the cells captured by the first molecule 104.

 第二の分子の標識は、1種類の蛍光物質又は複数種類の蛍光物質であってよい。例えば、1種類の蛍光物質を用いて1種類の細胞が認識されてもよい。代替的には、複数種類の蛍光物質を用いて、複数の種類の細胞が認識されてもよく、いわゆる多色分析などの手法が用いられてもよい。第二の分子が認識できなかった細胞は、該細胞が捕捉されているスポットの分解性リンカー103に刺激を付与し、刺激により分解性リンカー103が切断され、細胞が遊離する。遊離細胞は不要物として、洗浄液で培養容器101から洗い流すことができる。第二の分子を用いずに、明視野画像、位相差画像、偏光画像、及び、非染色画像と蛍光画像より学習された情報から識別され細胞の特徴ごとに疑似染色された画像をもとに細胞を識別し、光刺激によって細胞を遊離してもよい。当該識別は、後述する情報処理装置2により行われてよい。情報処理装置2は、当該識別の結果に基づき光学制御部210を駆動して前記光刺激を与えうる。本手法の場合、第二の分子が不要となり、プロセスのコスト削減に貢献できる。また、染色工程を省けるため、工程の短縮化に貢献する。 The label of the second molecule may be one type of fluorescent substance or multiple types of fluorescent substances. For example, one type of cell may be recognized using one type of fluorescent substance. Alternatively, multiple types of cells may be recognized using multiple types of fluorescent substances, and a technique such as so-called multicolor analysis may be used. Cells that cannot be recognized by the second molecule apply stimulation to the degradable linker 103 at the spot where the cell is captured, and the stimulation cleaves the degradable linker 103, releasing the cell. Free cells can be washed away from the culture container 101 with a washing solution as unnecessary substances. Based on pseudo-stained images for each cell feature identified from information learned from bright field images, phase contrast images, polarized images, unstained images, and fluorescent images without using a second molecule. Cells may be identified and released by light stimulation. The identification may be performed by the information processing device 2 described later. The information processing device 2 can drive the optical control unit 210 based on the result of the identification to apply the optical stimulation. In the case of this method, a second molecule is not required, which can contribute to reducing process costs. Also, since the dyeing process can be omitted, it contributes to shortening the process.

 洗浄液供給部111は、前記洗浄液を保持する。培養容器101における不要物等を洗浄するときに洗浄液を供給する。洗浄液は、細胞培養等に一般的に用いられるものでよい。洗浄液として、特に限定されないが、例えば、生理食塩水、Tris緩衝液、HEPES緩衝液、精製水等が挙げられる。 The cleaning liquid supply unit 111 holds the cleaning liquid. A cleaning liquid is supplied when cleaning unnecessary materials etc. in the culture container 101. The washing liquid may be one commonly used for cell culture and the like. Examples of the washing solution include, but are not limited to, physiological saline, Tris buffer, HEPES buffer, purified water, and the like.

 活性化剤供給部108は、細胞を活性化させる活性化剤、特には、当該活性化剤を含む液を保持する。活性化剤供給部108は、培養容器101内に活性化剤を供給するように構成されていてよい。活性化剤は細胞に合わせて選択されてよく、特に限定されないが、例えば、サイトカイン、ホルモン、インターロイキン、抗体等が挙げられる。活性化剤によって、細胞を培養する前に、培養している間に、又は、培養後に細胞を活性化することができる。 The activating agent supply unit 108 holds an activating agent for activating cells, particularly a liquid containing the activating agent. The activating agent supply unit 108 may be configured to supply an activating agent into the culture container 101. The activator may be selected depending on the cell and includes, but is not particularly limited to, cytokines, hormones, interleukins, antibodies, and the like. The activating agent can activate the cells before, during, or after culturing the cells.

 遺伝子供給部109は、細胞に導入したい遺伝子を保持する。遺伝子供給部109は、培養容器101内に当該遺伝子を供給するように構成されていてよい。当該遺伝子は、内在性遺伝子又は外来遺伝子のいずれでもよい。当該遺伝子は、遺伝子導入に適したファージベクター、プラスミドベクター、又はウイルスベクター等に組み込まれていてもよい。例えば、遺伝子供給部109は、目的遺伝子を組み込んだウイルスベクターを培養容器101に供給しうる。これにより、当該ウイルスベクターを細胞に感染させて遺伝子導入することができる。さらには、遺伝子供給部109は、例えば、CRISPR/Cas9システムのような特定の塩基配列と特定酵素を含むゲノム編集用試薬を培養容器101に供給してよく、これにより細胞に遺伝子が導入されてもよい。 The gene supply unit 109 holds genes that are desired to be introduced into cells. The gene supply unit 109 may be configured to supply the gene into the culture container 101. The gene may be an endogenous gene or a foreign gene. The gene may be incorporated into a phage vector, plasmid vector, viral vector, or the like suitable for gene introduction. For example, the gene supply unit 109 can supply a virus vector incorporating a target gene to the culture container 101. Thereby, cells can be infected with the virus vector to introduce genes. Furthermore, the gene supply unit 109 may supply a genome editing reagent containing a specific base sequence and a specific enzyme, such as the CRISPR/Cas9 system, to the culture container 101, thereby introducing the gene into the cells. Good too.

 培養液供給部110は、細胞に適した培養液を保持し、培養容器101に当該培養液を供給する。培養液は細胞に適したものを選択でき、例えば、イーグル培地、D-MEM培地、E-MEM培地、RPMI-1640培地、ダルベッコPBS培地等を用いることができる。なお、培養液をフェノールレッド等で着色しておけば、培養容器101で細胞を培養中、培養液のpH至適範囲(例えば、pH6.8~7.2)を管理することができる。 The culture solution supply unit 110 holds a culture solution suitable for cells and supplies the culture solution to the culture container 101. A culture medium suitable for the cells can be selected; for example, Eagle's medium, D-MEM medium, E-MEM medium, RPMI-1640 medium, Dulbecco's PBS medium, etc. can be used. Note that if the culture solution is colored with phenol red or the like, the optimum pH range of the culture solution (for example, pH 6.8 to 7.2) can be controlled while the cells are being cultured in the culture container 101.

 廃液貯留部112は、前記不要物を含む廃液又は培養液等を一旦受け入れる。廃液は必要に応じて滅菌処理等が行われ、そして、廃棄される。 The waste liquid storage section 112 temporarily receives the waste liquid, culture liquid, etc. containing the above-mentioned unnecessary substances. The waste liquid is subjected to sterilization treatment, etc., as necessary, and then discarded.

 細胞回収部113は、培養容器101で培養した細胞を回収し、保持する。回収方法は特に限定されないが、吸引や押出し、細胞回収部113を培養容器101の下方に配置すること等により可能である。 The cell collection unit 113 collects and retains the cells cultured in the culture container 101. The recovery method is not particularly limited, but can be performed by suction, extrusion, placing the cell recovery unit 113 below the culture container 101, or the like.

 物理化学的環境供給部114は、当該試料保持部100の物理化学的環境を保持又は提供する。培養中の前記物理化学的環境は細胞に合わせて適宜選択可能であり、特に限定されないが、例えば、湿度、pH、浸透圧、酸素分圧、二酸化炭素分圧等が挙げられる。これにより細胞に最適な物理化学的環境が提供され細胞の生存率を高めることができる。 The physicochemical environment supply unit 114 maintains or provides the physicochemical environment of the sample holding unit 100. The physicochemical environment during culture can be appropriately selected depending on the cells, and examples thereof include, but are not limited to, humidity, pH, osmotic pressure, oxygen partial pressure, carbon dioxide partial pressure, and the like. This provides cells with an optimal physicochemical environment and increases cell survival rate.

 連結部105は、培養容器101と上記各部位106~114のいずれか又は複数の部とをつなぎ、液が流れる。連結部105には、例えばチューブが用いられる。送液手法としては、接液しないペリスタポンプ等が好ましい。 The connecting part 105 connects the culture container 101 and any one or more of the above-mentioned parts 106 to 114, through which the liquid flows. For example, a tube is used for the connecting portion 105. As a liquid feeding method, a peristaltic pump or the like that does not come in contact with liquid is preferable.

 細胞培養部10は、更に、細胞培養部用制御部200を備えていてよく、細胞培養部用制御部200は、例えば、光学制御部210及び環境制御部を含む。細胞培養部用制御部200は、試料保持部100に含まれる細胞及び/又は細胞周囲の環境に対して物理化学的な制御を行う。 The cell culture section 10 may further include a cell culture section control section 200, and the cell culture section control section 200 includes, for example, an optical control section 210 and an environment control section. The cell culture section control section 200 performs physicochemical control on the cells included in the sample holding section 100 and/or the environment around the cells.

 前記光学制御部210は、光学制御により前記分解性リンカー103に対応する特定波長の光を照射することで刺激を付与してもよい。前記光学制御部210は、例えば、光源と、当該光源から出射された光を所定の位置(容器101中の所定の位置)に到達させるためのMEMS(Micro Electro Mechanical Systems)素子とを含んでよい。当該MEMS素子は、例えば、DMD又は走査ミラーであってよい。前記光学制御部210は、更に、当該光の形状及び/又は波長を制御するための光学素子(例えば、レンズ、フィルター、ミラー、プリズムなど)を含んでもよい。 The optical control unit 210 may apply stimulation by irradiating the degradable linker 103 with light of a specific wavelength through optical control. The optical control unit 210 may include, for example, a light source and a MEMS (Micro Electro Mechanical Systems) element for causing the light emitted from the light source to reach a predetermined position (a predetermined position in the container 101). . The MEMS device may be, for example, a DMD or a scanning mirror. The optical control unit 210 may further include an optical element (for example, a lens, a filter, a mirror, a prism, etc.) for controlling the shape and/or wavelength of the light.

 前記環境制御部は、物理化学的又は生理学的制御により当該試料保持部100に含まれる細胞周囲の物理化学的又は生理学的環境を保持又は提供してもよい。 The environment control unit may maintain or provide a physicochemical or physiological environment around the cells contained in the sample holding unit 100 through physicochemical or physiological control.

 図5に、前記光学制御部210の構成の一例を示す。図5に示される光学制御部210は、前記特定波長の光の照射を行うために、光源211、集束レンズ212、励起フィルター213、デジタルミラーデバイス214、及び映写レンズ215を備える。前記構成を有することにより、不要細胞の選択及び遊離を行うことができる。光源211は、前記分解性リンカー103に対応する波長の光を発する。集束レンズ212は該光を集束し、励起フィルター213は特定の波長の光のみを抽出し、透過させる。デジタルミラーデバイス214は、可動式のマイクロミラーで構成され、各マイクロミラーを傾斜させることにより、前記第一の分子104が固定化されたスポットごとに選択的に光照射することができる。映写レンズ215は、デジタルミラーデバイス214で反射した光を、前記第一の分子104が固定化されたスポットがある培養容器101の面に向けて光を照射する。前記光学制御部210による選択的な光照射により、遊離させたい細胞が捕捉されているスポットの分解性リンカー103を選択的に分解することができる。 FIG. 5 shows an example of the configuration of the optical control section 210. The optical control unit 210 shown in FIG. 5 includes a light source 211, a focusing lens 212, an excitation filter 213, a digital mirror device 214, and a projection lens 215 in order to irradiate the light of the specific wavelength. By having the above configuration, unnecessary cells can be selected and released. The light source 211 emits light of a wavelength corresponding to the degradable linker 103. A focusing lens 212 focuses the light, and an excitation filter 213 extracts and transmits only light of a specific wavelength. The digital mirror device 214 is composed of movable micromirrors, and by tilting each micromirror, it is possible to selectively irradiate each spot on which the first molecules 104 are immobilized. The projection lens 215 irradiates the light reflected by the digital mirror device 214 toward the surface of the culture container 101 where the spot where the first molecule 104 is immobilized is located. By selective light irradiation by the optical control unit 210, the degradable linker 103 in the spot where the cells to be released are captured can be selectively decomposed.

 前記光学制御部210は、前記第一のスポットごとに分解性リンカー103を刺激することを可能とする刺激制御部を更に備えていてよい。前記光学制御部210が光照射装置の場合、例えば、数十μmオーダーの間隔で培養容器101に配置された細胞に、個々に照射できればよいので、例えば、Digital Micromirror Device(DMD)や液晶パネル、MEMSシャッター等が利用できる。光源211とDMD214の間に励起フィルター213を配置し、目的に応じて最適なフィルター構成となるように、フィルターが回転するなどの機構を入れることで多色解析に対応可能である。フルHD数のマイクロミラーを備えたDMDが市販されているので、これを用いた光照射装置の刺激制御部は、1920×1080個のサイトを同時に制御(照射のON/OFF)できる。したがって、約2×10個の細胞への個別制御が同時に可能になる。例えば、1920×1080個のサイトで、30μmピッチで細胞(すなわち、Φ30um以下)を整列させた場合、約58×33mmの面積が必要となる。10個の細胞を処理したい場合は、これを10面用意する。2列に5面並べた場合、116×165mmであり、これはB6サイズよりも一回り小さいサイズであり、2×10個の細胞解析にも実現可能なサイズである。 The optical control unit 210 may further include a stimulation control unit that makes it possible to stimulate the degradable linker 103 for each of the first spots. If the optical control unit 210 is a light irradiation device, it is sufficient to individually irradiate cells arranged in the culture container 101 at intervals of several tens of μm, for example, a digital micromirror device (DMD), a liquid crystal panel, MEMS shutters etc. can be used. It is possible to support multicolor analysis by disposing an excitation filter 213 between the light source 211 and the DMD 214, and adding a mechanism for rotating the filter so as to obtain an optimal filter configuration depending on the purpose. Since a DMD equipped with a full HD number of micromirrors is commercially available, the stimulation control section of a light irradiation device using this can simultaneously control (turn ON/OFF irradiation on) 1920×1080 sites. Therefore, individual control of approximately 2×10 6 cells is possible at the same time. For example, when cells (ie, Φ30 um or less) are arranged at a pitch of 30 μm at 1920×1080 sites, an area of approximately 58×33 mm is required. If you want to treat 107 cells, prepare 10 sides of this. When five sides are arranged in two rows, the size is 116 x 165 mm, which is one size smaller than B6 size, and is a size that can be realized for analysis of 2 x 10 7 cells.

 前記環境制御部は、容器101内の物理化学的環境及び/又は生理学的環境を制御する。当該物理化学的環境の制御を行うために、前記環境制御部は、物理化学的環境供給部114を制御し、これにより、容器101内の湿度、pH、浸透圧、酸素分圧、又は二酸化炭素分圧等を制御することができる。これにより、培養環境下における細胞に最適な物理化学的環境が提供され細胞の生存率を高めることができる。当該生理学的環境の制御を行うためには、前記環境制御部は、活性化剤供給部108、遺伝子供給部109、及び培養液供給部110からなる群より選ばれる少なくとも1つ以上を制御しうる。これにより、培養環境下における細胞に最適な生理学的環境が提供され細胞の培養効率を向上させることができる。前記生理学的環境の制御は、培養液、刺激因子、転写因子、細胞密度のうち少なくとも1つによる制御を含みうる。 The environment control unit controls the physicochemical environment and/or physiological environment within the container 101. In order to control the physicochemical environment, the environment control section controls the physicochemical environment supply section 114, thereby controlling the humidity, pH, osmotic pressure, oxygen partial pressure, or carbon dioxide inside the container 101. Partial pressure, etc. can be controlled. This provides an optimal physicochemical environment for the cells in the culture environment and increases the survival rate of the cells. In order to control the physiological environment, the environment control section can control at least one selected from the group consisting of the activator supply section 108, the gene supply section 109, and the culture solution supply section 110. . This provides an optimal physiological environment for the cells in the culture environment and improves the efficiency of cell culture. Control of the physiological environment may include control by at least one of culture medium, stimulation factors, transcription factors, and cell density.

(2-2)測定部3 (2-2) Measuring section 3

 細胞培養システム1000は、処理前の細胞に関する情報、処理後の細胞に関する情報、及び処理中の細胞に関する情報からなる群より選ばれる少なくとも1つ以上を取得する測定部3を備える。測定部3は、画像を取得することで、細胞培養部用制御部200による処理中の細胞に関する情報を取得する画像取得部600を備えている。前記画像取得部600により取得される画像は、染色画像及び/又は非染色画像であってよい。 The cell culture system 1000 includes a measurement unit 3 that acquires at least one selected from the group consisting of information regarding cells before treatment, information regarding cells after treatment, and information regarding cells during treatment. The measurement unit 3 includes an image acquisition unit 600 that acquires information regarding cells being processed by the cell culture unit control unit 200 by acquiring images. The image acquired by the image acquisition unit 600 may be a stained image and/or a non-stained image.

 前記染色画像は、蛍光画像を含みうる。また、前記非染色画像は、明視野画像、位相差画像、偏光画像、及び、非染色画像と蛍光画像より学習された情報から識別され細胞の特徴ごとに疑似染色された画像のうち少なくとも1つを含みうる。なお、測定部3は、画像取得部600に加え、又は画像取得部600の代わりに、シグナルを取得することで細胞培養部10による処理中の細胞に関する情報を取得するシグナル検出部を備えていてもよい。例えば、当該画像取得部600は、以下(2-2-1)で説明する顕微鏡システム5000として構成されうる。また、測定部3が前記シグナル検出部を備えている場合は、測定部3は、生体試料分析装置6100として構成されてよい。当該生体試料分析装置6100については、「(2-2-2)生体試料分析装置6100」で説明する。 The stained image may include a fluorescent image. Further, the unstained image is at least one of a bright field image, a phase contrast image, a polarized light image, and an image that is identified from information learned from the unstained image and the fluorescent image and pseudostained for each cell feature. may include. In addition to the image acquisition section 600 or instead of the image acquisition section 600, the measurement section 3 includes a signal detection section that acquires information regarding the cells being processed by the cell culture section 10 by acquiring signals. Good too. For example, the image acquisition unit 600 may be configured as a microscope system 5000 described below (2-2-1). Furthermore, when the measuring section 3 includes the signal detecting section, the measuring section 3 may be configured as a biological sample analyzer 6100. The biological sample analysis device 6100 will be explained in “(2-2-2) Biological sample analysis device 6100”.

 なお、測定部3では、測定部3で取得した細胞塊の大きさや、細胞数に関する情報から細胞の増殖状態を解析することが可能である。例えば、T細胞の場合、細胞増殖時に細胞塊を作成することがある。当該細胞塊の面積を測定することによって、当該細胞の数を予測し、さらには当該塊の数を測定することで、容器内の全細胞数を予測することが可能となる。時系列で当該塊に関する測定値を取得することで、当該細胞の増殖状態を確認されうる。 Note that the measurement unit 3 can analyze the proliferation state of the cells from the information regarding the size of the cell mass and the number of cells acquired by the measurement unit 3. For example, in the case of T cells, cell clusters may be created during cell proliferation. By measuring the area of the cell cluster, it is possible to predict the number of cells, and by measuring the number of clusters, it is possible to predict the total number of cells in the container. By acquiring measurement values regarding the mass in time series, the proliferation state of the cells can be confirmed.

(2-2-1)顕微鏡システム5000 (2-2-1) Microscope system 5000

 顕微鏡システム5000の構成の一例を図6に示す。図6に示される顕微鏡システム5000は、顕微鏡装置5100、制御部5110、及び情報処理部5120を含む。顕微鏡装置5100は、光照射部5101、光学部5102、及び信号取得部5103を備えている。顕微鏡装置5100は、更に、細胞等の生体試料S1が配置される試料載置部5104を備えていてよい。なお、顕微鏡システム5000の構成は、図6に示されるものに限定されず、例えば、光照射部5101は、顕微鏡装置5100の外部に存在してもよく、例えば、顕微鏡装置5100に含まれない光源が光照射部5101として利用されてもよい。また、光照射部5101は、光照射部5101と光学部5102とによって試料載置部5104が挟まれるように配置されていてよく、例えば、光学部5102が存在する側に配置されてもよい。顕微鏡装置5100は、明視野観察、位相差観察、微分干渉観察、偏光観察、蛍光観察、及び暗視野観察からなる群より選ばれるいずれか1又は2以上で構成されてよい。 An example of the configuration of the microscope system 5000 is shown in FIG. A microscope system 5000 shown in FIG. 6 includes a microscope device 5100, a control section 5110, and an information processing section 5120. The microscope device 5100 includes a light irradiation section 5101, an optical section 5102, and a signal acquisition section 5103. The microscope device 5100 may further include a sample mounting section 5104 on which a biological sample S1 such as a cell is placed. Note that the configuration of the microscope system 5000 is not limited to that shown in FIG. may be used as the light irradiation unit 5101. Further, the light irradiation unit 5101 may be arranged so that the sample mounting unit 5104 is sandwiched between the light irradiation unit 5101 and the optical unit 5102, and may be arranged, for example, on the side where the optical unit 5102 is present. The microscope device 5100 may be configured with one or more selected from the group consisting of bright field observation, phase contrast observation, differential interference observation, polarized light observation, fluorescence observation, and dark field observation.

 顕微鏡システム5000は、いわゆるWSI(Whole Slide Imaging)システム又はデジタルパソロジーシステムとして構成されてよく、主に病理診断のために用いられうる。また、顕微鏡システム5000は、蛍光イメージングシステム、特には、多重蛍光イメージングシステムとして構成されてもよい。 The microscope system 5000 may be configured as a so-called WSI (Whole Slide Imaging) system or a digital pathology system, and may be used mainly for pathological diagnosis. The microscope system 5000 may also be configured as a fluorescence imaging system, particularly a multiplex fluorescence imaging system.

 また、顕微鏡システム5000は、術中病理診断又は遠隔病理診断を行うために用いられてよい。当該術中病理診断では、手術が行われている間に、顕微鏡装置5100が、当該手術の対象者から取得された生体試料S1のデータを取得し、そして、当該データを情報処理部5120へと送信しうる。当該遠隔病理診断では、顕微鏡装置5100は、取得した生体試料S1のデータを、顕微鏡装置5100とは離れた場所(例えば、別の部屋又は建物など)に存在する情報処理部5120へと送信しうる。そして、これらの診断において、情報処理部5120は、当該データを受信し、出力する。出力されたデータに基づき、情報処理部5120のユーザが、病理診断を行いうる。 Additionally, the microscope system 5000 may be used to perform intraoperative pathological diagnosis or remote pathological diagnosis. In the intraoperative pathological diagnosis, while the surgery is being performed, the microscope device 5100 acquires data of the biological sample S1 obtained from the patient undergoing the surgery, and transmits the data to the information processing unit 5120. I can do it. In the remote pathological diagnosis, the microscope device 5100 can transmit the data of the acquired biological sample S1 to the information processing unit 5120 located in a location apart from the microscope device 5100 (for example, in another room or building). . In these diagnoses, the information processing unit 5120 receives and outputs the data. Based on the output data, the user of the information processing unit 5120 can perform a pathological diagnosis.

(生体試料S1)
 生体試料S1は、生体成分を含む試料であってよい。前記生体成分は、生体の組織、細胞、生体の液状成分(例えば、血液や尿など)、培養物、又は生細胞(例えば、心筋細胞、神経細胞、受精卵など)であってよい。前記生体試料S1は、固形物であってよく、パラフィンなどの固定試薬によって固定された標本又は凍結により形成された固形物であってよい。前記生体試料S1は、当該固形物の切片でありうる。前記生体試料S1の具体例としては、生検試料の切片が挙げることができる。
(Biological sample S1)
The biological sample S1 may be a sample containing biological components. The biological component may be a biological tissue, a cell, a biological liquid component (eg, blood, urine, etc.), a culture, or a living cell (eg, a cardiac muscle cell, a nerve cell, a fertilized egg, etc.). The biological sample S1 may be a solid substance, and may be a specimen fixed with a fixing reagent such as paraffin or a solid substance formed by freezing. The biological sample S1 may be a section of the solid object. A specific example of the biological sample S1 is a section of a biopsy sample.

 前記生体試料S1は、染色又は標識などの処理が施されたものであってよい。当該処理は、生体成分の形態を示すための又は生体成分が有する物質(例えば、表面抗原など)を示すための染色であってよく、HE(Hematoxylin-Eosin)染色、免疫組織化学(Immunohistochemistry)染色等を挙げることができる。前記生体試料S1は、1又は2以上の試薬により前記処理が施されたものであってよく、当該試薬としては、蛍光色素、発色試薬、蛍光タンパク質、蛍光標識抗体等でありうる。 The biological sample S1 may be subjected to treatments such as staining or labeling. The treatment may be staining to show the form of the biological component or to show the substances (for example, surface antigens, etc.) that the biological component has, such as HE (Hematoxylin-Eosin) staining and immunohistochemistry staining. etc. can be mentioned. The biological sample S1 may be subjected to the above-mentioned treatment using one or more reagents, and the reagents may be fluorescent dyes, coloring reagents, fluorescent proteins, fluorescently labeled antibodies, or the like.

 前記標本は、人体から採取された検体又は組織サンプルから病理診断又は臨床検査などを目的に作製されたものであってよい。また、前記標本は、人体に限らず、動物、植物、又は他の材料に由来するものであってもよい。前記標本は、使用される組織(例えば、臓器、細胞など)の種類、対象となる疾病の種類、対象者の属性(例えば、年齢、性別、血液型、人種など)、対象者の生活習慣(例えば、食生活、運動習慣、喫煙習慣など)などにより、性質が異なる。前記標本は、各標本それぞれ識別可能な識別情報(例えば、各種バーコード情報等)を付されて管理されてよい。 The specimen may be prepared from a specimen or tissue sample collected from a human body for the purpose of pathological diagnosis or clinical examination. Further, the specimen is not limited to the human body, but may be derived from animals, plants, or other materials. The specimen includes the type of tissue used (e.g., organ, cell, etc.), the type of disease targeted, the attributes of the subject (e.g., age, sex, blood type, race, etc.), and the lifestyle habits of the subject. (For example, eating habits, exercise habits, smoking habits, etc.) The specimens may be managed by being assigned identification information (for example, various barcode information, etc.) that allows each specimen to be identified.

(光照射部5101)
 光照射部5101は、生体試料S1を照明するための光源、及び当該光源から照射された光を標本に導く光学部を備える。光源は、可視光、紫外光、若しくは赤外光、又はこれらの組合せを生体由来試料に照射しうる。光源は、ハロゲンランプ、レーザ光源、LEDランプ、水銀ランプ、及びキセノンランプからなる群より選択されるいずれか1又は2以上であってよい。蛍光観察における光源の種類及び/又は波長は、複数でもよく、当業者により適宜選択されてよい。光照射部5101は、透過型、反射型又は落射型(同軸落射型若しくは側射型)の構成を有しうる。
(Light irradiation unit 5101)
The light irradiation unit 5101 includes a light source for illuminating the biological sample S1 and an optical unit that guides the light irradiated from the light source to the sample. The light source can irradiate the biological sample with visible light, ultraviolet light, or infrared light, or a combination thereof. The light source may be one or more selected from the group consisting of a halogen lamp, a laser light source, an LED lamp, a mercury lamp, and a xenon lamp. A plurality of types and/or wavelengths of light sources may be used in fluorescence observation, and may be appropriately selected by those skilled in the art. The light irradiation unit 5101 can have a configuration of a transmission type, a reflection type, or an epi-illumination type (a coaxial epi-illumination type or a side-emission type).

(光学部5102)
 光学部5102は、生体試料S1からの光を信号取得部5103へと導くように構成される。光学部5102は、顕微鏡装置5100が生体試料S1を観察又は撮像することを可能とするように構成されうる。光学部5102は、対物レンズを含みうる。対物レンズの種類は、観察方式に応じて、当業者により適宜選択されてよい。また、光学部5102は、対物レンズによって拡大された像を信号取得部5103に中継するためのリレーレンズを含んでもよい。光学部5102は、前記対物レンズ及び前記リレーレンズ以外の光学部品、接眼レンズ、位相板、及びコンデンサレンズなどを更に含みうる。
(Optical section 5102)
The optical section 5102 is configured to guide light from the biological sample S1 to the signal acquisition section 5103. The optical unit 5102 may be configured to enable the microscope device 5100 to observe or image the biological sample S1. Optical section 5102 can include an objective lens. The type of objective lens may be appropriately selected by those skilled in the art depending on the observation method. Further, the optical section 5102 may include a relay lens for relaying the image magnified by the objective lens to the signal acquisition section 5103. The optical unit 5102 may further include optical components other than the objective lens and the relay lens, such as an eyepiece, a phase plate, and a condenser lens.

 また、光学部5102は、生体試料S1からの光のうちから所定の波長を有する光を分離するように構成された波長分離部を更に含んでいてよい。当該波長分離部は、所定の波長又は波長範囲の光を選択的に信号取得部に到達させるように構成されうる。当該波長分離部は、例えば、光を選択的に透過させるフィルター、偏光板、プリズム(ウォラストンプリズム)、及び回折格子からなる群より選ばれる1又は2以上を含んでよい。波長分離部に含まれる光学部品は、例えば、対物レンズから信号取得部5103までの光路上に配置されてよい。波長分離部は、蛍光観察が行われる場合、特には、励起光照射部を含む場合に、顕微鏡装置5100内に備えられる。波長分離部は、蛍光同士を互いに分離し又は白色光と蛍光とを分離するように構成されうる。 Furthermore, the optical section 5102 may further include a wavelength separation section configured to separate light having a predetermined wavelength from among the light from the biological sample S1. The wavelength separation section may be configured to selectively allow light of a predetermined wavelength or wavelength range to reach the signal acquisition section. The wavelength separation section may include, for example, one or more selected from the group consisting of a filter that selectively transmits light, a polarizing plate, a prism (Wollaston prism), and a diffraction grating. The optical components included in the wavelength separation unit may be placed on the optical path from the objective lens to the signal acquisition unit 5103, for example. The wavelength separation section is provided in the microscope apparatus 5100 when fluorescence observation is performed, particularly when the excitation light irradiation section is included. The wavelength separation unit may be configured to separate fluorescent light from each other or white light and fluorescent light.

(信号取得部5103)
 信号取得部5103は、生体試料S1からの光を受光し、当該光を電気信号、特には、デジタル電気信号へと変換することができるように構成されうる。信号取得部5103は、当該電気信号に基づき、生体試料S1に関するデータを取得することができるように構成されてよい。信号取得部5103は、生体試料S1の像(画像、特には、静止画像、タイムラプス画像、動画像)のデータを取得することができるように構成されてよく、特には、光学部によって拡大された画像のデータを取得するように構成されうる。信号取得部5103は、1次元又は2次元に並んで配列された複数の画素を備えている1つ又は複数の撮像素子、CMOS、CCDなどを含む。信号取得部5103は、低解像度画像取得用の撮像素子と高解像度画像取得用の撮像素子とを含んでよく、又は、AFなどのためのセンシング用撮像素子と観察などのための画像出力用撮像素子とを含んでもよい。撮像素子は、前記複数の画素に加え、各画素からの画素信号を用いた信号処理を行う信号処理部(CPU、DSP、及びメモリのうちの1つ、2つ、又は3つを含む)、及び、画素信号から生成された画像データ及び信号処理部により生成された処理データの出力の制御を行う出力制御部を含む信号処理センサであってもよい。更には、撮像素子は、入射光を光電変換する画素の輝度変化が所定の閾値を超えたことをイベントとして検出する非同期型のイベント検出センサを含みうる。前記複数の画素、前記信号処理部、及び前記出力制御部を含む撮像素子は、好ましくは1チップの半導体装置として構成されうる。
(Signal acquisition unit 5103)
The signal acquisition unit 5103 may be configured to receive light from the biological sample S1 and convert the light into an electrical signal, particularly a digital electrical signal. The signal acquisition unit 5103 may be configured to be able to acquire data regarding the biological sample S1 based on the electrical signal. The signal acquisition unit 5103 may be configured to be able to acquire data of an image (image, in particular, a still image, a time-lapse image, a moving image) of the biological sample S1, and in particular, an image of the biological sample S1 magnified by the optical unit. The image data may be configured to obtain image data. The signal acquisition unit 5103 includes one or more image sensors, CMOS, CCD, etc., each having a plurality of pixels arranged one-dimensionally or two-dimensionally. The signal acquisition unit 5103 may include an image sensor for obtaining a low-resolution image and an image sensor for obtaining a high-resolution image, or an image sensor for sensing for AF etc. and an image sensor for outputting images for observation etc. It may also include an element. In addition to the plurality of pixels, the image sensor includes a signal processing unit (including one, two, or three of a CPU, a DSP, and a memory) that performs signal processing using pixel signals from each pixel; The signal processing sensor may also include an output control section that controls output of image data generated from pixel signals and processed data generated by a signal processing section. Furthermore, the image sensor may include an asynchronous event detection sensor that detects as an event that a change in brightness of a pixel that photoelectrically converts incident light exceeds a predetermined threshold. The image sensor including the plurality of pixels, the signal processing section, and the output control section may preferably be configured as a one-chip semiconductor device.

(制御部5110)
 制御部5110は、顕微鏡装置5100による撮像を制御する。制御部5110は、撮像制御のために、光学部5102及び/又は試料載置部5104の移動を駆動して、光学部5102と試料載置部5104との間の位置関係を調節しうる。制御部5110は、光学部5102及び/又は試料載置部5104を、互いに近づく又は離れる方向(例えば、対物レンズの光軸方向など)に移動させうる。また、制御部5110は、光学部5102及び/又は試料載置部5104を、前記光軸方向と垂直な面におけるいずれかの方向に移動させてもよい。制御部5110は、撮像制御のために、光照射部5101及び/又は信号取得部5103を制御してもよい。
(Control unit 5110)
The control unit 5110 controls imaging by the microscope device 5100. The control unit 5110 can adjust the positional relationship between the optical unit 5102 and the sample platform 5104 by driving the movement of the optical unit 5102 and/or the sample platform 5104 for imaging control. The control unit 5110 can move the optical unit 5102 and/or the sample mounting unit 5104 in a direction toward or away from each other (for example, in the direction of the optical axis of the objective lens). Further, the control unit 5110 may move the optical unit 5102 and/or the sample mounting unit 5104 in any direction in a plane perpendicular to the optical axis direction. The control unit 5110 may control the light irradiation unit 5101 and/or the signal acquisition unit 5103 for imaging control.

(試料載置部5104)
 試料載置部5104は、生体試料S1の試料載置部5104上における位置が固定できるように構成されてよく、いわゆるステージであってよい。試料載置部5104は、生体試料S1の位置を、対物レンズの光軸方向及び/又は当該光軸方向と垂直な方向に移動させることができるように構成されうる。
(Sample placement section 5104)
The sample mounting section 5104 may be configured such that the position of the biological sample S1 on the sample mounting section 5104 can be fixed, and may be a so-called stage. The sample placement unit 5104 may be configured to be able to move the position of the biological sample S1 in the optical axis direction of the objective lens and/or in a direction perpendicular to the optical axis direction.

(情報処理部5120)
 情報処理部5120は、顕微鏡装置5100が取得したデータ(例えば、撮像データなど)を、顕微鏡装置5100から取得しうる。情報処理部5120は、撮像データに対する画像処理を実行しうる。当該画像処理は、色分離処理を含んでよい。当該色分離処理は、撮像データから所定の波長又は波長範囲の光成分のデータを抽出して画像データを生成する処理、又は、撮像データから所定の波長又は波長範囲の光成分のデータを除去する処理などを含みうる。また、当該画像処理は、組織切片の自家蛍光成分と色素成分を分離する自家蛍光分離処理や互いに蛍光波長が異なる色素間の波長を分離する蛍光分離処理を含みうる。前記自家蛍光分離処理では、同一ないし性質が類似する前記複数の標本のうち、一方から抽出された自家蛍光シグナルを用いて他方の標本の画像情報から自家蛍光成分を除去する処理を行ってもよい。
(Information processing unit 5120)
The information processing unit 5120 can acquire data (for example, imaging data, etc.) acquired by the microscope device 5100 from the microscope device 5100. The information processing unit 5120 can perform image processing on imaging data. The image processing may include color separation processing. The color separation process is a process of extracting data of a light component of a predetermined wavelength or wavelength range from imaging data to generate image data, or removing data of a light component of a predetermined wavelength or wavelength range from the imaging data. This may include processing, etc. Further, the image processing may include autofluorescence separation processing that separates the autofluorescence component and dye component of the tissue section, and fluorescence separation processing that separates the wavelengths of dyes that have different fluorescence wavelengths from each other. In the autofluorescence separation process, an autofluorescence signal extracted from one of the plurality of samples that are the same or have similar properties may be used to remove an autofluorescence component from image information of the other sample. .

 情報処理部5120は、制御部5110に撮像制御のためのデータを送信してよく、当該データを受信した制御部5110が、当該データに従い顕微鏡装置5100による撮像を制御してもよい。情報処理部5120は、汎用のコンピュータなどの情報処理部として構成されていてよく、CPU、RAM、及びROMを備えていてよい。情報処理部5120は、顕微鏡装置5100の筐体内に含まれていてよく、又は、当該筐体の外にあってもよい。また、情報処理部による各種処理又は機能は、ネットワークを介して接続されたサーバコンピュータ又はクラウドにより実現されてもよい。 The information processing unit 5120 may transmit data for controlling imaging to the control unit 5110, and the control unit 5110 that has received the data may control imaging by the microscope device 5100 in accordance with the data. The information processing unit 5120 may be configured as an information processing unit such as a general-purpose computer, and may include a CPU, RAM, and ROM. The information processing unit 5120 may be included within the casing of the microscope device 5100, or may be located outside the casing. Moreover, various processes or functions by the information processing unit may be realized by a server computer or cloud connected via a network.

 なお、信号取得部5103により取得される画像は、染色画像及び/又は非染色画像であってもよい。信号取得部5103は、画像から特徴量として、処理前、処理中、及び処理後の細胞に関する情報を取得してもよい。当該細胞に関する情報の具体例は、後述する。 Note that the image acquired by the signal acquisition unit 5103 may be a stained image and/or a non-stained image. The signal acquisition unit 5103 may acquire information regarding cells before processing, during processing, and after processing as feature amounts from the image. Specific examples of information regarding the cells will be described later.

 染色画像は、例えば、蛍光試薬により染色された生体試料S1に対し、光照射部5101が励起光を照射することで得られる蛍光画像である。これにより、例えば、CD4やCD8等のバイオマーカーを有する生体試料S1の分子マーカー解析が簡便且つ定量的となる。当該非染色画像は、非染色の生体試料S1から得られた明視野画像、位相差画像、偏光画像であってもよい。更には、当該非染色画像は、非染色画像と蛍光画像より学習された情報から識別され細胞の特徴ごとに疑似染色された画像であってもよい。当該疑似染色された画像は、非染色画像から核、細胞タイプ(例えば、神経など)、細胞状態(例えば、細胞死など)などの様々なラベルを予測することが可能であり、化学的な染色による蛍光スペクトルの重なりによる同時ラベル数の制限を解消することが可能となる。当該疑似染色された画像の具体的な手法に関しては、従来公知の手法を用いることができ、本技術では特に限定されない。 The stained image is, for example, a fluorescent image obtained by the light irradiation unit 5101 irradiating excitation light onto the biological sample S1 stained with a fluorescent reagent. Thereby, for example, molecular marker analysis of the biological sample S1 having biomarkers such as CD4 and CD8 becomes simple and quantitative. The unstained image may be a bright field image, a phase contrast image, or a polarized image obtained from the unstained biological sample S1. Furthermore, the non-stained image may be an image that is identified from information learned from the non-stained image and the fluorescent image and pseudo-stained for each cell feature. The pseudo-stained images allow prediction of various labels such as nucleus, cell type (e.g. nerve), cell state (e.g. cell death, etc.) from unstained images, and chemical staining It becomes possible to eliminate the limitation on the number of simultaneous labels due to the overlap of fluorescence spectra. As for the specific method of generating the pseudo-stained image, a conventionally known method can be used, and the present technology is not particularly limited.

(2-2-2)生体試料分析装置6100 (2-2-2) Biological sample analyzer 6100

 生体試料分析装置6100の構成の一例を図7に示す。図7に示される生体試料分析装置6100は、流路Cを流れる生体試料S2に光を照射する光照射部6101、前記照射によって生じた光を検出する検出部6102、及び前記検出部6102により検出された光に関する情報を処理する情報処理部6103を含む。生体試料分析装置6100の具体例としては、例えば、フローサイトメータや、イメージングサイトメータを挙げることができる。生体試料分析装置6100は、生体試料S2内の特定の生体粒子Pの分取を行う分取部6104を含んでもよい。分取部6104を含む生体試料分析装置6100の具体例としては、例えば、セルソータを挙げることができる。 An example of the configuration of the biological sample analyzer 6100 is shown in FIG. The biological sample analyzer 6100 shown in FIG. The information processing unit 6103 includes an information processing unit 6103 that processes information regarding the emitted light. Specific examples of the biological sample analyzer 6100 include a flow cytometer and an imaging cytometer. The biological sample analyzer 6100 may include a sorting section 6104 that sorts out specific biological particles P in the biological sample S2. A specific example of the biological sample analyzer 6100 including the sorting section 6104 is a cell sorter.

(生体試料S2)
 生体試料S2は、生体粒子Pを含む液状試料であってよい。当該生体粒子Pは、例えば、細胞又は非細胞性生体粒子である。前記細胞は、生細胞であってよく、より具体的な例としては、例えば、赤血球や白血球等の血液細胞や、精子や受精卵等の生殖細胞等を挙げることができる。また、前記細胞は全血等検体から直接採取されたものでもよいし、培養後に取得された培養細胞であってもよい。前記非細胞性生体粒子として、細胞外小胞、特には、エクソソーム、マイクロベシクル等を挙げることができる。前記生体粒子Pは、1つ又は複数の標識物質(例えば、色素(特には、蛍光色素)、蛍光色素標識抗体など)によって標識されていてもよい。なお、本実施形態に係る生体試料分析装置6100により、生体粒子P以外の粒子が分析されてもよく、キャリブレーションなどのために、ビーズなどが分析されてもよい。
(Biological sample S2)
The biological sample S2 may be a liquid sample containing biological particles P. The biological particles P are, for example, cells or non-cellular biological particles. The cells may be living cells, and more specific examples include blood cells such as red blood cells and white blood cells, and reproductive cells such as sperm and fertilized eggs. Further, the cells may be directly collected from a specimen such as whole blood, or may be cultured cells obtained after culturing. Examples of the non-cellular biological particles include extracellular vesicles, particularly exosomes, microvesicles, and the like. The biological particles P may be labeled with one or more labeling substances (for example, a dye (particularly a fluorescent dye), a fluorescent dye-labeled antibody, etc.). Note that the biological sample analyzer 6100 according to this embodiment may analyze particles other than the biological particles P, and beads or the like may be analyzed for calibration or the like.

(流路C)
 流路Cは、生体試料S2が流れるように、特には、前記生体試料S2に含まれる生体粒子が略一列に並んだ流れが形成されるように構成されうる。流路Cを含む流路構造は、層流が形成されるように設計されてよく、特には、生体試料S2の流れ(サンプル流)がシース液の流れによって包まれた層流が形成されるように設計される。当該流路構造の設計は、当業者により適宜選択されてよく、既知のものが採用されてもよい。流路Cは、マイクロチップ(マイクロメートルオーダーの流路を有するチップ)又はフローセルなどの流路構造体(flow channel structure)中に形成されてよい。流路Cの幅は、1mm以下であり、特には、10μm以上1mm以下であってよい。流路C及び/又はそれを含む流路構造体は、プラスチックやガラスなどの材料から形成されてよい。
(Flow path C)
The flow path C may be configured to allow the biological sample S2 to flow, in particular, to form a flow in which biological particles contained in the biological sample S2 are substantially aligned. The channel structure including the channel C may be designed to form a laminar flow, and in particular, a laminar flow is formed in which the flow of the biological sample S2 (sample flow) is surrounded by the flow of the sheath liquid. Designed to be. The design of the channel structure may be appropriately selected by those skilled in the art, and a known design may be adopted. The flow channel C may be formed in a flow channel structure such as a microchip (a chip having a flow channel on the order of micrometers) or a flow cell. The width of the channel C may be 1 mm or less, particularly 10 μm or more and 1 mm or less. The channel C and/or the channel structure including the channel C may be formed from a material such as plastic or glass.

 流路C内を流れる生体試料S2、特には、当該生体試料S2中の生体粒子Pに、前記光照射部6101からの光が照射されるように、本実施形態に係る生体試料分析装置6100は構成されてよい。生体試料分析装置6100は、生体試料S2に対する光の照射点(interrogation point)が、流路Cが形成されている流路構造体中にあるように構成されてよく、又は、当該光の照射点が、当該流路構造体の外にあるように構成されてもよい。前者の例としては、マイクロチップ又はフローセル内の流路Cに前記光が照射される構成等を挙げることができる。後者の例としては、流路構造体(特には、そのノズル部)から出た後の生体粒子Pに前記光が照射されてよく、例えばJet in Air方式のフローサイトメータを挙げることができる。 The biological sample analyzer 6100 according to the present embodiment is configured such that the biological sample S2 flowing in the flow path C, in particular, the biological particles P in the biological sample S2, is irradiated with the light from the light irradiation unit 6101. may be configured. The biological sample analyzer 6100 may be configured such that the interrogation point of the light on the biological sample S2 is in the channel structure in which the channel C is formed, or the interrogation point of the light may be configured to be located outside the channel structure. Examples of the former include a configuration in which the light is irradiated onto a channel C within a microchip or a flow cell. As an example of the latter, the biological particles P may be irradiated with the light after exiting from the flow path structure (particularly, the nozzle portion thereof), and for example, a jet-in-air type flow cytometer can be mentioned.

(光照射部6101)
 光照射部6101は、光を出射する光源部と、当該光を流路Cへと導く導光光学系とを含む。当該光源部は、1又は複数の光源を含む。光源の種類は、例えば、レーザ光源又はLEDでありうる。各光源から出射される光の波長は、紫外光、可視光、又は赤外光のいずれかの波長であってよい。導光光学系は、例えば、ビームスプリッター群、ミラー群、又は光ファイバなどの光学部品を含む。また、導光光学系は、光を集光するためのレンズ群を含んでよく、例えば、対物レンズを含みうる。生体試料S2に対する光の照射点は、1つ又は複数であってよい。光照射部6101は、一の照射点に対して、一つ又は異なる複数の光源から照射された光を集光するよう構成されていてもよい。
(Light irradiation unit 6101)
The light irradiation unit 6101 includes a light source unit that emits light, and a light guide optical system that guides the light to the flow path C. The light source section includes one or more light sources. The type of light source may be, for example, a laser light source or an LED. The wavelength of light emitted from each light source may be any wavelength of ultraviolet light, visible light, or infrared light. The light guide optical system includes, for example, optical components such as a beam splitter group, a mirror group, or an optical fiber. Further, the light guiding optical system may include a lens group for condensing light, and may include, for example, an objective lens. The number of light irradiation points on the biological sample S2 may be one or more. The light irradiation unit 6101 may be configured to collect light irradiated from one or a plurality of different light sources onto one irradiation point.

(検出部6102)
 検出部6102は、光照射部6101による生体粒子Pへの光照射により生じた光を検出する少なくとも一つの光検出器を備えている。検出する光は、例えば、蛍光又は散乱光(例えば、前方散乱光、後方散乱光、及び側方散乱光からなる群より選ばれるいずれか1つ以上)である。各光検出器は、1以上の受光素子を含み、例えば、受光素子アレイを有する。各光検出器は、受光素子としては、1又は複数のPMT(光電子増倍管)及び/又はAPD及びMPPC等のフォトダイオードを含んでよい。当該光検出器は、例えば、複数のPMTを一次元方向に配列したPMTアレイを含む。また、検出部6102は、例えば、CCD、CMOSなどの撮像素子を含んでもよい。検出部は、当該撮像素子により、生体粒子の画像(例えば、明視野画像、暗視野画像、蛍光画像など)を取得しうる。
(Detection unit 6102)
The detection unit 6102 includes at least one photodetector that detects light generated by the light irradiation of the biological particles P by the light irradiation unit 6101. The light to be detected is, for example, fluorescence or scattered light (for example, any one or more selected from the group consisting of forward scattered light, back scattered light, and side scattered light). Each photodetector includes one or more light receiving elements, and has, for example, a light receiving element array. Each photodetector may include one or more photomultiplier tubes (PMTs) and/or photodiodes such as APDs and MPPCs as light receiving elements. The photodetector includes, for example, a PMT array in which a plurality of PMTs are arranged in one dimension. Further, the detection unit 6102 may include, for example, an image sensor such as a CCD or a CMOS. The detection unit can acquire images of biological particles (for example, bright field images, dark field images, fluorescence images, etc.) using the imaging device.

 検出部6102は、所定の検出波長の光を、対応する光検出器に到達させる検出光学系を含む。検出光学系は、プリズムや回折格子等の分光部又はダイクロイックミラーや、光学フィルター等の波長分離部を含む。検出光学系は、例えば、生体粒子Pからの光を分光し、蛍光色素の数より多い複数の光検出器にて異なる波長域の光が検出されるよう構成されてもよい。このような検出光学系を含むフローサイトメータは、スペクトル型フローサイトメータと称される。また、検出光学系は、例えば、生体粒子Pからの光より蛍光色素の蛍光波長域に対応する光を分離し、当該分離された光を、対応する光検出器に検出させるよう構成されてもよい。 The detection unit 6102 includes a detection optical system that causes light of a predetermined detection wavelength to reach a corresponding photodetector. The detection optical system includes a spectroscopic section such as a prism or a diffraction grating, or a wavelength separation section such as a dichroic mirror or an optical filter. The detection optical system may be configured, for example, to separate light from the biological particles P, and to detect light in different wavelength ranges by a plurality of photodetectors, the number of which is greater than the number of fluorescent dyes. A flow cytometer including such a detection optical system is called a spectral flow cytometer. Further, the detection optical system may be configured, for example, to separate light corresponding to the fluorescence wavelength range of the fluorescent dye from the light from the biological particle P, and to cause the corresponding photodetector to detect the separated light. good.

 また、検出部6102は、光検出器により得られた電気信号をデジタル信号に変換する信号処理部を含みうる。当該信号処理部が、当該変換を行う装置としてA/D変換器を含んでよい。当該信号処理部による変換により得られたデジタル信号が、情報処理部に送信されうる。前記デジタル信号が、情報処理部により、光に関するデータ(以下、「光データ」ともいう)として取り扱われうる。前記光データは、例えば、蛍光データを含む光データであってよい。より具体的には、前記光データは、光強度データであってよく、当該光強度は、蛍光を含む光の光強度データ(例えば、Area、Height、Width等の特徴量を含んでもよい)であってよい。 Additionally, the detection unit 6102 may include a signal processing unit that converts the electrical signal obtained by the photodetector into a digital signal. The signal processing section may include an A/D converter as a device that performs the conversion. A digital signal obtained by conversion by the signal processing section can be transmitted to the information processing section. The digital signal can be handled as data related to light (hereinafter also referred to as "optical data") by the information processing section. The optical data may include, for example, fluorescence data. More specifically, the light data may be light intensity data, and the light intensity may be light intensity data of light including fluorescence (for example, may include feature quantities such as Area, Height, and Width). It's good.

(情報処理部6103)
 情報処理部6103は、例えば、各種データ(例えば、光データ)の処理を実行する処理部、及び各種データを記憶する記憶部を含む。処理部は、蛍光色素に対応する光データを検出部より取得した場合、光強度データに対し蛍光漏れ込み補正(コンペンセーション処理)を行いうる。また、処理部は、スペクトル型フローサイトメータの場合、光データに対して蛍光分離処理を実行し、蛍光色素に対応する光強度データを取得する。
(Information processing unit 6103)
The information processing unit 6103 includes, for example, a processing unit that processes various data (for example, optical data) and a storage unit that stores various data. When the processing section acquires light data corresponding to a fluorescent dye from the detection section, the processing section can perform fluorescence leakage correction (compensation processing) on the light intensity data. Further, in the case of a spectral flow cytometer, the processing unit performs fluorescence separation processing on the optical data and obtains light intensity data corresponding to the fluorescent dye.

 前記蛍光分離処理は、例えば、特開2011-232259号公報に記載されたアンミキシング方法に従って行われてよい。検出部6102が撮像素子を含む場合、処理部は、撮像素子により取得された画像に基づき、生体粒子の形態情報を取得してもよい。記憶部は、取得された光データを格納できるように構成されていてよい。記憶部は、更に、前記アンミキシング処理において用いられるスペクトラルリファレンスデータを格納できるように構成されていてよい。 The fluorescence separation process may be performed, for example, according to the unmixing method described in JP-A No. 2011-232259. When the detection unit 6102 includes an imaging device, the processing unit may acquire morphological information of the biological particles based on the image acquired by the imaging device. The storage unit may be configured to store the acquired optical data. The storage unit may further be configured to store spectral reference data used in the unmixing process.

 生体試料分析装置6100が後述する分取部6104を含む場合、情報処理部6103は、光データ及び/又は形態情報に基づき、生体粒子Pを分取するか否かの判定を実行しうる。そして、情報処理部6103は、当該判定の結果に基づき当該分取部6104を制御し、分取部6104による生体粒子Pの分取が行われうる。 When the biological sample analyzer 6100 includes a sorting section 6104 described below, the information processing section 6103 can determine whether or not to sort out the biological particles P based on the optical data and/or the morphological information. Then, the information processing unit 6103 controls the sorting unit 6104 based on the result of the determination, so that the sorting unit 6104 can sort out the biological particles P.

 情報処理部6103は、各種データ(例えば、光データ、画像など)を出力することができるように構成されていてよい。例えば、情報処理部6103は、光データに基づき生成された各種データ(例えば、二次元プロット、スペクトルプロットなど)を出力しうる。また、情報処理部6103は、各種データの入力を受け付けることができるように構成されていてよく、例えば、ユーザによるプロット上へのゲーティング処理を受け付ける。情報処理部6103は、当該出力又は当該入力を実行させるための出力部及び/又はユーザインターフェースを含みうる。 The information processing unit 6103 may be configured to be able to output various data (for example, optical data, images, etc.). For example, the information processing unit 6103 can output various data (eg, two-dimensional plot, spectral plot, etc.) generated based on the optical data. Further, the information processing unit 6103 may be configured to be able to accept input of various data, for example, accept gating processing on a plot by a user. The information processing unit 6103 can include an output unit and/or a user interface for executing the output or input.

 情報処理部6103は、汎用のコンピュータとして構成されてよく、例えば、CPU、RAM、及びROMを備えている情報処理部6103として構成されてよい。情報処理部6103は、光照射部6101及び検出部6102が備えられている筐体内に含まれていてよく、又は、当該筐体の外にあってもよい。また、情報処理部6103による各種処理又は機能は、ネットワークを介して接続されたサーバコンピュータ又はクラウドにより実現されてもよい。 The information processing unit 6103 may be configured as a general-purpose computer, and may be configured as an information processing unit 6103 that includes a CPU, RAM, and ROM, for example. The information processing unit 6103 may be included in the casing in which the light irradiation unit 6101 and the detection unit 6102 are provided, or may be located outside the casing. Further, various processes or functions by the information processing unit 6103 may be realized by a server computer or cloud connected via a network.

(分取部6104)
 分取部6104は、例えば、情報処理部6103による判定結果に応じて、生体粒子Pの分取を実行しうる。分取の方式は、振動により生体粒子Pを含む液滴を生成し、分取対象の液滴に対して電荷をかけ、当該液滴の進行方向を電極により制御する方式であってよい。分取の方式は、流路構造体内にて生体粒子Pの進行方向を制御し分取を行う方式であってもよい。当該流路構造体には、例えば、圧力(噴射や吸引)又は電荷による制御機構が設けられる。当該流路構造体の具体例としては、例えば、流路Cがその下流で回収流路及び廃液流路へと分岐している流路構造を有し、特定の生体粒子が当該回収流路へ回収されるチップ(例えば、特開2020-76736号公報に記載されたチップなど)を挙げることができる。
(Preparative separation section 6104)
The sorting unit 6104 can perform sorting of the biological particles P, for example, according to the determination result by the information processing unit 6103. The separation method may be a method in which droplets containing biological particles P are generated by vibration, an electric charge is applied to the droplets to be separated, and the traveling direction of the droplets is controlled by electrodes. The fractionation method may be a method in which the traveling direction of the biological particles P is controlled within the flow path structure and the fractionation is performed. The flow path structure is provided with a control mechanism using, for example, pressure (injection or suction) or electric charge. As a specific example of the flow path structure, for example, the flow path C has a flow path structure in which the flow path C branches into a recovery flow path and a waste fluid flow path downstream thereof, and specific biological particles are directed to the recovery flow path. Examples include chips that are collected (for example, the chip described in Japanese Patent Application Laid-open No. 2020-76736).

(3)情報処理装置2 (3) Information processing device 2

 情報処理装置2は、図1に示されるように、制御部300を少なくとも有する。また、必要に応じて、入力部301、記憶部302、出力部303、表示部304、学習部400、データベース500などを有していてもよい。なお、情報処理装置2の各部位は、ネットワークを介して接続されていてもよい。また、これら各部位は、複数あってもよく、クラウド等の外部に設けて、ネットワークを介して接続されていてもよい。 The information processing device 2 has at least a control section 300, as shown in FIG. Further, it may include an input section 301, a storage section 302, an output section 303, a display section 304, a learning section 400, a database 500, etc., as necessary. Note that each part of the information processing device 2 may be connected via a network. In addition, there may be a plurality of these parts, and they may be provided externally, such as in a cloud, and connected via a network.

 また、情報処理装置2は、汎用のコンピュータとして構成されてよく、例えば、CPU、RAM、及びROMを備えている情報処理部として構成されてよい。情報処理装置2は、細胞培養部10及び測定部3が備えられている筐体内に含まれていてよく、又は、当該筐体の外にあってもよい。また、情報処理装置2による各種処理又は機能は、ネットワークを介して接続されたサーバコンピュータ又はクラウドにより実現されてもよい。
 以下、情報処理装置2の各部位について詳細に説明する。
Further, the information processing device 2 may be configured as a general-purpose computer, and may be configured as an information processing section including a CPU, RAM, and ROM, for example. The information processing device 2 may be included in the housing in which the cell culture section 10 and the measurement section 3 are provided, or may be located outside the housing. Further, various processes or functions performed by the information processing device 2 may be realized by a server computer or cloud connected via a network.
Each part of the information processing device 2 will be described in detail below.

(制御部300)
 制御部300は、異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測し、且つ、前記培養予測結果として培養された細胞構成及び細胞の増殖過程に関する情報を可視化するよう制御する。これにより、培養条件ごとの培養予測結果を一覧俯瞰的に見ることができ、ユーザが複数の培養条件の選択肢の中から、所望の細胞群に到達するための予測を培養条件と紐づけて効率的に行うことができる。制御部300で行われる具体的な処理については、後述する「(4)制御工程S120」にて説明する。
(Control unit 300)
The control unit 300 predicts a plurality of culture prediction results for each culture condition of a cell group including different cells, and performs control to visualize information regarding the cultured cell composition and cell proliferation process as the culture prediction results. . This makes it possible to see a bird's-eye view of the culture prediction results for each culture condition, and allows the user to select from multiple culture condition options and link the predictions for reaching the desired cell group with the culture conditions to increase efficiency. It can be done in a specific manner. The specific process performed by the control unit 300 will be explained in "(4) Control step S120" described later.

(入力部301)
 入力部301は、ユーザ等が前記可視化された培養予測結果を操作する。これにより、例えば、実行する培養条件を選択することができる。この場合、制御部300は、入力部301で選択された培養条件に基づいて培養条件の制御を行いうる。
(Input section 301)
The input unit 301 allows a user or the like to operate the visualized culture prediction results. This allows, for example, to select the culture conditions to be performed. In this case, the control unit 300 can control the culture conditions based on the culture conditions selected by the input unit 301.

 また、ユーザ等は、入力部301を介して、細胞培養装置1や情報処理装置2の各部位にアクセスし、これら各部位を操作する。 Further, the user etc. access each part of the cell culture device 1 and the information processing device 2 via the input unit 301 and operate these parts.

 なお、入力部301の設置場所や設置数は特に限定されず、制御部300を有する筐体側に設置されていてよく、上述した細胞培養装置1側に設置されていてよく、或いは、その両方に設置されていてもよい。 Note that the installation location and number of input units 301 are not particularly limited, and they may be installed on the side of the casing that includes the control unit 300, on the side of the cell culture device 1 described above, or on both sides. It may be installed.

 入力部301としては、例えば、1又は複数のボタン、マウス、キーボード、タッチパネル、携帯情報端末などを用いることができる。また、入力部301は、情報処理装置2において必須の構成ではなく、クラウド等の外部に設置し、ネットワークを介して制御部300に接続したり、外部の記憶装置を用いたりしてもよい。 As the input unit 301, for example, one or more buttons, a mouse, a keyboard, a touch panel, a mobile information terminal, etc. can be used. Furthermore, the input unit 301 is not an essential component of the information processing device 2, and may be installed outside the cloud or the like and connected to the control unit 300 via a network, or may use an external storage device.

(記憶部302)
 記憶部302は、本技術に係る細胞培養システム1000におけるあらゆる事項を記憶しうる。なお、記憶部302としては、外部の記憶装置等を用いて、本技術に係る細胞培養システム1000に関わるあらゆる事項を記憶してもよい。
(Storage unit 302)
The storage unit 302 can store all matters in the cell culture system 1000 according to the present technology. Note that as the storage unit 302, an external storage device or the like may be used to store all matters related to the cell culture system 1000 according to the present technology.

 なお、記憶部302の設置場所や設置数などは特に限定されず、上述した制御部300を有する筐体側に設置されていてよい。また、記憶部302は、情報処理装置2において必須の構成ではなく、クラウド等の外部に設置し、ネットワークを介して制御部300に接続したり、外部の記憶装置を用いたりしてもよい。 Note that the installation location and number of storage units 302 are not particularly limited, and they may be installed on the side of the casing that includes the control unit 300 described above. Furthermore, the storage unit 302 is not an essential component of the information processing device 2, and may be installed outside the cloud or the like and connected to the control unit 300 via a network, or an external storage device may be used.

(出力部303)
 出力部303は、制御部300による指示を受け、例えば、本技術に係る細胞培養システム1000に関わるあらゆる事項を出力する。
(Output section 303)
The output unit 303 receives instructions from the control unit 300 and outputs, for example, all matters related to the cell culture system 1000 according to the present technology.

 なお、出力部303の設置場所や設置数は特に限定されず、制御部300を有する筐体側に設置されていてよく、上述した細胞培養装置1側に設置されていてよく、或いは、その両方に設置されていてもよい。 Note that the installation location and number of output units 303 are not particularly limited, and they may be installed on the side of the casing that includes the control unit 300, on the side of the cell culture device 1 described above, or on both sides. It may be installed.

 出力部303としては、プリンタ、スピーカー、携帯情報端末などを用いることができる。また、出力部303は、情報処理装置2において必須の構成ではなく、クラウド等の外部に設置し、ネットワークを介して制御部300に接続したり、外部の出力装置を用いたりしてもよい。 As the output unit 303, a printer, speaker, mobile information terminal, etc. can be used. Further, the output unit 303 is not an essential component of the information processing device 2, and may be installed outside the cloud or the like and connected to the control unit 300 via a network, or an external output device may be used.

(表示部304)
 表示部304は、制御部300による指示を受け、例えば、本技術に係る細胞培養システム1000に関わるあらゆる事項を表示する。
(Display section 304)
The display unit 304 receives instructions from the control unit 300 and displays, for example, all matters related to the cell culture system 1000 according to the present technology.

 なお、表示部304の設置場所や設置数は特に限定されず、制御部300を有する筐体側に設置されていてよく、上述した細胞培養装置1側に設置されていてよく、或いは、その両方に設置されていてもよい。 Note that the installation location and number of display units 304 are not particularly limited, and they may be installed on the side of the casing that includes the control unit 300, on the side of the cell culture device 1 described above, or on both sides. It may be installed.

 表示部304としては、ディスプレイ、タッチパネル、プロジェクター、携帯情報端末などを用いることができる。また、表示部304は、情報処理装置2において必須の構成ではなく、クラウド等の外部に設置し、ネットワークを介して制御部300に接続したり、外部の出力装置を用いたりしてもよい。 As the display unit 304, a display, a touch panel, a projector, a mobile information terminal, etc. can be used. Furthermore, the display unit 304 is not an essential component of the information processing device 2, and may be installed outside the cloud or the like and connected to the control unit 300 via a network, or may use an external output device.

(学習部400)
 学習部400は、制御部300により予測された処理条件により処理された細胞に関する情報と、当該細胞を用いた治療に関する情報とを学習用入力情報として、前記細胞と前記治療に関する情報の関連性を学習する第一学習器、及び、前記処理前の細胞に関する情報と、前記制御部300により予測された前記処理条件と、前記処理条件により処理された前記処理前の細胞とを学習用入力情報として、前記処理前の細胞に関する情報と前記処理条件の関連性を学習する第二学習器を備える。これによって、細胞群における処理前の細胞に関する情報から所望の細胞群に達成するための処理条件(特には、培養条件)及び所望の細胞の治療効果を達成するための処理後の細胞群に関する情報を予測することが可能となり、細胞培養プロセスの効率性を高めることができる。
(Learning Department 400)
The learning unit 400 uses information regarding the cells processed under the processing conditions predicted by the control unit 300 and information regarding the treatment using the cells as input information for learning, and determines the relationship between the cells and the information regarding the treatment. A first learning device to learn, information regarding the unprocessed cells, the processing conditions predicted by the control unit 300, and the unprocessed cells processed according to the processing conditions as input information for learning. , a second learning device that learns the relationship between the information regarding the cells before treatment and the treatment conditions. Thereby, information regarding the treatment conditions (in particular, culture conditions) for achieving the desired cell group and the information regarding the cell group after treatment for achieving the desired therapeutic effect of the cells is obtained from information regarding the cells before treatment in the cell group. can be predicted, increasing the efficiency of the cell culture process.

(データベース500)
 データベース500は、細胞培養部10により取得された細胞の処理条件、測定部3により取得された細胞に関する情報及び外部データベースから取得された細胞の治療に関する情報を取得し、保持する。データベース500は当該制御部300と当該学習部400に対し上記情報を送信するように構成されてよい。これにより、当該制御部300及び当該学習部400は、データベース500に保持された情報を参照することが可能となり、制御部300及び当該学習部400の予測効率及び学習効率が向上する。
(Database 500)
The database 500 acquires and retains processing conditions for cells acquired by the cell culture unit 10, information regarding cells acquired by the measurement unit 3, and information regarding cell treatment acquired from an external database. The database 500 may be configured to transmit the above information to the control section 300 and the learning section 400. Thereby, the control unit 300 and the learning unit 400 can refer to the information held in the database 500, and the prediction efficiency and learning efficiency of the control unit 300 and the learning unit 400 are improved.

2.第2実施形態(情報処理方法) 2. Second embodiment (information processing method)

(1)全体構成 (1) Overall composition

 本技術に係る情報処理方法のフローの一例を図8に示す。図8に示される通り、本技術に係る情報処理方法は、サンプル調製工程S100、処理前の細胞に関する情報取得工程S110、制御工程S120、処理工程S130、及び処理後の細胞に関する情報取得工程S140を含みうる。
 以下、これら各工程について詳細に説明する。
FIG. 8 shows an example of the flow of the information processing method according to the present technology. As shown in FIG. 8, the information processing method according to the present technology includes a sample preparation step S100, an information acquisition step S110 regarding cells before treatment, a control step S120, a treatment step S130, and an information acquisition step S140 regarding cells after treatment. It can be included.
Each of these steps will be explained in detail below.

(2)サンプル調製工程S100 (2) Sample preparation step S100

 サンプル調製工程S100において、細胞培養部10は、対象とする細胞(対象細胞)を含む細胞群を調製する。対象細胞の種類は特に限定されず、ヒト由来細胞、免疫細胞、動物由来細胞、植物由来細胞、微生物由来細胞、がん細胞、正常細胞、幹細胞、上皮細胞、及びオルガノイドからなる群より選ばれる少なくとも1種以上でもよい。例えば、動物細胞の場合、細胞として、血液中の細胞及び生体組織から採取した細胞等が挙げられる。また、対象細胞は、接着性細胞や、非接着性細胞のいずれであってもよい。更には、当該細胞群は、患者又はドナーから採取された末梢血単核球分画(PBMC:Peripheral blood mononuclear cells)であってもよい。当該採取されたPBMCに対して培養増殖及び/又は遺伝子導入を行うことによって、特定のがん細胞を攻撃する細胞を含む細胞群が製造され、当該細胞群は、例えば、細胞製剤として治療用途で利用される。当該PBMCは、様々な免疫細胞群で構成され、T細胞、B細胞、マクロファージなどを含む。当該T細胞は、更に、ナイーブT細胞、セントラルメモリーT細胞、及びエフェクターT細胞などを含む、T細胞サブセットで構成されていてもよい。 In the sample preparation step S100, the cell culture unit 10 prepares a cell group containing target cells (target cells). The type of target cells is not particularly limited, and at least one selected from the group consisting of human-derived cells, immune cells, animal-derived cells, plant-derived cells, microbial-derived cells, cancer cells, normal cells, stem cells, epithelial cells, and organoids. One or more types may be used. For example, in the case of animal cells, examples of the cells include cells in blood and cells collected from living tissue. Further, the target cells may be either adherent cells or non-adherent cells. Furthermore, the cell group may be peripheral blood mononuclear cells (PBMC) collected from a patient or donor. By culturing and propagating the collected PBMC and/or introducing genes, a cell group containing cells that attack specific cancer cells is produced, and the cell group can be used for therapeutic purposes as a cell preparation, for example. used. The PBMC is composed of various immune cell groups, including T cells, B cells, macrophages, and the like. The T cells may further be comprised of T cell subsets, including naive T cells, central memory T cells, effector T cells, and the like.

 サンプル調製工程S100は、サンプル投入工程を含みうる。サンプル投入工程において、細胞培養部10の細胞投入部106から投入された対象細胞を含む細胞群は、細胞と結合可能な第一の分子104により培養容器101に捕捉される。この工程において、対象外の細胞は培養容器101に捕捉されることなく、廃液貯留部112又は細胞回収部113より回収されてもよい。 The sample preparation step S100 may include a sample input step. In the sample input step, a group of cells including target cells input from the cell input unit 106 of the cell culture unit 10 is captured in the culture container 101 by the first molecules 104 that can bind to cells. In this step, non-target cells may be collected from the waste liquid storage section 112 or the cell collection section 113 without being captured in the culture container 101.

 また、サンプル調製工程S100は、第二の分子供給工程を含みうる。第二の分子供給工程において、培養容器101に捕捉された細胞は、第二の分子供給部より供給された第二の分子と結合されうる。供給された第二の分子は、例えば、蛍光試薬であってもよく、これにより測定部3による対象細胞の判別が可能となる。なお、当該第二の分子と結合されず、測定部3により対象細胞と判別されなかった細胞は、廃液貯留部112又は細胞回収部113より回収されてもよい。また、本技術では、第二の分子を用いずに、明視野画像、位相差画像、偏光画像、及び、非染色画像と蛍光画像より学習された情報から識別され細胞の特徴ごとに疑似染色された画像をもとに細胞を識別し、光刺激によって細胞を遊離してもよい。当該識別は、情報処理装置2により行われてよい。情報処理装置2は、当該識別の結果に基づき光学制御部210を駆動する。光学制御部210が、前記光刺激を実行しうる。 Additionally, the sample preparation step S100 may include a second molecule supply step. In the second molecule supply step, the cells captured in the culture vessel 101 can be combined with the second molecule supplied from the second molecule supply unit. The supplied second molecule may be, for example, a fluorescent reagent, which allows the measurement unit 3 to identify the target cell. Note that cells that are not bound to the second molecule and that are not determined as target cells by the measurement unit 3 may be collected from the waste liquid storage unit 112 or the cell recovery unit 113. In addition, this technology uses information learned from bright field images, phase contrast images, polarized images, unstained images, and fluorescent images to perform pseudo-staining for each cell feature without using a second molecule. The cells may be identified based on the image obtained, and the cells may be released by light stimulation. The identification may be performed by the information processing device 2. The information processing device 2 drives the optical control unit 210 based on the result of the identification. An optical control unit 210 may perform the optical stimulation.

 更に、サンプル調製工程S100は、環境制御工程を含みうる。環境制御工程において、培養容器101は、前記環境制御部より処理前の細胞を含む培養容器の環境を制御される。例えば、培養容器101は、前記環境制御部による物理化学的な環境の制御を受け、物理化学的環境供給部114から湿度、pH、浸透圧、酸素分圧、二酸化炭素分圧等の物理化学的環境を供給されてもよい。あるいは、例えば、培養容器101は、前記環境制御部による生理学的な環境の制御を受け、活性化剤供給部108、遺伝子供給部109、培養液供給部110のうち少なくとも1つから、刺激因子、培養液、ホルモン、サイトカイン、インターロイキン等の生理学的環境を供給されてもよい。これにより、培養環境下における対象細胞に最適な環境が提供され細胞の生存率及び/又は培養効率を高めることができる。これにより、培養環境下における対象細胞に最適な生理学的環境が提供され細胞の培養効率を向上させることができる。なお、環境制御工程は、サンプル調製工程S100のみならず、当該前後の工程において適宜実行されてもよい。 Further, the sample preparation step S100 may include an environment control step. In the environment control step, the environment of the culture container 101 containing the cells before treatment is controlled by the environment control section. For example, the culture container 101 receives physicochemical environment control by the environment control section, and receives physicochemical environment control such as humidity, pH, osmotic pressure, oxygen partial pressure, carbon dioxide partial pressure, etc. from the physicochemical environment supply section 114. environment may be provided. Alternatively, for example, the culture container 101 is subjected to physiological environment control by the environment control section, and receives stimulation factors, A physiological environment such as culture media, hormones, cytokines, interleukins, etc. may be provided. This provides an optimal environment for the target cells in the culture environment, thereby increasing cell survival rate and/or culture efficiency. This provides an optimal physiological environment for the target cells in the culture environment and improves the efficiency of cell culture. Note that the environmental control step may be performed not only in the sample preparation step S100 but also in steps before and after the step as appropriate.

(3)処理前の細胞に関する情報取得工程S110 (3) Information acquisition step S110 regarding cells before treatment

 処理前の細胞に関する情報取得工程S110において、情報処理装置2は、サンプル調製工程S100で調製された処理前の対象細胞に関する情報を取得する。処理前の細胞に関する情報取得工程S110は、処理前の細胞測定工程を含みうる。処理前の情報取得工程S110において、測定部3(特には、前記画像取得部及び/又は前記シグナル検出部)は画像情報及び/又はシグナル情報を取得する。取得された画像情報及び/又はシグナル情報より、処理前の対象細胞に関する情報を抽出することが可能となる。当該画像情報及び/又は信号情報は、サンプル調製工程S100において付与された第二の分子、例えば、蛍光試薬由来の情報であってもよい。 In the information acquisition step S110 regarding cells before treatment, the information processing device 2 acquires information regarding the target cells before treatment prepared in the sample preparation step S100. The information acquisition step S110 regarding cells before treatment may include a step of measuring cells before treatment. In the pre-processing information acquisition step S110, the measurement unit 3 (particularly the image acquisition unit and/or the signal detection unit) acquires image information and/or signal information. From the acquired image information and/or signal information, it is possible to extract information regarding the target cells before treatment. The image information and/or signal information may be information derived from the second molecule, for example, a fluorescent reagent, provided in the sample preparation step S100.

 測定部3により抽出された処理前の細胞に関する情報としては、例えば、細胞形態、細胞構成(特には、細胞数、細胞割合)、細胞の増殖過程(特には、細胞増殖率、細胞生存率)、細胞の種類、遺伝情報、及び分子に関する情報からなる群より選ばれる少なくとも1つ以上であってもよい。本明細書において、「細胞形態」とは、細胞の形状、又は細胞の外観をいう。当該分子に関する情報は、転写因子や転写制御因子等の遺伝子発現制御因子、分子マーカー情報、細胞表面抗原の情報、配列情報、分子量、種類等が含まれるが特に限定されない。当該細胞に関する情報は、測定部3により取得された後、制御部300に送信される。また、当該細胞に関する情報は、情報処理装置2のデータベース500に送信され、当該データベース500が更新されてもよい。 The information on the cells before processing extracted by the measurement unit 3 includes, for example, cell morphology, cell composition (in particular, cell number, cell ratio), and cell growth process (in particular, cell proliferation rate, cell survival rate). , cell type, genetic information, and information regarding molecules. As used herein, "cell morphology" refers to the shape of a cell or the appearance of a cell. Information regarding the molecule includes, but is not particularly limited to, gene expression control factors such as transcription factors and transcription control factors, molecular marker information, cell surface antigen information, sequence information, molecular weight, type, and the like. Information regarding the cells is acquired by the measurement unit 3 and then transmitted to the control unit 300. Further, information regarding the cells may be transmitted to the database 500 of the information processing device 2, and the database 500 may be updated.

 処理前の細胞に関する情報取得工程S110は、処理条件(特には、培養条件)受け付け工程を含みうる。処理条件受け付け工程において、情報処理装置2は、所定の処理条件、又は所定の処理後の対象細胞に関する情報を受け付ける工程を含みうる。所定の処理条件及び所定の処理後の対象細胞に関する情報は、情報処理装置2に設定された入力部301により受け付けられてよい。これにより、後述する制御工程S120において、ユーザの所望の処理後の細胞に関する情報や、所望の処理条件を得るための処理条件を予測することが可能となる。更には、所定の処理条件及び所定の処理後の対象細胞に関する情報は、データベース500及び/又は外部のデータベースより閾値を入手されてもよい。これにより、後述する制御工程S120において、当該閾値を活用することができる。 The information acquisition step S110 regarding cells before treatment may include a step of accepting treatment conditions (in particular, culture conditions). In the processing condition receiving step, the information processing device 2 may include a step of receiving information regarding the predetermined processing conditions or the target cells after the predetermined treatment. Information regarding the predetermined processing conditions and the target cells after the predetermined processing may be received by the input unit 301 set in the information processing device 2 . Thereby, in the control step S120, which will be described later, it becomes possible to predict the information regarding the cells after the user's desired treatment and the treatment conditions for obtaining the desired treatment conditions. Furthermore, information regarding the predetermined treatment conditions and target cells after the predetermined treatment may be obtained by obtaining threshold values from the database 500 and/or an external database. Thereby, the threshold value can be utilized in the control step S120, which will be described later.

 当該処理条件受け付け工程において、情報処理装置2は、更に、データベース500及び/又は外部のデータベースより、閾値として製品化された当該細胞の承認に関する情報を受け付ける工程を含みうる。これにより、後述する制御工程S120において、既存の製品化された当該細胞の承認に関する情報を参照にすることで、承認基準を満たすために必要な当該細胞の処理条件や細胞に関する情報をユーザに提示することができる。当該細胞の承認に関する情報は、細胞に関する情報や細胞の処理条件、治療に関する情報から適宜選択されうる。なお、当該細胞の承認に関する情報は、情報処理装置2に適宜設定されたユーザインターフェースにより受けつけ可能である。前記制御部300は、前記細胞の承認に関する情報に基づいて、前記所定の細胞に関する情報及び/又は前記所定の処理条件を設定してよい。 In the processing condition receiving step, the information processing device 2 may further include a step of receiving information regarding approval of the commercialized cell as a threshold value from the database 500 and/or an external database. As a result, in the control step S120, which will be described later, by referring to information regarding the approval of existing commercialized cells, the processing conditions for the cells and information regarding the cells necessary to meet the approval criteria are presented to the user. can do. Information regarding the approval of the cells can be appropriately selected from information regarding the cells, processing conditions for the cells, and information regarding the treatment. Note that information regarding the approval of the cell can be received through a user interface appropriately set in the information processing device 2. The control unit 300 may set information regarding the predetermined cell and/or the predetermined processing condition based on information regarding approval of the cell.

 前記処理条件は、特には、培養条件であり、培養条件としては、例えば、刺激因子、培養日数、培養試薬の種類、培養試薬数、培養工程数、培養工程の煩雑さ、及び培養コストからなる群より選ばれるいずれか1つ以上とすることができる。また、指定された当該所定の処理条件は、後述する通り、細胞培養部用制御部200により処理される細胞選別や細胞培養制御であってもよい。 The processing conditions are particularly culture conditions, and the culture conditions include, for example, stimulating factors, number of culture days, types of culture reagents, number of culture reagents, number of culture steps, complexity of culture steps, and culture cost. It can be one or more selected from the group. Further, the specified predetermined processing conditions may be cell sorting or cell culture control processed by the cell culture unit control unit 200, as described later.

 処理後の対象細胞に関する情報は、上述する処理前の細胞に関する情報に加えて、当該細胞の治療に関する情報であってもよい。治療に関する情報としては、例えば、当該細胞の患者に対する治療効果、奏効率、再発率、副作用、及び患者の治療履歴からなる群より選ばれるいずれか1つ以上とすることができる。これにより、後述する学習工程において当該治療に関する情報に達するための処理後の細胞に関する情報が学習され、患者個人に準じた細胞構成及び細胞の増殖過程を実行することが可能となる。 Information regarding the target cells after treatment may be information regarding treatment of the cells in addition to the information regarding the cells before treatment described above. The information regarding the treatment can be, for example, any one or more selected from the group consisting of the therapeutic effect of the cells on the patient, the response rate, the recurrence rate, the side effects, and the patient's treatment history. As a result, in the learning process described later, information regarding the treated cells is learned in order to arrive at information regarding the treatment, and it becomes possible to execute the cell configuration and cell proliferation process in accordance with the individual patient.

 情報処理装置2が受け付けた所定の処理条件又は所定の処理後の対象細胞に関する情報は制御部300及び/又はデータベース500に適宜送信されうる。 Information regarding the predetermined processing conditions or target cells after the predetermined processing received by the information processing device 2 may be transmitted to the control unit 300 and/or the database 500 as appropriate.

(4)制御工程S120 (4) Control process S120

 制御工程S120において、制御部300は、異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測する。当該培養予測結果は、処理前の情報取得工程S110において取得された処理前の対象細胞に関する情報と、処理条件受け付け工程において取得された所定の処理条件及び所定の処理後の対象細胞に関する情報のうち少なくとも1つに基づいて、所定の細胞に関する情報に前記細胞群を導出可能な処理条件、又は、前記所定の処理条件により導出される前記細胞群の処理後の細胞に関する情報を予測条件として予測する。本明細書内において、予測条件は、前記制御部300による予測処理によって生成された「前記所定の細胞に関する情報に前記細胞群を導出可能な処理条件」、若しくは、前記制御部300による予測処理によって生成された「前記所定の処理条件により導出される前記細胞群の処理後の細胞に関する情報」であってよい。すなわち、前記予測条件は、予測された予測条件又は予測された細胞に関する情報を意味してよい。 In the control step S120, the control unit 300 predicts a plurality of culture prediction results for each culture condition of a cell group containing different cells. The culture prediction result is selected from among the information regarding the target cells before treatment acquired in the pre-processing information acquisition step S110 and the information regarding the target cells after the predetermined treatment conditions and predetermined treatment acquired in the treatment condition receiving step. Based on at least one, a processing condition that allows the cell group to be derived from information regarding a predetermined cell, or information regarding the cell after processing of the cell group derived by the predetermined processing condition is predicted as a prediction condition. . In this specification, the prediction condition refers to "a processing condition that allows the cell group to be derived from the information regarding the predetermined cells" generated by the prediction process by the control unit 300, or a prediction condition by the prediction process by the control unit 300. It may be the generated "information regarding the cells after the treatment of the cell group derived from the predetermined treatment conditions." That is, the prediction condition may mean information regarding a predicted prediction condition or a predicted cell.

 所定の細胞に関する情報に前記細胞群を導出可能な処理条件とは、当該処理条件受け付け工程において指定された所定の細胞に関する情報に到達するために細胞培養部用制御部200が導出可能な処理条件であり、特には、培養条件であってもよい。 Processing conditions that allow the cell group to be derived from information regarding predetermined cells are processing conditions that can be derived by the cell culture unit control unit 200 in order to arrive at information regarding the predetermined cells specified in the processing condition receiving step. In particular, it may be a culture condition.

 前記所定の処理条件により導出される前記細胞群の処理後の細胞に関する情報とは、前記細胞培養部用制御部200が、ユーザにより指定された所定の処理を実行することにより取得され得る処理後の細胞に関する情報である。ユーザにより指定された所定の処理は、後述する処理工程S130における処理条件であれば特に限定されない。処理後の細胞に関する情報は、上記記載の通りであれば特に限定されない。前記処理後の細胞に関する情報としては、例えば、細胞形態、細胞構成(特には、細胞数、細胞割合)、細胞の増殖過程(特には、細胞増殖率、細胞生存率)、細胞の種類、遺伝情報、及び分子に関する情報からなる群より選ばれる少なくとも1つ以上であってもよい。 The information regarding the processed cells of the cell group derived based on the predetermined processing conditions is the post-processing information that can be obtained by the cell culture unit control unit 200 executing a predetermined process specified by the user. This is information about cells. The predetermined process specified by the user is not particularly limited as long as it is a process condition in process step S130, which will be described later. Information regarding the cells after treatment is not particularly limited as long as it is as described above. Information regarding the cells after the treatment includes, for example, cell morphology, cell composition (in particular, cell number, cell ratio), cell proliferation process (in particular, cell proliferation rate, cell survival rate), cell type, and genetics. The information may be at least one selected from the group consisting of information and information regarding molecules.

 本技術の制御工程S120のフローの一例を図9に示す。図9に示される通り、制御工程S120は、予測結果生成工程S121と、可視化工程S122とを含みうる。予測結果生成工程S121において、制御部300は、処理前の細胞測定工程において取得された処理前の対象細胞に関する情報と、処理条件受け付け工程において取得された所定の処理条件と、に基づいて前記細胞群の処理後の細胞に関する情報を予測し、予測結果を生成する。或いは、制御部300は、処理前の細胞測定工程において取得された処理前の対象細胞に関する情報と、処理条件受け付け工程において取得された所定の処理後の対象細胞に関する情報と、に基づいて所定の細胞に関する情報に前記細胞群を導出可能な処理条件を予測し、結果を生成する。 FIG. 9 shows an example of the flow of the control step S120 of the present technology. As shown in FIG. 9, the control step S120 may include a prediction result generation step S121 and a visualization step S122. In the prediction result generation step S121, the control unit 300 selects the cell based on the information regarding the target cell before treatment acquired in the pre-treatment cell measurement step and the predetermined treatment conditions acquired in the treatment condition reception step. Predict information about the cells after processing the group and generate prediction results. Alternatively, the control unit 300 performs a predetermined measurement based on the information regarding the target cells before treatment acquired in the pre-treatment cell measurement step and the information regarding the target cells after a predetermined treatment acquired in the treatment condition receiving step. A processing condition that allows the cell group to be derived is predicted based on the information regarding the cells, and a result is generated.

 制御部300は、測定部3及び/又はデータベース500より処理前の対象細胞に関する情報を取得してもよい。更には、制御部300は、データベース500、外部のデータベース、及び情報処理装置2のユーザインターフェースからなる群のうち少なくとも1つから、ユーザの所望の処理後の細胞に関する情報や所望の処理条件を取得してもよい。 The control unit 300 may acquire information regarding the target cells before processing from the measurement unit 3 and/or the database 500. Furthermore, the control unit 300 acquires information regarding the cells after the user's desired treatment and desired treatment conditions from at least one of the group consisting of the database 500, an external database, and the user interface of the information processing device 2. You may.

 予測結果生成工程S121において、制御部300は、更に、後述する学習工程において学習部400により生成された第一学習器及び第二学習器のいずれか一方を用いて予測結果を生成してもよい。なお、本明細書内において、制御工程S120では、対象細胞に関する情報などに基づき、前記導出可能な処理条件又は前記処理後の細胞に関する情報を生成する処理を実行する工程を意味し、すなわち、機械学習分野における推論処理を包含する。 In the prediction result generation step S121, the control unit 300 may further generate a prediction result using either one of the first learning device and the second learning device generated by the learning unit 400 in the learning step described later. . Note that in this specification, the control step S120 means a step of executing a process of generating information regarding the derivable treatment conditions or the treated cells based on information regarding the target cells, that is, Includes inference processing in the field of learning.

 制御工程S120は、可視化工程S122を含みうる。可視化工程S122において、制御部300は、予測結果生成工程S121において作成された、異なる細胞を含む細胞群の培養条件ごとに複数の予測結果のうち、特には、複数の培養予測結果を、前記培養予測結果として培養された細胞構成及び細胞の増殖過程に関する情報を可視化するよう制御する。その他にも、上述した予測結果生成工程S121において生成された予測条件を可視化するよう制御してもよい。当該培養予測結果は、例えば、情報処理装置2において設定された表示部304を介してユーザに対して提示されてもよい。これによりユーザが当該培養予測結果を視認することが可能となる。 The control step S120 may include a visualization step S122. In the visualization step S122, the control unit 300 particularly selects a plurality of culture prediction results from among the plurality of prediction results for each culture condition of a cell group containing different cells created in the prediction result generation step S121. Control is performed to visualize information regarding the cultured cell composition and cell growth process as a prediction result. In addition, control may be performed to visualize the prediction conditions generated in the prediction result generation step S121 described above. The culture prediction result may be presented to the user via the display section 304 set in the information processing device 2, for example. This allows the user to visually recognize the culture prediction results.

 当該提示された培養予測結果は、データベース500に送信され、当該データベース500は更新されてもよい。また、当該出力された培養予測結果は、細胞培養部10の細胞培養部用制御部200に送信されてもよく、当該出力条件に基づいて細胞培養部用制御部200は、細胞培養部10内の対象細胞に対して処理することが可能となる。 The presented culture prediction results may be transmitted to the database 500, and the database 500 may be updated. Further, the output culture prediction result may be transmitted to the cell culture unit control unit 200 of the cell culture unit 10, and the cell culture unit control unit 200 controls the cell culture unit 10 based on the output conditions. It becomes possible to treat target cells.

 図11~16は、可視化工程S122における可視化の様子を説明する図である。前記可視化は、例えば、前記培養予測結果を、例えば、表、グラフ、ツリー等の図示、又は三次元立体化することにより行われるが、特には、図示することが好ましく、中でも特には、ツリー状に図示することが好ましい。 FIGS. 11 to 16 are diagrams illustrating the state of visualization in the visualization step S122. The visualization is performed, for example, by illustrating the culture prediction results in a table, graph, tree, etc., or three-dimensionally, but it is particularly preferable to present the results in a tree shape. It is preferable to illustrate this.

 図11は、培養予測結果の一例を示す図である。本実施形態では、異なる細胞タイプが、階層的に分類された体系図において、線分と、当該線分の端点を用いて、細胞構成及び細胞の増殖過程を図示している。具体的には、図11では、線分を用いて細胞の増殖過程(特には、細胞増殖率)を図示しており、当該線分が長いほど、細胞増殖率が高いことを示している。一方で、図11では、線分の端点を用いて細胞構成(特には、細胞数)を図示しており、当該線分の端には各細胞タイプの名称が提示され、大きさが異なる端点が示されており、この端点の大きさが大きいほど、名称が提示された各細胞タイプの割合が高いことを示している。 FIG. 11 is a diagram showing an example of culture prediction results. In this embodiment, in a systematic diagram in which different cell types are hierarchically classified, the cell configuration and cell growth process are illustrated using line segments and end points of the line segments. Specifically, in FIG. 11, the cell proliferation process (in particular, the cell proliferation rate) is illustrated using line segments, and the longer the line segment, the higher the cell proliferation rate. On the other hand, in FIG. 11, the cell composition (in particular, the number of cells) is illustrated using the end points of the line segment, and the name of each cell type is presented at the end of the line segment, and the end points of different sizes are shown. is shown, and the larger the size of this endpoint, the higher the proportion of each cell type whose name was presented.

 また、図12は、図11とは異なる、培養予測結果の一例を示す図である。具体的には、図12では、線分の太さを用いて細胞の増殖過程(特には、細胞生存率)を図示しており、当該線分の太さが太いほど、細胞生存率が高いことを示している。一方で、図12では、線分の端点を用いて細胞構成(特には、細胞数)を図示しており、当該線分の端には各細胞タイプの名称が提示され、色が異なる端点が示され、この端点の色が濃いほど、細胞数が多いことを示している。なお、図12で提示した色は、一例に過ぎず、端点の色が薄いほど名称が提示された各細胞タイプの割合が多いとしてもよいし、その他、白黒のみならずあらゆる色を適宜用いて細胞構成を示すことができる。 Further, FIG. 12 is a diagram showing an example of culture prediction results, which is different from FIG. 11. Specifically, in FIG. 12, the thickness of the line segment is used to illustrate the cell proliferation process (in particular, cell survival rate), and the thicker the line segment, the higher the cell survival rate. It is shown that. On the other hand, in FIG. 12, the cell composition (in particular, the number of cells) is illustrated using the end points of the line segment, and the name of each cell type is presented at the end of the line segment, and the end points with different colors are shown. The darker the color of this end point, the greater the number of cells. Note that the colors presented in Figure 12 are only an example; the lighter the color of the endpoints, the higher the proportion of each cell type whose name is presented, or any other color may be used as appropriate, not just black and white. Cell composition can be shown.

 本実施形態において、培養条件の起点は、図11のように分離して表示してもよいし、図12のように1つとして表示してもよい。図12のように1つとして表示するのは、対象となる細胞が予め決まっており、その対象細胞に基づいて体系図を作成できる場合に有用である。また、培養条件の起点(図11及び12では、「lymphocyte」)から、線分が伸びる方向は特に限定されず、上下左右に限らず、後述する図13で示される通り、360度、あらゆる方向に伸びることができる。また、各起点、各線分、及び各端点には、細胞タイプ(細胞の種類)、細胞数、細胞割合、培養日数、培養液の種類、培養液補充日、培養液交換日、培養温度、培養湿度などの情報が提示されていてもよい。ユーザはこれらの情報に基づき、適宜所望の培養結果が得られる培養条件を選択することができる。 In this embodiment, the starting points of the culture conditions may be displayed separately as shown in FIG. 11, or may be displayed as one as shown in FIG. 12. Displaying the cells as one as shown in FIG. 12 is useful when the target cells are determined in advance and a systematic diagram can be created based on the target cells. In addition, the direction in which the line segment extends from the starting point of the culture conditions ("lymphocyte" in FIGS. 11 and 12) is not particularly limited, and is not limited to the top, bottom, left, and right, but 360 degrees, all directions, as shown in FIG. 13 (described later). can be extended to. In addition, each starting point, each line segment, and each end point include cell type (cell type), cell number, cell ratio, number of culture days, culture medium type, culture medium replenishment date, culture medium exchange date, culture temperature, culture Information such as humidity may also be presented. Based on this information, the user can appropriately select culture conditions that will yield desired culture results.

 本実施形態では、細胞構成としては、特には、細胞数、又は細胞割合であり、細胞の増殖過程としては、特には、細胞増殖率、又は細胞生存率である。 In the present embodiment, the cell composition is particularly the cell number or cell ratio, and the cell proliferation process is particularly the cell proliferation rate or cell survival rate.

 図13は、図11及び12とは異なる、培養予測結果の一例を示す図である。具体的には、図13では、線分の長さを用いて細胞の増殖過程(特には、細胞増殖率)を図示しており、当該線分の長さが長いほど、細胞増殖率が高いことを示している。一方で、図13では、線分の端点を用いて細胞構成(特には、細胞数)を図示しており、当該線分の端には・BR>E細胞タイプの名称が提示され、形状が異なる端点が示され、この形状が円に近いほど、細胞数が多いことを示している。 FIG. 13 is a diagram showing an example of culture prediction results, which is different from FIGS. 11 and 12. Specifically, in FIG. 13, the length of the line segment is used to illustrate the cell proliferation process (in particular, the cell proliferation rate), and the longer the line segment is, the higher the cell proliferation rate is. It is shown that. On the other hand, in Figure 13, the cell composition (in particular, the number of cells) is illustrated using the end points of the line segment, and at the end of the line segment, the name of the BR>E cell type is presented, and the shape is Different endpoints are shown, and the closer the shape is to a circle, the greater the number of cells.

 本実施形態では、前記線分は、線分の長さ、線分の種類(例えば、実線、破線、一点鎖線、二重線など)、線分の太さ、及び線分の色からなる群より選ばれるいずれか1つ以上を用いて、細胞構成及び細胞の増殖過程(特には、細胞の増殖過程)を可視化し、ユーザに提示することができる。更に、前記線分の端点は、端点の大きさ、端点の形状、端点の種類(例えば、パイチャート、グラフなど)、及び端点の色からなる群より選ばれるいずれか1つ以上を用いて、細胞構成及び細胞の増殖過程(特には、細胞構成)を可視化し、ユーザに提示することができる。なお、前記端点の種類の内部には、細胞タイプの名称等が提示されていてもよい。 In this embodiment, the line segment is a group consisting of the length of the line segment, the type of the line segment (for example, a solid line, a broken line, a dashed line, a double line, etc.), the thickness of the line segment, and the color of the line segment. Using any one or more of these methods, the cell composition and the cell growth process (in particular, the cell growth process) can be visualized and presented to the user. Furthermore, the end point of the line segment is determined by using one or more selected from the group consisting of the size of the end point, the shape of the end point, the type of the end point (e.g., pie chart, graph, etc.), and the color of the end point, Cell composition and cell proliferation process (particularly cell composition) can be visualized and presented to the user. Note that the name of the cell type, etc. may be presented inside the type of the end point.

 図14は、図11~13とは異なる、培養予測結果の一例を示す図である。図14は、上述した図12とは異なり、対象となる細胞が複数あり、その割合を端点で示した場合である。対象となる細胞が2種類の場合は、比率を端点の大きさで示し、3種類以上の場合は、更に、端点の種類をパイチャートとするなどして割合を示すことができる。具体的には、図14では、線分の長さを用いて細胞の増殖過程(特には、細胞増殖率)を図示しており、当該線分の長さが長いほど、細胞増殖率が高いことを示している。一方で、図14では、線分の端点を用いて細胞構成(特には、細胞割合)を図示しており、当該線分の端には各細胞タイプの名称とその割合が提示され、大きさが異なる端点が示されており、この端点の大きさが大きいほど、細胞割合が高いことを示している。 FIG. 14 is a diagram showing an example of culture prediction results, which is different from FIGS. 11 to 13. Unlike FIG. 12 described above, FIG. 14 shows a case where there are a plurality of target cells and the proportion thereof is shown by end points. If there are two types of target cells, the ratio can be shown by the size of the endpoints, and if there are three or more types, the ratio can be further shown by using a pie chart as the type of endpoints. Specifically, in FIG. 14, the length of the line segment is used to illustrate the cell proliferation process (in particular, the cell proliferation rate), and the longer the line segment is, the higher the cell proliferation rate is. It is shown that. On the other hand, in FIG. 14, the end points of the line segment are used to illustrate the cell composition (in particular, the cell proportion), and the name and proportion of each cell type are presented at the end of the line segment, and the size The endpoints with different values are shown, and the larger the endpoint, the higher the cell percentage.

 本実施形態では、「(3)処理前の細胞に関する情報取得工程S110」にて上述した通り、制御部300は、ユーザ又はデータベース500等により閾値を設定し、設定された閾値を用いて、培養条件を判定することができる。閾値としては、例えば、上述した細胞構成及び細胞の増殖過程が、所望の条件を満たすか否かなどを設定することができる。例えば、図14では、「CD4CD62L/CD8CD62L≧1」と設定している。そして、当該所望の条件を満たさないと判定された場合は、例えば、図14に示すように、ツリーをグレーアウトする、或いはツリー自体を消去するなどして、可視化してもよい。また、当該可視化に伴い、閾値を満たさない培養条件を自動的に選択できなくなるようにしてもよい。これにより、複数の選択肢の中から、有効な選択肢を絞ることができ、ユーザビリティが向上する。 In this embodiment, as described above in "(3) Information acquisition step S110 regarding cells before processing," the control unit 300 sets a threshold value by the user or the database 500, and uses the set threshold value to perform the culture. Conditions can be determined. The threshold value can be set, for example, as to whether or not the above-described cell configuration and cell growth process satisfy desired conditions. For example, in FIG. 14, "CD4CD62L/CD8CD62L≧1" is set. If it is determined that the desired condition is not satisfied, the tree may be visualized by graying out the tree or erasing the tree itself, for example, as shown in FIG. Moreover, along with the visualization, culture conditions that do not satisfy the threshold value may not be automatically selected. This makes it possible to narrow down effective options from a plurality of options, improving usability.

 また、本実施形態では、前記閾値を用いて、ユーザが設定したモードに適する培養条件を提示することもできる。なお、前記モードとしては、例えば、細胞生存率を優先する生存優先モード、細胞増殖率を優先する増殖優先モード、細胞割合を優先する割合優先モード、又は細胞の純度を優先する純度優先モードのいずれかとすることができる。例えば、図15は、図11~14とは異なる、培養予測結果の一例を示す図であるが、最終的に、J1~J4の4つの系統が現れることが予測されている。ここで、前記閾値を用いて、例えば、生存優先モードや増殖優先モードを設定した場合は、線分が最長又は一定の閾値以上となる培養条件を選択すればよい。一方で、割合優先モードや純度優先モードを設定した場合は、線分の端点の大きさが最大若しくは最小又は一定の閾値以上若しくは以下となる培養条件を選択すればよい。図15では、細胞増殖率を優先する増殖優先モードを設定した場合を示しており、線分が最も長い系統J4となるように培養条件を設定することが考えられる。なお、各優先モードにおいて、例えば、割合優先モードとしつつ、細胞の増殖過程を考慮するなど、ユーザにより適宜考慮する条件を更に付与することもできる。 Furthermore, in this embodiment, the threshold value can be used to present culture conditions suitable for the mode set by the user. The mode may be, for example, a survival priority mode that prioritizes cell survival rate, a proliferation priority mode that prioritizes cell proliferation rate, a ratio priority mode that prioritizes cell proportion, or a purity priority mode that prioritizes cell purity. It can be done. For example, FIG. 15 is a diagram showing an example of culture prediction results, which is different from FIGS. 11 to 14, and it is predicted that four strains J1 to J4 will eventually appear. Here, if a survival priority mode or a proliferation priority mode is set using the threshold value, for example, a culture condition in which the line segment is the longest or is equal to or greater than a certain threshold value may be selected. On the other hand, when the ratio priority mode or the purity priority mode is set, culture conditions may be selected such that the size of the end point of the line segment is the maximum or minimum, or above or below a certain threshold value. FIG. 15 shows a case where a proliferation priority mode that prioritizes the cell proliferation rate is set, and culture conditions may be set so that line segment J4 has the longest line segment. In addition, in each priority mode, for example, while setting the ratio priority mode, the user can further give conditions to take into consideration as appropriate, such as considering the cell proliferation process.

 更には、本実施形態では、このようにして、モードに適した培養条件を「positive selection」とし、モードに適さない培養条件を「negative selection」として、ユーザに提示してもよい。当該提示には、単純に文言を表記することだけでなく、ツリーをグレーアウトする、或いは、図15に示される通り、ツリー自体を消去するなどの可視化手法を含む。なお、本実施形態では、例えば、後段の処理工程S130に進むべきか否かを選択可能な入力部301が設けられていてもよい。 Furthermore, in this embodiment, culture conditions suitable for the mode may be presented to the user as "positive selection" and culture conditions unsuitable for the mode may be presented as "negative selection". This presentation includes not only simply notation but also visualization techniques such as graying out the tree or erasing the tree itself as shown in FIG. 15. Note that in this embodiment, for example, an input unit 301 may be provided that allows selection of whether or not to proceed to the subsequent processing step S130.

 加えて、本実施形態では、ユーザが設定したモードに適する培養条件の提示において、刺激因子、培養日数、培養試薬の種類、培養試薬数、培養工程数、培養工程の煩雑さ、及び培養コストからなる群より選ばれるいずれか1つ以上のパラメータを考慮することができる。当該パラメータには、上述したものと同様の手法にて、閾値を設定することが可能であり、当該閾値を満たすものについては、上述したように、「positive selection」とし、満たさないものについては、「negative selection」として、ユーザに提示してもよい。当該提示には、単純に文言を表記することだけでなく、ツリーをグレーアウトする、或いはツリー自体を消去するなどの可視化手法を含む。 In addition, in this embodiment, in presenting culture conditions suitable for the mode set by the user, consideration is given to stimulation factors, number of culture days, types of culture reagents, number of culture reagents, number of culture steps, complexity of culture steps, and culture cost. Any one or more parameters selected from the group consisting of: It is possible to set a threshold value for the parameter using the same method as described above, and those that meet the threshold are treated as "positive selection" as described above, and those that do not meet the threshold, It may be presented to the user as a "negative selection." This presentation includes not only simply writing the words, but also visualization methods such as graying out the tree or erasing the tree itself.

 図16は、図11~15とは異なる、培養予測結果の一例を示す図である。可視化工程S122では、前記制御部300は、図16に示すように、時系列に沿って前記図示を行ってもよい。図16では、培養0日目から2日目までの細胞構成及び細胞の増殖過程を時系列的に示しているが、本実施形態では、これに限定されず、数分間、数時間、数日間、数週間等の単位で、時系列的に細胞構成及び細胞の増殖過程を可視化することができる。 FIG. 16 is a diagram showing an example of culture prediction results, which is different from FIGS. 11 to 15. In the visualization step S122, the control unit 300 may perform the illustration in chronological order, as shown in FIG. 16. Although FIG. 16 shows the cell composition and the cell proliferation process from day 0 to day 2 of culture in chronological order, this embodiment is not limited to this, and may be used for several minutes, several hours, or several days. , it is possible to visualize the cell composition and cell growth process in a time-series manner over a period of several weeks or the like.

(5)処理工程S130 (5) Processing step S130

 処理工程S130において、制御部300は、処理前の細胞に関する情報取得工程S110により取得された細胞に関する情報と、制御工程において出力された予測条件に基づいて細胞を含むサンプルに関する処理を行う。細胞を含むサンプルに関する処理は、例えば、細胞培養装置1に捕捉された処理前の細胞に対し、細胞選別や培養制御を行ってもよい。 In the processing step S130, the control unit 300 performs processing regarding the sample containing the cells based on the information regarding the cells acquired in the information acquisition step S110 regarding the cells before treatment and the prediction conditions output in the control step. Processing regarding a sample containing cells may be performed, for example, by performing cell sorting or culture control on unprocessed cells captured in the cell culture device 1.

 細胞選別は、例えば、前記光学制御部210による光学制御により分解性リンカー103を刺激し、分解性リンカー103を介して試料保持部100に結合している細胞を遊離する。処理前の細胞に関する情報取得工程S110において取得した細胞に関する情報、例えば、細胞に付与された第二の分子由来の蛍光信号に基づいて処理され得る細胞と対象外の細胞を判別し、対象外の細胞のみを当該刺激により遊離することが可能となる。第二の分子を用いずに、明視野画像、位相差画像、偏光画像、及び、非染色画像と蛍光画像より学習された情報から識別され細胞の特徴ごとに疑似染色された画像をもとに細胞を識別し、光刺激によって細胞を遊離してもよい。当該識別は情報処理装置2により行われてよい。情報処理装置2は、当該識別の結果に基づき前記光学制御部210を駆動しうる。前記光学制御部210が光刺激を実行しうる。 In cell sorting, for example, the degradable linker 103 is stimulated by optical control by the optical control unit 210, and cells bound to the sample holding unit 100 via the degradable linker 103 are released. Cells that can be treated and non-target cells are determined based on the information on the cells acquired in the information acquisition step S110 regarding the cells before treatment, for example, the fluorescence signal derived from the second molecule imparted to the cells, and the non-target cells are determined. Only cells can be released by the stimulation. Based on pseudo-stained images for each cell feature identified from information learned from bright field images, phase contrast images, polarized images, unstained images, and fluorescent images without using a second molecule. Cells may be identified and released by light stimulation. The identification may be performed by the information processing device 2. The information processing device 2 can drive the optical control section 210 based on the result of the identification. The optical control unit 210 may perform optical stimulation.

 培養制御は、例えば、前記環境制御部による環境制御により試料保持部100に結合している細胞を含むサンプルを培養する。例えば、培養容器101は、処理前の細胞に関する情報取得工程S110において取得された細胞に関する情報に基づいて、前記環境制御部によるフィードバック制御を受け、物理化学的環境供給部114から湿度、pH、浸透圧、酸素分圧、二酸化炭素分圧等の物理化学的環境を供給されてもよい。或いは、例えば、培養容器101は、処理前の細胞に関する情報取得工程S110において取得された細胞に関する情報に基づいて、前記環境制御部によるフィードバック制御を受け、活性化剤供給部108、遺伝子供給部109、及び培養液供給部110からなる群より選ばれる少なくとも1つから、刺激因子、転写因子、転写制御因子、培養液、ホルモン、サイトカイン、インターロイキン等の生理学的環境を供給されてもよい。これにより、培養環境下における対象細胞に最適な環境が提供され細胞の生存率及び/又は培養効率を高めることができる。 In culture control, for example, a sample containing cells bound to the sample holding unit 100 is cultured under environmental control by the environmental control unit. For example, the culture container 101 is subjected to feedback control by the environment control section based on the information about the cells acquired in the information acquisition step S110 about the cells before treatment, and the physicochemical environment supply section 114 provides humidity, pH, osmosis, etc. Physicochemical environments such as pressure, oxygen partial pressure, carbon dioxide partial pressure, etc. may be provided. Alternatively, for example, the culture container 101 is subjected to feedback control by the environment control unit based on the information about the cells acquired in the information acquisition step S110 about the cells before treatment, and the activator supply unit 108 and the gene supply unit 109 , and the culture solution supply unit 110, a physiological environment such as a stimulation factor, a transcription factor, a transcription control factor, a culture solution, a hormone, a cytokine, an interleukin, etc. may be supplied. This provides an optimal environment for the target cells in the culture environment, thereby increasing cell survival rate and/or culture efficiency.

 処理前の細胞に関する情報取得工程S110におけるフィードバック制御の一例を以下に示す。例えば、PBMCを培養処理前の初期の細胞群として当該細胞培養システム1000における処理を実行する場合、培養液の種類、刺激分子の種類及び濃度、培養日数に応じて、当該培養処理後の細胞群に含まれるCD4及びCD8陽性細胞の増殖は異なりうる。更には、当該細胞群に含まれるナイーブT細胞、セントラルメモリーT細胞、エフェクター細胞の割合、つまりT細胞サブセットの割合も異なりうる。上記細胞群が当該細胞培養システム1000内の活性化剤供給部108よりanti-CD3 antibodyを添加された場合、CD8陽性細胞は有意に増殖する一方、anti-CD3/CD28 antibodyを添加された場合では、CD4及びCD8陽性細胞の割合は、維持されたまま増殖しうる。更に、培養液、サイトカイン、及び/又はサイトカイン種類や濃度によって、ある一定日数培養後のT細胞サブセットの割合は異なりうる。 An example of feedback control in the information acquisition step S110 regarding cells before processing is shown below. For example, when processing in the cell culture system 1000 is performed using PBMC as an initial cell group before culture processing, the cell group after culture processing may be The proliferation of CD4- and CD8-positive cells contained in the cells may be different. Furthermore, the proportions of naïve T cells, central memory T cells, and effector cells included in the cell group, that is, the proportions of T cell subsets, may also differ. When anti-CD3 antibody is added to the cell group from the activator supply unit 108 in the cell culture system 1000, CD8-positive cells proliferate significantly, whereas when anti-CD3/CD28 antibody is added to the cell group, CD8-positive cells proliferate significantly. , the proportion of CD4 and CD8 positive cells can be maintained and proliferated. Furthermore, depending on the culture medium, cytokines, and/or cytokine type and concentration, the proportion of T cell subsets after a certain number of days of culture may vary.

 例えば、処理前の細胞に関する情報取得工程S110におけるフィードバック制御において、前記環境制御部は、初期の培養工程では、活性化剤供給部108を、anti-CD3 antibodyのみ培養容器101内に供給するように制御しうる。これにより、当該細胞群内のCD8陽性細胞の割合が増える。そして、測定部3が、CD8陽性細胞の割合が目的の値に達したと判断したことに応じて、前記環境制御部は、活性化剤供給部108によるanti-CD3 antibodyの供給を停止するように、活性化剤供給部108を制御してもよい。 For example, in the feedback control in the information acquisition step S110 regarding cells before treatment, the environment control section controls the activating agent supply section 108 to supply only anti-CD3 antibodies into the culture vessel 101 in the initial culture step. Can be controlled. This increases the proportion of CD8 positive cells within the cell group. Then, in response to the measurement unit 3 determining that the percentage of CD8 positive cells has reached the target value, the environmental control unit causes the activator supply unit 108 to stop supplying the anti-CD3 antibody. Additionally, the activating agent supply section 108 may be controlled.

 このように、前記環境制御部は、活性化剤供給部108が、細胞群内の1以上の所定細胞の割合を増加又は減少させるように活性化剤を培養容器101内に供給するように制御しうる。また、前記環境制御部は、活性化剤供給部108が、細胞群内の1以上の所定細胞の生存率を増加又は減少させるように活性化剤を培養容器101内に供給するように制御しうる。更には、前記環境制御部は、活性化剤供給部108が、細胞群内の1以上の所定細胞の遺伝子導入効率を増加又は減少させるように活性化剤を培養容器101内に供給するように制御しうる。 In this way, the environmental control unit controls the activating agent supply unit 108 to supply the activating agent into the culture container 101 so as to increase or decrease the proportion of one or more predetermined cells in the cell group. I can do it. The environment control unit also controls the activating agent supply unit 108 to supply the activating agent into the culture container 101 so as to increase or decrease the survival rate of one or more predetermined cells in the cell group. sell. Furthermore, the environmental control unit is configured such that the activating agent supply unit 108 supplies the activating agent into the culture vessel 101 so as to increase or decrease the gene introduction efficiency of one or more predetermined cells in the cell group. Can be controlled.

 更には、前記環境制御部は、活性化剤供給部108を、anti-CD28 antibodyを培養容器101内に追加供給するよう制御してもよい。これにより、当該細胞群におけるCD4及びCD8陽性細胞の割合を維持しながら当該細胞群を増殖させることができる。更には、測定部3が、当該細胞群のT細胞サブセットの割合が目的に達したと判断したことに応じて、前記環境制御部は、活性化剤供給部108により供給される培養液、並びにサイトカインの種類及び/又は濃度を変更するように、活性化剤供給部108を制御してもよい。 Furthermore, the environment control unit may control the activating agent supply unit 108 to additionally supply anti-CD28 antibody into the culture container 101. This allows the cell group to proliferate while maintaining the proportion of CD4- and CD8-positive cells in the cell group. Furthermore, in response to the measurement unit 3 determining that the proportion of T cell subsets in the cell group has reached the target, the environment control unit controls the culture solution supplied by the activating agent supply unit 108 and The activator supply 108 may be controlled to change the type and/or concentration of the cytokine.

 このように、前記環境制御部は、活性化剤供給部108が、細胞群内の1以上の所定細胞の割合を維持するように活性化剤を培養容器101内に供給するように制御しうる。 In this way, the environmental control unit can control the activating agent supply unit 108 to supply the activating agent into the culture vessel 101 so as to maintain the proportion of one or more predetermined cells in the cell group. .

 当該細胞選別及び/又は培養制御により処理された処理条件は、データベース500に送信され、当該データベース500は更新されてもよい。これにより、予測結果生成工程S121における予測条件の生成の精度が向上する。なお、当該細胞選別及び/又は培養制御により処理された内容は実際の処理条件に加え、例えば、培養日数、培養液補充日、又は培養液交換日などの日付や期間が保存されていてもよい。 The processing conditions processed by the cell sorting and/or culture control may be transmitted to the database 500, and the database 500 may be updated. This improves the accuracy of generating prediction conditions in the prediction result generation step S121. In addition to the actual processing conditions, the content processed by the cell sorting and/or culture control may also include dates and periods, such as the number of culture days, the date of culture solution replenishment, or the date of culture solution exchange. .

 処理工程S130は、処理実行工程S131(特には、培養工程)を含みうる。上述した通り、培養工程において細胞培養部用制御部200は、前記環境制御部による環境制御により試料保持部100に結合している細胞を含むサンプルを培養する。処理実行工程S131では、例えば、入力部301を介して、ユーザが実行する培養条件を選択することができる。この場合、制御部300は、入力部301で選択された培養条件に基づいて培養条件の制御を行いうる。 The treatment step S130 may include a treatment execution step S131 (in particular, a culturing step). As described above, in the culturing process, the cell culture section control section 200 cultivates the sample containing the cells bound to the sample holding section 100 under the environmental control by the environment control section. In the process execution step S131, the user can select the culture conditions to be executed, for example, via the input unit 301. In this case, the control unit 300 can control the culture conditions based on the culture conditions selected by the input unit 301.

 処理工程S130は、処理中細胞情報取得工程S132(特には、測定工程)を含みうる。処理中細胞情報取得工程S132において、細胞培養部用制御部200は、測定部3が測定を開始するよう制御し、処理中の細胞に関する情報を取得する。測定部3による測定方法は、例えば、上述した通りであり、特に限定されない。経時的に細胞に関する情報を取得することで、細胞を常に観察可能となり、細胞の異常を即座に検知することが可能となる。当該処理中に関する情報は、上述した処理前の細胞に関する情報と同様であり、特に限定されない。当該処理中の細胞に関する情報は、データベース500に送信され、当該データベース500は更新されてもよい。 The processing step S130 may include an in-process cell information acquisition step S132 (particularly a measurement step). In processing cell information acquisition step S132, the cell culture section control section 200 controls the measurement section 3 to start measurement, and obtains information regarding the processing cells. The measuring method by the measuring section 3 is, for example, as described above, and is not particularly limited. By acquiring information about cells over time, cells can be constantly observed and abnormalities in cells can be immediately detected. The information regarding the processing is the same as the information regarding the cells before the treatment described above, and is not particularly limited. Information regarding the cells being processed may be sent to a database 500, and the database 500 may be updated.

 以下に、処理中細胞情報取得工程S132において処理中の細胞に関する情報を取得する一例を示す。例えば、PBMCを採取した場合、当該PBMCは画像取得部600及び/又はシグナル検出部700を有する測定部3により測定されうる。上記測定部3により取得された前方散乱光、側方散乱光、又は後方散乱光に基づいてリンパ球分画が特定され、蛍光及び/又は金属標識抗体により染色された対象細胞の蛍光に関する情報より、T細胞、B細胞、マクロファージなどの細胞の種類や、ナイーブT細胞、セントラルメモリーT細胞、エフェクターT細胞などのT細胞サブセット、対象細胞の核染色に関する情報から生細胞の数や割合が特定されうる。また当該PBMCは、非染色画像と蛍光画像より学習された情報から識別され細胞の特徴ごとに疑似染色された画像から得られてもよい。これにより、処理工程中に細胞情報を取得できるため、処理工程S130において細胞を選別し、培養容器101から抜き取る移動工程や抜き取った後の測定工程を省略することが可能となる。これにより、培養容器101から滅菌状態を維持したまま細胞を移動させることが可能となり、更には、測定部3における測定工程を省略することで、細胞培養システム1000における各工程を簡素化することが可能となる。 An example of acquiring information regarding the cells being processed in the processing cell information acquisition step S132 will be shown below. For example, when PBMCs are collected, the PBMCs can be measured by the measurement unit 3 having the image acquisition unit 600 and/or the signal detection unit 700. The lymphocyte fraction is identified based on the forward scattered light, side scattered light, or back scattered light acquired by the measurement unit 3, and from information regarding the fluorescence of the target cells stained with fluorescence and/or metal-labeled antibodies. The number and percentage of living cells can be identified from information about cell types such as T cells, B cells, and macrophages, T cell subsets such as naive T cells, central memory T cells, and effector T cells, and nuclear staining of target cells. sell. The PBMC may also be obtained from images that are identified from information learned from unstained images and fluorescent images and pseudo-stained for each cell feature. As a result, cell information can be acquired during the treatment process, so that it is possible to select the cells in the treatment process S130 and omit the moving process of extracting them from the culture container 101 and the measurement process after the cells have been extracted. This makes it possible to move cells from the culture container 101 while maintaining a sterile state, and furthermore, by omitting the measurement process in the measurement unit 3, each process in the cell culture system 1000 can be simplified. It becomes possible.

 処理工程S130は、比較工程S133を含みうる。比較工程S133において細胞培養部用制御部200は、処理中細胞情報取得工程S132において取得された処理中の細胞に関する情報と、処理条件受け付け工程において取得された処理条件との比較を行い、処理判断を実行する。例えば、細胞培養部用制御部200は、処理中の細胞に関する情報が処理条件を満たす場合は、後段の培養工程に進むことが可能となるが、当該処理条件を満たさない場合は、選別工程により不要な細胞を除去するか、制御部300に対して細胞の製造を停止するよう制御する製造中止工程か、制御部300に対して細胞を再採取するよう制御するかを適宜選択することができる。これにより、測定部3から処理中の細胞に関する情報を経時的に観察することで、プロセスの途中でプロセスの内容を切り替え、最適化処理することが可能となる。 The processing step S130 may include a comparison step S133. In the comparison step S133, the cell culture unit control unit 200 compares the information regarding the cells being processed acquired in the in-process cell information acquisition step S132 and the treatment conditions acquired in the treatment condition acceptance step, and makes a treatment decision. Execute. For example, if the information regarding the cells being processed satisfies the processing conditions, the cell culture section control section 200 can proceed to the subsequent culture step, but if the processing conditions are not satisfied, the cell culture section control section 200 It is possible to select as appropriate whether unnecessary cells are removed, a manufacturing stop process is performed in which the control unit 300 is controlled to stop cell production, or the control unit 300 is controlled to re-collect the cells. . Thereby, by observing information regarding the cells being processed from the measurement unit 3 over time, it becomes possible to switch the process content midway through the process and perform optimization processing.

(6)処理後細胞に関する情報取得工程S140 (6) Information acquisition step S140 regarding treated cells

 処理後細胞に関する情報取得工程S140において、測定部3は処理後の細胞に関する情報を取得する。処理後の細胞に関する情報が所定値に達した場合は、細胞回収部113より当該細胞群が回収される。回収された細胞は、情報処理装置2により治療に関する情報を評価されてもよいし、当該システム外の評価装置により評価されてもいい。当該評価された処理後の細胞の治療に関する情報は、評価後にデータベース500に送信され、当該データベース500は更新されてもよい。 In the information acquisition step S140 regarding the treated cells, the measurement unit 3 acquires information regarding the treated cells. When the information regarding the cells after processing reaches a predetermined value, the cell collection unit 113 collects the cell group. The collected cells may be evaluated for information regarding treatment by the information processing device 2, or may be evaluated by an evaluation device outside the system. Information regarding the treatment of the evaluated treated cells may be sent to the database 500 after the evaluation, and the database 500 may be updated.

 処理後の対象細胞に関する情報は、上述した処理前の細胞に関する情報に加え、当該細胞の治療に関する情報であってもよい。治療に関する情報は、当該細胞の患者に対する治療効果、奏効率、再発率、副作用、及び患者の治療履歴からなる群より選択されるいずれか1つ以上であってよい。これにより、後述する学習工程において当該治療に関する情報に達するための処理後の細胞に関する情報が学習され、患者個人に準じた処理条件(特には、培養条件)を実行することが可能となる。 Information regarding the target cells after treatment may be information regarding treatment of the cells in addition to the information regarding the cells before treatment described above. The information regarding the treatment may be any one or more selected from the group consisting of the therapeutic effect of the cells on the patient, the response rate, the recurrence rate, the side effects, and the patient's treatment history. As a result, in the learning process described later, information regarding the treated cells is learned in order to arrive at information regarding the treatment, and it becomes possible to execute treatment conditions (in particular, culture conditions) according to the individual patient.

(7)学習工程 (7) Learning process

 本技術に従う情報処理方法は、更に、学習工程を含んでいてよい。当該学習工程において、学習部400は、細胞に関する情報と当該細胞の治療に関する情報との関連性を学習し、第一学習器を生成する。或いは、学習部400は、細胞に関する情報と処理条件の関連性を学習し第二学習器を生成する。これによって、細胞群における処理前の細胞に関する情報から所望の細胞群に達成するための処理条件(特には、培養条件)及び所望の細胞の治療効果を予測することが可能となり、細胞処理プロセスの効率性を高めることができる。また、前記制御部300は、生成された第一学習器及び/又は第二学習器を用いて、上述した予測処理を実行してもよい。 The information processing method according to the present technology may further include a learning step. In the learning step, the learning unit 400 learns the relationship between information regarding cells and information regarding treatment of the cells, and generates a first learning device. Alternatively, the learning unit 400 learns the relationship between information regarding cells and processing conditions and generates a second learning device. This makes it possible to predict the treatment conditions (in particular, culture conditions) to achieve a desired cell group and the desired therapeutic effect of the cells from information about the cells in the cell group before treatment, and to improve the cell treatment process. Efficiency can be increased. Further, the control unit 300 may execute the above-described prediction process using the generated first learning device and/or second learning device.

 当該第一学習器は、前記制御部300により予測された予測条件により処理された細胞に関する情報と、当該細胞の治療に関する情報とを学習用入力情報として、前記細胞と前記治療に関する情報の関連性を学習する。処理後の細胞に関する情報と処理後の細胞の治療に関する情報は、上述した通りである。制御部300は、当該学習器によって生成された学習器を用いて推論してもよい。これにより、患者に応じて最適な処理条件(特には、培養条件)を予測することも可能となる。 The first learning device uses information regarding cells processed according to the prediction conditions predicted by the control unit 300 and information regarding the treatment of the cells as input information for learning, and determines the relevance of the information regarding the cells and the treatment. Learn. The information regarding the cells after treatment and the treatment of the cells after treatment are as described above. The control unit 300 may perform inference using a learning device generated by the learning device. This also makes it possible to predict optimal treatment conditions (especially culture conditions) depending on the patient.

 例えば、細胞培養システム1000において処理された細胞群がPBMCの場合、当該PBMCは治療用途として利用される。当該PBMCの細胞構成、細胞の増殖過程等の培養後の細胞群に関する情報とドナー情報、治療の奏功率、副作用の発生率、細胞の品質等の治療に関する情報との関連性を学習することで、PBMCを採取するタイミングの最適化も可能である。これによって、細胞群における処理前の細胞に関する情報から所望の細胞群に達成するための処理条件及び所望の細胞の治療効果を予測することが可能となり、細胞処理プロセスの効率性を高めることができる。 For example, when the cell group treated in the cell culture system 1000 is PBMC, the PBMC is used for therapeutic purposes. By learning the relationship between information about the cell group after culture, such as the cell composition of the PBMC and the cell proliferation process, and information about the treatment, such as donor information, treatment success rate, incidence of side effects, and cell quality. , it is also possible to optimize the timing of collecting PBMC. This makes it possible to predict the treatment conditions to achieve a desired cell group and the desired cell treatment effect from information about the cells in the cell group before treatment, increasing the efficiency of the cell treatment process. .

 当該第二学習器は、前記処理前の細胞に関する情報と、前記制御部300により予測された前記処理条件と、前記処理条件により処理された前記処理前の細胞とを学習用入力情報として、前記処理前の細胞に関する情報と前記処理条件の関連性を学習する。当該処理条件は、処理工程において処理される条件であれば、特に限定されない。これによって、細胞群における処理前の細胞に関する情報から所望の細胞群に達成するための処理条件(特には、培養条件)及び所望の細胞の治療効果を予測することが可能となり、細胞処理プロセスの効率性を高めることができる。制御部300は、当該学習器によって生成された学習器を用いて推論してもよい。これにより、処理条件(特には、培養条件)及び治療効果の予測が可能となる。 The second learning device uses the information regarding the unprocessed cells, the processing conditions predicted by the control unit 300, and the unprocessed cells processed according to the processing conditions as input information for learning, and uses the information regarding the unprocessed cells as learning input information. The relationship between information about cells before treatment and the treatment conditions is learned. The processing conditions are not particularly limited as long as they are conditions that can be processed in the processing step. This makes it possible to predict the treatment conditions (in particular, culture conditions) to achieve a desired cell group and the desired therapeutic effect of the cells from information about the cells in the cell group before treatment, and to improve the cell treatment process. Efficiency can be increased. The control unit 300 may perform inference using a learning device generated by the learning device. This makes it possible to predict treatment conditions (especially culture conditions) and therapeutic effects.

 前記第一学習器は、細胞に関する情報と当該細胞の治療に関する情報とを含むデータセットを機械学習させることによって生成された学習器であってよい。当該機械学習は、例えばディープラーニングであってよい。当該機械学習は、例えば、国際公開第2021/049365号パンフレットに記載された情報処理装置又は情報処理方法に従って実行されてよい。当該機械学習において、前記細胞に関する情報は、説明変数として取り扱われてよく、且つ、前記細胞の治療に関する情報は目的変数として取り扱われてよい。 The first learning device may be a learning device generated by performing machine learning on a data set including information regarding cells and information regarding treatment of the cells. The machine learning may be, for example, deep learning. The machine learning may be performed, for example, according to the information processing device or the information processing method described in International Publication No. 2021/049365 pamphlet. In the machine learning, information regarding the cells may be treated as an explanatory variable, and information regarding treatment of the cells may be treated as a target variable.

 また、前記第二学習器は、前記処理前の細胞に関する情報と、前記処理条件と、前記処理条件により処理された前記処理前の細胞に関する情報(すなわち、前記処理後の細胞に関する情報)と、を含むデータセットを機械学習させることによって生成された学習器であってよい。当該機械学習は、例えば、ディープラーニングであってよい。当該機械学習は、例えば、国際公開第2021/049365号パンフレットに記載された情報処理装置又は情報処理方法に従って実行されてよい。 Further, the second learning device includes information regarding the cells before the treatment, the treatment conditions, and information regarding the cells before the treatment that have been treated according to the treatment conditions (i.e., information regarding the cells after the treatment); The learning device may be generated by performing machine learning on a data set including the following. The machine learning may be, for example, deep learning. The machine learning may be performed, for example, according to the information processing device or the information processing method described in International Publication No. 2021/049365 pamphlet.

 当該機械学習において、前記処理前の細胞に関する情報及び前記処理条件が説明変数として取り扱われてよく、且つ、前記処理後の細胞に関する情報が目的変数として取り扱われてよい。このような説明変数及び目的変数の取扱いは、例えば、前記制御部300が前記細胞群の処理後の細胞に関する情報を予測する実施態様において適用されてよい。 In the machine learning, information regarding the cells before the treatment and the treatment conditions may be treated as explanatory variables, and information regarding the cells after the treatment may be treated as the objective variable. Such handling of explanatory variables and objective variables may be applied, for example, in an embodiment in which the control unit 300 predicts information regarding cells after processing the cell group.

 代替的には、当該機械学習において、前記処理前の細胞に関する情報及び前記処理後の細胞に関する情報が説明変数として取り扱われてよく、且つ、前記処理条件が目的変数として取り扱われてよい。このような説明変数及び目的変数の取扱は、例えば、前記制御部300が前記所定の細胞に関する情報を前記細胞群から導出可能とするための処理条件(特には、培養条件)を予測する実施態様において適用されてよい。 Alternatively, in the machine learning, information regarding the cells before the treatment and information regarding the cells after the treatment may be treated as explanatory variables, and the treatment conditions may be treated as the objective variable. Such handling of explanatory variables and objective variables is, for example, an embodiment in which the control unit 300 predicts processing conditions (in particular, culture conditions) to enable the control unit 300 to derive information regarding the predetermined cells from the cell group. may be applied in

 なお、本技術では、以下の構成を採用することもできる。
〔1〕
 異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測する制御部を有し、
 前記制御部は、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御する、情報処理装置。
〔2〕
 前記可視化は、前記培養予測結果を図示することにより行われる、〔1〕に記載の情報処理装置。
〔3〕
 前記図示は、線分及び/又は前記線分の端点により行われる、〔2〕に記載の情報処理装置。
〔4〕
 前記細胞構成は、細胞数、又は細胞割合である、〔1〕から〔3〕のいずれかに記載の情報処理装置。
〔5〕
 前記細胞の増殖過程は、細胞増殖率、又は細胞生存率である、〔1〕から〔4〕のいずれかに記載の情報処理装置。
〔6〕
 前記線分は、線分の長さ、線分の種類、線分の太さ、及び線分の色からなる群より選ばれるいずれか1つ以上を用いて、前記細胞の増殖過程を可視化する、〔3〕に記載の情報処理装置。
〔7〕
 前記線分の端点は、端点の大きさ、端点の形状、端点の種類、及び端点の色からなる群より選ばれるいずれか1つ以上を用いて、前記細胞構成を可視化する、〔3〕に記載の情報処理装置。
〔8〕
 前記制御部は、設定された閾値を用いて、前記培養条件を判定する、〔1〕から〔7〕のいずれかに記載の情報処理装置。
〔9〕
 前記閾値を満たさない細胞培養条件を可視化する、〔8〕に記載の情報処理装置。
〔10〕
 前記閾値を用いて、ユーザが設定したモードに適する培養条件を提示する、〔8〕に記載の情報処理装置。
〔11〕
 前記モードは、細胞生存率を優先する生存優先モード、細胞増殖率を優先する増殖優先モード、細胞割合を優先する割合優先モード、又は細胞の純度を優先する純度優先モードのいずれかである、〔10〕に記載の情報処理装置。
〔12〕
 前記制御部は、前記提示において、培養コスト、培養日数、及び培養工程の煩雑さからなる群より選ばれるいずれか1つ以上のパラメータを考慮する、〔10〕又は〔11〕に記載の情報処理装置。
〔13〕
 前記制御部は、時系列に沿って前記図示を行う、〔2〕に記載の情報処理装置。
〔14〕
 前記可視化された培養予測結果を操作する入力部を更に有する、〔1〕から〔13〕のいずれかに記載の情報処理装置。
〔15〕
 前記入力部は、実行する培養条件を選択する、〔14〕に記載の情報処理装置。
〔16〕
 前記制御部は、前記入力部で選択された培養条件に基づいて培養条件の制御を行う、〔15〕に記載の情報処理装置。
〔17〕
 異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測する制御工程を有し、
 前記制御工程では、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御する、情報処理方法。
〔18〕
 異なる細胞を含む細胞群を培養する細胞培養部と、前記細胞群の細胞構成及び細胞の増殖過程を測定する測定部と、を有する細胞培養装置と、
 異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測する制御部を有し、前記制御部は、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御する、情報処理装置と、
を有する、細胞培養システム。
〔19〕
 異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測し、且つ、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御するステップを含む処理をコンピュータに実行させる、プログラム。
Note that in the present technology, the following configuration can also be adopted.
[1]
It has a control unit that predicts multiple culture prediction results for each culture condition of a cell group containing different cells,
The control unit is an information processing device that performs control to visualize the cultured cell composition and cell proliferation process as the culture prediction result.
[2]
The information processing device according to [1], wherein the visualization is performed by illustrating the culture prediction results.
[3]
The information processing device according to [2], wherein the illustration is performed using line segments and/or end points of the line segments.
[4]
The information processing device according to any one of [1] to [3], wherein the cell configuration is a cell number or a cell ratio.
[5]
The information processing device according to any one of [1] to [4], wherein the cell proliferation process is a cell proliferation rate or a cell survival rate.
[6]
The line segment is used to visualize the cell proliferation process using any one or more selected from the group consisting of line segment length, line segment type, line segment thickness, and line segment color. , the information processing device according to [3].
[7]
In [3], the end points of the line segment are visualized by using any one or more selected from the group consisting of the size of the end point, the shape of the end point, the type of the end point, and the color of the end point. The information processing device described.
[8]
The information processing device according to any one of [1] to [7], wherein the control unit determines the culture conditions using a set threshold value.
[9]
The information processing device according to [8], which visualizes cell culture conditions that do not satisfy the threshold value.
[10]
The information processing device according to [8], which uses the threshold value to present culture conditions suitable for a mode set by the user.
[11]
The mode is any one of a survival priority mode that prioritizes cell survival rate, a proliferation priority mode that prioritizes cell proliferation rate, a ratio priority mode that prioritizes cell proportion, or a purity priority mode that prioritizes cell purity. 10].
[12]
The information processing according to [10] or [11], wherein the control unit considers any one or more parameters selected from the group consisting of culture cost, number of culture days, and complexity of the culture process in the presentation. Device.
[13]
The information processing device according to [2], wherein the control unit performs the illustration in chronological order.
[14]
The information processing device according to any one of [1] to [13], further comprising an input unit for operating the visualized culture prediction results.
[15]
The information processing device according to [14], wherein the input unit selects culture conditions to be executed.
[16]
The information processing device according to [15], wherein the control unit controls culture conditions based on the culture conditions selected by the input unit.
[17]
It has a control process that predicts multiple culture prediction results for each culture condition of a cell group containing different cells,
In the control step, the information processing method is controlled to visualize the cultured cell composition and cell proliferation process as the culture prediction result.
[18]
A cell culture device having a cell culture section for culturing cell groups containing different cells, and a measurement section for measuring the cell composition and cell growth process of the cell group;
The control unit includes a control unit that predicts a plurality of culture prediction results for each culture condition of a cell group containing different cells, and the control unit controls so as to visualize the cultured cell composition and cell growth process as the culture prediction result. an information processing device;
A cell culture system with
[19]
A process including a step of predicting a plurality of culture prediction results for each culture condition of a cell group containing different cells, and controlling the cultured cell composition and cell growth process to be visualized as the culture prediction results is performed on a computer. A program to be executed.

1:細胞培養装置
2:情報処理装置
3:測定部
10:細胞培養部
100:試料保持部
200:細胞培養部用制御部
300:制御部
301:入力部
302:記憶部
303:出力部
304:表示部
400:学習部
500:データベース
600:画像取得部
1000:細胞培養システム
5000:顕微鏡システム
6100:生体試料分析装置
  
1: Cell culture device 2: Information processing device 3: Measurement section 10: Cell culture section 100: Sample holding section 200: Cell culture section control section 300: Control section 301: Input section 302: Storage section 303: Output section 304: Display unit 400: Learning unit 500: Database 600: Image acquisition unit 1000: Cell culture system 5000: Microscope system 6100: Biological sample analyzer

Claims (19)

 異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測する制御部を有し、
 前記制御部は、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御する、情報処理装置。
It has a control unit that predicts multiple culture prediction results for each culture condition of a cell group containing different cells,
The control unit is an information processing device that performs control to visualize the cultured cell composition and cell proliferation process as the culture prediction result.
 前記可視化は、前記培養予測結果を図示することにより行われる、請求項1に記載の情報処理装置。 The information processing device according to claim 1, wherein the visualization is performed by illustrating the culture prediction results.  前記図示は、線分及び/又は前記線分の端点により行われる、請求項2に記載の情報処理装置。 The information processing device according to claim 2, wherein the illustration is performed using a line segment and/or an end point of the line segment.  前記細胞構成は、細胞数、又は細胞割合である、請求項1に記載の情報処理装置。 The information processing device according to claim 1, wherein the cell composition is a cell number or a cell ratio.  前記細胞の増殖過程は、細胞増殖率、又は細胞生存率である、請求項1に記載の情報処理装置。 The information processing device according to claim 1, wherein the cell proliferation process is a cell proliferation rate or a cell survival rate.  前記線分は、線分の長さ、線分の種類、線分の太さ、及び線分の色からなる群より選ばれるいずれか1つ以上を用いて、前記細胞の増殖過程を可視化する、請求項3に記載の情報処理装置。 The line segment is used to visualize the cell proliferation process using any one or more selected from the group consisting of line segment length, line segment type, line segment thickness, and line segment color. , the information processing device according to claim 3.  前記線分の端点は、端点の大きさ、端点の形状、端点の種類、及び端点の色からなる群より選ばれるいずれか1つ以上を用いて、前記細胞構成を可視化する、請求項3に記載の情報処理装置。 4. The cell configuration is visualized using one or more of the endpoints of the line segments selected from the group consisting of the size of the endpoint, the shape of the endpoint, the type of the endpoint, and the color of the endpoint. The information processing device described.  前記制御部は、設定された閾値を用いて、前記培養条件を判定する、請求項1に記載の情報処理装置。 The information processing device according to claim 1, wherein the control unit determines the culture conditions using a set threshold value.  前記閾値を満たさない培養条件を可視化する、請求項8に記載の情報処理装置。 The information processing device according to claim 8, which visualizes culture conditions that do not satisfy the threshold value.  前記閾値を用いて、ユーザが設定したモードに適する培養条件を提示する、請求項8に記載の情報処理装置。 The information processing device according to claim 8, which uses the threshold value to present culture conditions suitable for a mode set by the user.  前記モードは、細胞生存率を優先する生存優先モード、細胞増殖率を優先する増殖優先モード、細胞割合を優先する割合優先モード、又は細胞の純度を優先する純度優先モードのいずれかである、請求項10に記載の情報処理装置。 The mode is any one of a survival priority mode that prioritizes cell survival rate, a proliferation priority mode that prioritizes cell proliferation rate, a ratio priority mode that prioritizes cell proportion, or a purity priority mode that prioritizes cell purity. Item 10. Information processing device according to item 10.  前記制御部は、前記提示において、刺激因子、培養日数、培養試薬の種類、培養試薬数、培養工程数、培養工程の煩雑さ、及び培養コストからなる群より選ばれるいずれか1つ以上のパラメータを考慮する、請求項10に記載の情報処理装置。 In the presentation, the control unit selects one or more parameters selected from the group consisting of stimulation factor, number of culture days, type of culture reagent, number of culture reagents, number of culture steps, complexity of culture step, and culture cost. The information processing device according to claim 10, which takes into account.  前記制御部は、時系列に沿って前記図示を行う、請求項2に記載の情報処理装置。 The information processing device according to claim 2, wherein the control unit performs the illustration in chronological order.  前記可視化された培養予測結果を操作する入力部を更に有する、請求項1に記載の情報処理装置。 The information processing device according to claim 1, further comprising an input unit for operating the visualized culture prediction result.  前記入力部は、実行する培養条件を選択する、請求項14に記載の情報処理装置。 The information processing device according to claim 14, wherein the input unit selects culture conditions to be executed.  前記制御部は、前記入力部で選択された培養条件に基づいて培養条件の制御を行う、請求項15に記載の情報処理装置。 The information processing device according to claim 15, wherein the control unit controls culture conditions based on the culture conditions selected by the input unit.  異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測する制御工程を有し、
 前記制御工程では、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御する、情報処理方法。
It has a control process that predicts multiple culture prediction results for each culture condition of a cell group containing different cells,
In the control step, the information processing method is controlled to visualize the cultured cell composition and cell proliferation process as the culture prediction result.
 異なる細胞を含む細胞群を培養する細胞培養部と、前記細胞群の細胞構成及び細胞の増殖過程を測定する測定部と、を有する細胞培養装置と、
 異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測する制御部を有し、前記制御部は、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御する、情報処理装置と、
を有する、細胞培養システム。
A cell culture device having a cell culture section for culturing cell groups containing different cells, and a measurement section for measuring the cell composition and cell growth process of the cell group;
The control unit includes a control unit that predicts a plurality of culture prediction results for each culture condition of a cell group containing different cells, and the control unit controls so as to visualize the cultured cell composition and cell growth process as the culture prediction result. an information processing device;
A cell culture system with
 異なる細胞を含む細胞群の培養条件ごとに複数の培養予測結果を予測し、且つ、前記培養予測結果として培養された細胞構成及び細胞の増殖過程を可視化するよう制御するステップを含む処理をコンピュータに実行させる、プログラム。
  
A process including a step of predicting a plurality of culture prediction results for each culture condition of a cell group containing different cells, and controlling the cultured cell composition and cell growth process to be visualized as the culture prediction results is performed on a computer. A program to be executed.
PCT/JP2023/008548 2022-03-31 2023-03-07 Information processing apparatus, information processing method, cell culturing system, and program Ceased WO2023189281A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022059421 2022-03-31
JP2022-059421 2022-03-31

Publications (1)

Publication Number Publication Date
WO2023189281A1 true WO2023189281A1 (en) 2023-10-05

Family

ID=88201354

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2023/008548 Ceased WO2023189281A1 (en) 2022-03-31 2023-03-07 Information processing apparatus, information processing method, cell culturing system, and program

Country Status (1)

Country Link
WO (1) WO2023189281A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013145283A1 (en) * 2012-03-30 2013-10-03 株式会社日立製作所 Cell culture device, control device, and method
JP2019041656A (en) * 2017-08-31 2019-03-22 株式会社Ihi Culture support device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013145283A1 (en) * 2012-03-30 2013-10-03 株式会社日立製作所 Cell culture device, control device, and method
JP2019041656A (en) * 2017-08-31 2019-03-22 株式会社Ihi Culture support device

Similar Documents

Publication Publication Date Title
US12020492B2 (en) Cell analysis method, cell analysis device, and cell analysis system
JP5328663B2 (en) Apparatus and method for analyzing biological samples
JP5307539B2 (en) Biological sample imaging method and biological sample imaging apparatus
US10105712B2 (en) Methods and devices for sorting cells and other biological particulates
JP7500560B2 (en) Device and method for microdroplet detection of cells
JP2020511126A (en) Method and system for studying biological cells
US10545091B2 (en) Device and method for analyzing biological objects with Raman spectroscopy
CN106520537B (en) A kind of the micro-fluidic optical analysis system and analysis method of T cell immune response
CN102834718A (en) Systems and methods for counting cells and biomolecules
JP5289064B2 (en) Apparatus and method for imaging and modification of biological samples
CN109690294A (en) Device and method for measuring transfection
US20230174970A1 (en) Spatial multiomics and live biology with continuous imaging
CN114585904A (en) Method for collecting microparticles, microchip for sorting microparticles, device for collecting microparticles, method for preparing emulsion, and emulsion
JP6629429B2 (en) Cell analysis system
JP6965874B2 (en) Cell culture method
US20240301342A1 (en) Cell treatment system, cell treatment method, and learning data creation method
EP3646010A1 (en) Quantitative liquid biopsy diagnostic system and methods
JP7683329B2 (en) Information processing device, biological sample analysis method, biological sample detection device, and biological sample detection system
WO2023189281A1 (en) Information processing apparatus, information processing method, cell culturing system, and program
CN118451311A (en) System and method for precise manufacturing of biomaterial-encapsulated cell clusters
KR102097566B1 (en) Method and apparatus for selecting and separating of biospecimen
WO2024203378A1 (en) Cell treatment system, cell treatment method, and learning device
KR102681568B1 (en) Method for Circulating tumor cell detection using cell culture in microfluidic chip and low magnification image analysis
US20250271415A1 (en) Bioparticle analysis system, information processing device, and bioparticle analysis method
CN118891355A (en) Information processing device, information processing method, and program

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23779308

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 23779308

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP